000003604712/312020Q2FALSEP1Y311—00000360472020-01-012020-09-300000036047us-gaap:CommonStockMember2020-01-012020-09-300000036047us-gaap:PreferredStockMember2020-01-012020-09-30xbrli:shares00000360472020-10-28iso4217:USD00000360472020-09-3000000360472019-12-31iso4217:USDxbrli:shares00000360472020-07-012020-09-3000000360472019-07-012019-09-3000000360472019-01-012019-09-3000000360472018-12-3100000360472019-09-300000036047us-gaap:CommonStockMember2020-06-300000036047us-gaap:AdditionalPaidInCapitalMember2020-06-300000036047us-gaap:RetainedEarningsMember2020-06-300000036047us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-3000000360472020-06-300000036047us-gaap:RetainedEarningsMember2020-07-012020-09-300000036047us-gaap:CommonStockMember2020-07-012020-09-300000036047us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300000036047us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300000036047us-gaap:CommonStockMember2020-09-300000036047us-gaap:AdditionalPaidInCapitalMember2020-09-300000036047us-gaap:RetainedEarningsMember2020-09-300000036047us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-300000036047us-gaap:CommonStockMember2019-06-300000036047us-gaap:AdditionalPaidInCapitalMember2019-06-300000036047us-gaap:RetainedEarningsMember2019-06-300000036047us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-3000000360472019-06-300000036047us-gaap:RetainedEarningsMember2019-07-012019-09-300000036047us-gaap:CommonStockMember2019-07-012019-09-300000036047us-gaap:AdditionalPaidInCapitalMember2019-07-012019-09-300000036047us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-07-012019-09-300000036047us-gaap:CommonStockMember2019-09-300000036047us-gaap:AdditionalPaidInCapitalMember2019-09-300000036047us-gaap:RetainedEarningsMember2019-09-300000036047us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-300000036047us-gaap:CommonStockMember2019-12-310000036047us-gaap:AdditionalPaidInCapitalMember2019-12-310000036047us-gaap:RetainedEarningsMember2019-12-310000036047us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000036047us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310000036047srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310000036047us-gaap:RetainedEarningsMember2020-01-012020-09-300000036047us-gaap:CommonStockMember2020-01-012020-09-300000036047us-gaap:AdditionalPaidInCapitalMember2020-01-012020-09-300000036047us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-09-300000036047us-gaap:CommonStockMember2018-12-310000036047us-gaap:AdditionalPaidInCapitalMember2018-12-310000036047us-gaap:RetainedEarningsMember2018-12-310000036047us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310000036047us-gaap:RetainedEarningsMember2019-01-012019-09-300000036047us-gaap:CommonStockMember2019-01-012019-09-300000036047us-gaap:AdditionalPaidInCapitalMember2019-01-012019-09-300000036047us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-09-300000036047clgx:SenatorInvestmentGroupLPAndCannaeHoldingsIncMember2020-06-260000036047clgx:SenatorInvestmentGroupLPAndCannaeHoldingsIncMember2020-09-14clgx:director0000036047clgx:SenatorInvestmentGroupLPAndCannaeHoldingsIncMember2020-08-090000036047clgx:SenatorInvestmentGroupLPAndCannaeHoldingsIncMember2020-01-012020-09-30xbrli:pure0000036047us-gaap:SalesRevenueNetMemberclgx:TenLargestClientsMemberus-gaap:CustomerConcentrationRiskMember2020-07-012020-09-300000036047us-gaap:SalesRevenueNetMemberclgx:TenLargestClientsMemberus-gaap:CustomerConcentrationRiskMember2019-07-012019-09-300000036047us-gaap:SalesRevenueNetMemberclgx:TenLargestClientsMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-09-300000036047us-gaap:SalesRevenueNetMemberclgx:TenLargestClientsMemberus-gaap:CustomerConcentrationRiskMember2019-01-012019-09-3000000360472019-01-012019-12-310000036047clgx:ComplianceEaseMember2020-07-012020-09-300000036047clgx:LocationIncMember2020-01-310000036047clgx:LocationIncMember2020-01-012020-01-310000036047clgx:PIRMSegmentMemberclgx:LocationIncMember2020-01-310000036047clgx:PIRMSegmentMemberclgx:LocationIncMember2020-01-012020-01-310000036047clgx:LocationIncMember2020-01-012020-03-3100000360472020-07-3100000360472020-07-012020-07-310000036047us-gaap:SubsequentEventMember2020-10-012020-10-31clgx:business_day0000036047srt:MinimumMember2020-01-012020-09-300000036047srt:MaximumMember2020-01-012020-09-300000036047us-gaap:AccountsPayableAndAccruedLiabilitiesMember2020-09-300000036047us-gaap:AccountsPayableAndAccruedLiabilitiesMember2019-12-3100000360472020-01-010000036047us-gaap:LandMember2020-09-300000036047us-gaap:LandMember2019-12-310000036047us-gaap:BuildingMember2020-09-300000036047us-gaap:BuildingMember2019-12-310000036047clgx:FurnitureAndEquipmentMember2020-09-300000036047clgx:FurnitureAndEquipmentMember2019-12-310000036047us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2020-09-300000036047us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2019-12-310000036047us-gaap:LeaseholdImprovementsMember2020-09-300000036047us-gaap:LeaseholdImprovementsMember2019-12-310000036047us-gaap:ConstructionInProgressMember2020-09-300000036047us-gaap:ConstructionInProgressMember2019-12-310000036047clgx:PIRMSegmentMember2019-12-310000036047clgx:UWSSegmentMember2019-12-310000036047clgx:PIRMSegmentMember2020-01-012020-09-300000036047clgx:UWSSegmentMember2020-01-012020-09-300000036047clgx:PIRMSegmentMember2020-09-300000036047clgx:UWSSegmentMember2020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:PIRMSegmentMember2020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:UWSSegmentMember2020-09-300000036047us-gaap:CustomerListsMember2020-09-300000036047us-gaap:CustomerListsMember2019-12-310000036047us-gaap:NoncompeteAgreementsMember2020-09-300000036047us-gaap:NoncompeteAgreementsMember2019-12-310000036047us-gaap:TradeNamesMember2020-09-300000036047us-gaap:TradeNamesMember2019-12-310000036047clgx:TermLoanFacilityMemberclgx:TermLoanDueMay2024Member2020-09-300000036047clgx:TermLoanFacilityMemberclgx:TermLoanDueMay2024Member2019-12-310000036047us-gaap:RevolvingCreditFacilityMemberclgx:LineofCreditDueMay2024Member2020-09-300000036047us-gaap:RevolvingCreditFacilityMemberclgx:LineofCreditDueMay2024Member2019-12-310000036047clgx:SeniorDebenturesApril2028Memberus-gaap:SeniorNotesMember1998-04-300000036047clgx:SeniorDebenturesApril2028Memberus-gaap:SeniorNotesMember2020-09-300000036047clgx:SeniorDebenturesApril2028Memberus-gaap:SeniorNotesMember2019-12-310000036047clgx:VariousInterestRateLoansMemberus-gaap:NotesPayableOtherPayablesMember2020-09-300000036047clgx:VariousInterestRateLoansMemberus-gaap:NotesPayableOtherPayablesMember2019-12-310000036047clgx:TermLoanFacilityMemberclgx:TermLoanA1DueMay2024Member2019-05-310000036047clgx:TermLoanFacilityMemberclgx:TermLoanA1DueMay2024Member2019-05-012019-05-310000036047clgx:LineofCreditDueMay2024Memberus-gaap:RevolvingCreditFacilityMember2019-05-310000036047clgx:LineofCreditDueMay2024Memberus-gaap:RevolvingCreditFacilityMember2019-05-012019-05-310000036047us-gaap:RevolvingCreditFacilityMemberclgx:LineofCreditDueMay2024Member2019-05-310000036047us-gaap:LetterOfCreditMemberclgx:LineofCreditDueMay2024Member2019-05-3100000360472019-05-310000036047clgx:LineofCreditDueMay2024Memberus-gaap:RevolvingCreditFacilityMember2020-09-3000000360472019-10-012019-12-310000036047us-gaap:InterestRateSwapMember2020-09-300000036047us-gaap:InterestRateSwapMembersrt:MinimumMember2020-09-300000036047us-gaap:InterestRateSwapMembersrt:MaximumMember2020-09-300000036047us-gaap:InterestRateSwapMembersrt:ScenarioForecastMember2021-09-300000036047us-gaap:InterestRateSwapMembersrt:ScenarioForecastMember2021-10-010000036047us-gaap:InterestRateSwapMembersrt:ScenarioForecastMember2022-08-310000036047us-gaap:InterestRateSwapMembersrt:ScenarioForecastMember2022-09-010000036047us-gaap:InterestRateSwapMembersrt:ScenarioForecastMember2025-12-310000036047us-gaap:InterestRateSwapMembersrt:ScenarioForecastMember2022-03-310000036047us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2020-09-300000036047us-gaap:InterestRateSwapMember2019-12-310000036047us-gaap:SwapMember2020-07-012020-09-300000036047us-gaap:SwapMember2019-07-012019-09-300000036047us-gaap:SwapMember2020-01-012020-09-300000036047us-gaap:SwapMember2019-01-012019-09-300000036047us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-09-300000036047us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-09-300000036047us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-09-300000036047us-gaap:FairValueMeasurementsRecurringMember2020-09-300000036047us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-09-300000036047us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-09-300000036047us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-09-300000036047us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2020-09-300000036047us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310000036047us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310000036047us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310000036047us-gaap:FairValueMeasurementsRecurringMember2019-12-310000036047us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310000036047us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310000036047us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310000036047us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310000036047clgx:UWSSegmentMemberus-gaap:PropertyPlantAndEquipmentMember2020-01-012020-09-300000036047clgx:UWSSegmentMemberus-gaap:PropertyPlantAndEquipmentMember2019-01-012019-09-300000036047clgx:UWSSegmentMemberus-gaap:PropertyPlantAndEquipmentMember2019-07-012019-09-300000036047us-gaap:CustomerListsMember2019-01-012019-09-300000036047us-gaap:LicenseMember2019-01-012019-09-300000036047clgx:NationalTaxSearchLLCMembersrt:MaximumMember2019-08-060000036047srt:MaximumMemberclgx:MyriadDevelopmentInc.InsignificantAcquisitionMember2017-12-310000036047clgx:MyriadDevelopmentInc.InsignificantAcquisitionMember2017-12-310000036047us-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMemberclgx:PropertyInsightsMember2020-07-012020-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:PropertyInsightsMember2020-07-012020-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:PropertyInsightsMember2020-07-012020-09-300000036047clgx:PropertyInsightsMember2020-07-012020-09-300000036047us-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMemberclgx:InsuranceAndSpatialSolutionsMember2020-07-012020-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:InsuranceAndSpatialSolutionsMember2020-07-012020-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:InsuranceAndSpatialSolutionsMember2020-07-012020-09-300000036047clgx:InsuranceAndSpatialSolutionsMember2020-07-012020-09-300000036047us-gaap:OperatingSegmentsMemberclgx:FloodDataServicesMemberclgx:PIRMSegmentMember2020-07-012020-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:FloodDataServicesMember2020-07-012020-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:FloodDataServicesMember2020-07-012020-09-300000036047clgx:FloodDataServicesMember2020-07-012020-09-300000036047us-gaap:OperatingSegmentsMemberclgx:ValuationsSolutionsMemberclgx:PIRMSegmentMember2020-07-012020-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:ValuationsSolutionsMember2020-07-012020-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:ValuationsSolutionsMember2020-07-012020-09-300000036047clgx:ValuationsSolutionsMember2020-07-012020-09-300000036047clgx:PropertyTaxSolutionsMemberus-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMember2020-07-012020-09-300000036047clgx:UWSSegmentMemberclgx:PropertyTaxSolutionsMemberus-gaap:OperatingSegmentsMember2020-07-012020-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:PropertyTaxSolutionsMember2020-07-012020-09-300000036047clgx:PropertyTaxSolutionsMember2020-07-012020-09-300000036047clgx:OtherSolutionsMemberus-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMember2020-07-012020-09-300000036047clgx:UWSSegmentMemberclgx:OtherSolutionsMemberus-gaap:OperatingSegmentsMember2020-07-012020-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:OtherSolutionsMember2020-07-012020-09-300000036047clgx:OtherSolutionsMember2020-07-012020-09-300000036047us-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMember2020-07-012020-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMember2020-07-012020-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMember2020-07-012020-09-300000036047us-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMemberclgx:PropertyInsightsMember2019-07-012019-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:PropertyInsightsMember2019-07-012019-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:PropertyInsightsMember2019-07-012019-09-300000036047clgx:PropertyInsightsMember2019-07-012019-09-300000036047us-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMemberclgx:InsuranceAndSpatialSolutionsMember2019-07-012019-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:InsuranceAndSpatialSolutionsMember2019-07-012019-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:InsuranceAndSpatialSolutionsMember2019-07-012019-09-300000036047clgx:InsuranceAndSpatialSolutionsMember2019-07-012019-09-300000036047us-gaap:OperatingSegmentsMemberclgx:FloodDataServicesMemberclgx:PIRMSegmentMember2019-07-012019-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:FloodDataServicesMember2019-07-012019-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:FloodDataServicesMember2019-07-012019-09-300000036047clgx:FloodDataServicesMember2019-07-012019-09-300000036047us-gaap:OperatingSegmentsMemberclgx:ValuationsSolutionsMemberclgx:PIRMSegmentMember2019-07-012019-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:ValuationsSolutionsMember2019-07-012019-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:ValuationsSolutionsMember2019-07-012019-09-300000036047clgx:ValuationsSolutionsMember2019-07-012019-09-300000036047clgx:PropertyTaxSolutionsMemberus-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMember2019-07-012019-09-300000036047clgx:UWSSegmentMemberclgx:PropertyTaxSolutionsMemberus-gaap:OperatingSegmentsMember2019-07-012019-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:PropertyTaxSolutionsMember2019-07-012019-09-300000036047clgx:PropertyTaxSolutionsMember2019-07-012019-09-300000036047clgx:OtherSolutionsMemberus-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMember2019-07-012019-09-300000036047clgx:UWSSegmentMemberclgx:OtherSolutionsMemberus-gaap:OperatingSegmentsMember2019-07-012019-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:OtherSolutionsMember2019-07-012019-09-300000036047clgx:OtherSolutionsMember2019-07-012019-09-300000036047us-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMember2019-07-012019-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMember2019-07-012019-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMember2019-07-012019-09-300000036047us-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMemberclgx:PropertyInsightsMember2020-01-012020-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:PropertyInsightsMember2020-01-012020-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:PropertyInsightsMember2020-01-012020-09-300000036047clgx:PropertyInsightsMember2020-01-012020-09-300000036047us-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMemberclgx:InsuranceAndSpatialSolutionsMember2020-01-012020-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:InsuranceAndSpatialSolutionsMember2020-01-012020-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:InsuranceAndSpatialSolutionsMember2020-01-012020-09-300000036047clgx:InsuranceAndSpatialSolutionsMember2020-01-012020-09-300000036047us-gaap:OperatingSegmentsMemberclgx:FloodDataServicesMemberclgx:PIRMSegmentMember2020-01-012020-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:FloodDataServicesMember2020-01-012020-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:FloodDataServicesMember2020-01-012020-09-300000036047clgx:FloodDataServicesMember2020-01-012020-09-300000036047us-gaap:OperatingSegmentsMemberclgx:ValuationsSolutionsMemberclgx:PIRMSegmentMember2020-01-012020-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:ValuationsSolutionsMember2020-01-012020-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:ValuationsSolutionsMember2020-01-012020-09-300000036047clgx:ValuationsSolutionsMember2020-01-012020-09-300000036047clgx:PropertyTaxSolutionsMemberus-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMember2020-01-012020-09-300000036047clgx:UWSSegmentMemberclgx:PropertyTaxSolutionsMemberus-gaap:OperatingSegmentsMember2020-01-012020-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:PropertyTaxSolutionsMember2020-01-012020-09-300000036047clgx:PropertyTaxSolutionsMember2020-01-012020-09-300000036047clgx:OtherSolutionsMemberus-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMember2020-01-012020-09-300000036047clgx:UWSSegmentMemberclgx:OtherSolutionsMemberus-gaap:OperatingSegmentsMember2020-01-012020-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:OtherSolutionsMember2020-01-012020-09-300000036047clgx:OtherSolutionsMember2020-01-012020-09-300000036047us-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMember2020-01-012020-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMember2020-01-012020-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMember2020-01-012020-09-300000036047us-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMemberclgx:PropertyInsightsMember2019-01-012019-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:PropertyInsightsMember2019-01-012019-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:PropertyInsightsMember2019-01-012019-09-300000036047clgx:PropertyInsightsMember2019-01-012019-09-300000036047us-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMemberclgx:InsuranceAndSpatialSolutionsMember2019-01-012019-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:InsuranceAndSpatialSolutionsMember2019-01-012019-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:InsuranceAndSpatialSolutionsMember2019-01-012019-09-300000036047clgx:InsuranceAndSpatialSolutionsMember2019-01-012019-09-300000036047us-gaap:OperatingSegmentsMemberclgx:FloodDataServicesMemberclgx:PIRMSegmentMember2019-01-012019-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:FloodDataServicesMember2019-01-012019-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:FloodDataServicesMember2019-01-012019-09-300000036047clgx:FloodDataServicesMember2019-01-012019-09-300000036047us-gaap:OperatingSegmentsMemberclgx:ValuationsSolutionsMemberclgx:PIRMSegmentMember2019-01-012019-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMemberclgx:ValuationsSolutionsMember2019-01-012019-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:ValuationsSolutionsMember2019-01-012019-09-300000036047clgx:ValuationsSolutionsMember2019-01-012019-09-300000036047clgx:PropertyTaxSolutionsMemberus-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMember2019-01-012019-09-300000036047clgx:UWSSegmentMemberclgx:PropertyTaxSolutionsMemberus-gaap:OperatingSegmentsMember2019-01-012019-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:PropertyTaxSolutionsMember2019-01-012019-09-300000036047clgx:PropertyTaxSolutionsMember2019-01-012019-09-300000036047clgx:OtherSolutionsMemberus-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMember2019-01-012019-09-300000036047clgx:UWSSegmentMemberclgx:OtherSolutionsMemberus-gaap:OperatingSegmentsMember2019-01-012019-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMemberclgx:OtherSolutionsMember2019-01-012019-09-300000036047clgx:OtherSolutionsMember2019-01-012019-09-300000036047us-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMember2019-01-012019-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMember2019-01-012019-09-300000036047clgx:CorporateReconcilingItemsAndEliminationsMember2019-01-012019-09-300000036047us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2020-09-300000036047us-gaap:OtherNoncurrentAssetsMember2020-09-300000036047us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2019-12-310000036047us-gaap:OtherNoncurrentAssetsMember2019-12-3100000360472020-10-012020-09-3000000360472021-01-012020-09-3000000360472022-01-012020-09-3000000360472023-01-012020-09-300000036047clgx:CoreLogic2018PerformanceIncentivePlanMember2018-05-310000036047us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-09-300000036047us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-09-300000036047us-gaap:RestrictedStockUnitsRSUMember2019-12-310000036047us-gaap:RestrictedStockUnitsRSUMember2020-09-300000036047clgx:PbrsuMember2020-01-012020-09-300000036047clgx:PbrsuMember2019-01-012019-09-300000036047clgx:PbrsuMember2019-12-310000036047clgx:PbrsuMember2020-09-300000036047us-gaap:EmployeeStockOptionMember2019-12-310000036047us-gaap:EmployeeStockOptionMember2020-01-012020-09-300000036047us-gaap:EmployeeStockOptionMember2020-09-300000036047us-gaap:EmployeeStockOptionMember2019-01-012019-09-300000036047us-gaap:RestrictedStockUnitsRSUMember2020-07-012020-09-300000036047us-gaap:RestrictedStockUnitsRSUMember2019-07-012019-09-300000036047clgx:PbrsuMember2020-07-012020-09-300000036047clgx:PbrsuMember2019-07-012019-09-300000036047us-gaap:EmployeeStockOptionMember2020-07-012020-09-300000036047us-gaap:EmployeeStockOptionMember2019-07-012019-09-300000036047us-gaap:EmployeeStockMember2020-07-012020-09-300000036047us-gaap:EmployeeStockMember2019-07-012019-09-300000036047us-gaap:EmployeeStockMember2020-01-012020-09-300000036047us-gaap:EmployeeStockMember2019-01-012019-09-300000036047clgx:CostOfServicesMember2020-07-012020-09-300000036047clgx:CostOfServicesMember2019-07-012019-09-300000036047clgx:CostOfServicesMember2020-01-012020-09-300000036047clgx:CostOfServicesMember2019-01-012019-09-300000036047clgx:IncomeLossFromDiscontinuedOperationsNetMember2019-07-012019-09-300000036047clgx:IncomeLossFromDiscontinuedOperationsNetMember2020-07-012020-09-300000036047clgx:IncomeLossFromDiscontinuedOperationsNetMember2019-01-012019-09-300000036047clgx:IncomeLossFromDiscontinuedOperationsNetMember2020-01-012020-09-30clgx:consumer0000036047clgx:FairCreditReportingActClassActionMember2019-07-292019-07-290000036047us-gaap:DomesticCountryMemberus-gaap:InternalRevenueServiceIRSMemberclgx:TaxYears2010To2012Member2020-09-300000036047us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-09-300000036047clgx:PbrsuMember2019-01-012019-09-300000036047clgx:PbrsuMember2020-01-012020-09-300000036047clgx:PbrsuMember2019-07-012019-09-300000036047us-gaap:RestrictedStockUnitsRSUMember2020-07-012020-09-300000036047us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-09-300000036047clgx:PbrsuMember2020-07-012020-09-300000036047us-gaap:RestrictedStockUnitsRSUMember2019-07-012019-09-300000036047us-gaap:TechnologyBasedIntangibleAssetsMemberclgx:PIRMSegmentMemberclgx:LocationIncMember2020-01-310000036047us-gaap:TechnologyBasedIntangibleAssetsMemberclgx:PIRMSegmentMemberclgx:LocationIncMember2020-01-012020-01-310000036047clgx:PIRMSegmentMemberus-gaap:CustomerListsMemberclgx:LocationIncMember2020-01-310000036047clgx:PIRMSegmentMemberus-gaap:CustomerListsMemberclgx:LocationIncMember2020-01-012020-01-310000036047clgx:PIRMSegmentMemberclgx:LocationIncMemberus-gaap:TrademarksMember2020-01-310000036047clgx:PIRMSegmentMemberclgx:LocationIncMemberus-gaap:TrademarksMember2020-01-012020-01-310000036047us-gaap:NoncompeteAgreementsMemberclgx:PIRMSegmentMemberclgx:LocationIncMember2020-01-310000036047us-gaap:NoncompeteAgreementsMemberclgx:PIRMSegmentMemberclgx:LocationIncMember2020-01-012020-01-310000036047clgx:NationalTaxSearchLLCMember2019-08-012019-08-310000036047clgx:NationalTaxSearchLLCMemberclgx:UWSSegmentMemberus-gaap:CustomerListsMember2019-08-310000036047clgx:NationalTaxSearchLLCMemberclgx:UWSSegmentMemberus-gaap:CustomerListsMember2019-08-012019-08-310000036047clgx:NationalTaxSearchLLCMemberclgx:UWSSegmentMemberus-gaap:TechnologyBasedIntangibleAssetsMember2019-08-310000036047clgx:NationalTaxSearchLLCMemberclgx:UWSSegmentMemberus-gaap:TechnologyBasedIntangibleAssetsMember2019-08-012019-08-310000036047clgx:NationalTaxSearchLLCMemberclgx:UWSSegmentMemberus-gaap:TrademarksMember2019-08-310000036047clgx:NationalTaxSearchLLCMemberclgx:UWSSegmentMemberus-gaap:TrademarksMember2019-08-012019-08-310000036047clgx:NationalTaxSearchLLCMemberclgx:UWSSegmentMemberus-gaap:NoncompeteAgreementsMember2019-08-310000036047clgx:NationalTaxSearchLLCMemberclgx:UWSSegmentMemberus-gaap:NoncompeteAgreementsMember2019-08-012019-08-310000036047clgx:NationalTaxSearchLLCMemberclgx:UWSSegmentMember2019-08-310000036047clgx:NationalTaxSearchLLCMemberclgx:UWSSegmentMember2020-01-012020-09-30clgx:segment0000036047clgx:PIRMSegmentMember2020-07-012020-09-300000036047clgx:PIRMSegmentMember2019-07-012019-09-300000036047clgx:PIRMSegmentMember2019-01-012019-09-300000036047clgx:UWSSegmentMember2020-07-012020-09-300000036047clgx:UWSSegmentMember2019-07-012019-09-300000036047clgx:UWSSegmentMember2019-01-012019-09-300000036047us-gaap:CorporateNonSegmentMember2020-07-012020-09-300000036047us-gaap:CorporateNonSegmentMember2020-01-012020-09-300000036047us-gaap:CorporateNonSegmentMember2019-07-012019-09-300000036047us-gaap:CorporateNonSegmentMember2019-01-012019-09-300000036047us-gaap:CorporateNonSegmentMember2020-07-012020-09-300000036047us-gaap:IntersegmentEliminationMember2020-07-012020-09-300000036047us-gaap:CorporateNonSegmentMember2019-07-012019-09-300000036047us-gaap:IntersegmentEliminationMember2019-07-012019-09-300000036047us-gaap:CorporateNonSegmentMember2020-01-012020-09-300000036047us-gaap:IntersegmentEliminationMember2020-01-012020-09-300000036047us-gaap:CorporateNonSegmentMember2019-01-012019-09-300000036047us-gaap:IntersegmentEliminationMember2019-01-012019-09-300000036047us-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMember2020-09-300000036047us-gaap:OperatingSegmentsMemberclgx:PIRMSegmentMember2019-12-310000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMember2020-09-300000036047clgx:UWSSegmentMemberus-gaap:OperatingSegmentsMember2019-12-310000036047us-gaap:CorporateNonSegmentMember2020-09-300000036047us-gaap:CorporateNonSegmentMember2019-12-310000036047us-gaap:IntersegmentEliminationMember2020-09-300000036047us-gaap:IntersegmentEliminationMember2019-12-310000036047us-gaap:DiscontinuedOperationsHeldforsaleMemberclgx:CreditSolutionsAndRealPropertySolutionsMember2020-07-012020-09-300000036047us-gaap:DiscontinuedOperationsHeldforsaleMemberclgx:CreditSolutionsAndRealPropertySolutionsMember2020-01-012020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:EmployerAndLitigationServicesSegmentMember2019-12-012019-12-310000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberus-gaap:SubsequentEventMemberclgx:CreditSolutionsAndRealPropertySolutionsMember2020-10-310000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:EmployerAndLitigationServicesSegmentMember2020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:AssetManagementAndProcessingSolutionsSegmentMember2020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:PIRMSegmentMember2019-12-310000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:UWSSegmentMember2019-12-310000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:EmployerAndLitigationServicesSegmentMember2019-12-310000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:AssetManagementAndProcessingSolutionsSegmentMember2019-12-310000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2019-12-310000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:PIRMSegmentMember2020-07-012020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:UWSSegmentMember2020-07-012020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:EmployerAndLitigationServicesSegmentMember2020-07-012020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:AssetManagementAndProcessingSolutionsSegmentMember2020-07-012020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2020-07-012020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:PIRMSegmentMember2019-07-012019-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:UWSSegmentMember2019-07-012019-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:EmployerAndLitigationServicesSegmentMember2019-07-012019-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:AssetManagementAndProcessingSolutionsSegmentMember2019-07-012019-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2019-07-012019-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:PIRMSegmentMember2020-01-012020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:UWSSegmentMember2020-01-012020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:EmployerAndLitigationServicesSegmentMember2020-01-012020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:AssetManagementAndProcessingSolutionsSegmentMember2020-01-012020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2020-01-012020-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:PIRMSegmentMember2019-01-012019-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:UWSSegmentMember2019-01-012019-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:EmployerAndLitigationServicesSegmentMember2019-01-012019-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberclgx:AssetManagementAndProcessingSolutionsSegmentMember2019-01-012019-09-300000036047us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2019-01-012019-09-30


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
  
          QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020

OR

           TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to

Commission file number 001-13585
CLGX-20200930_G1.JPG
CORELOGIC, INC.
(Exact name of registrant as specified in its charter)
 
Delaware 95-1068610
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
 
40 Pacifica Irvine California 92618
(Street Address) (City) (State) (Zip Code)
 
(949) 214-1000
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class: Trading symbol(s) Name of exchange on which registered
Common Stock, $0.00001 par value CLGX New York Stock Exchange
Preferred Stock Purchase Rights CLGX New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No   
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes       No   
 
Indicate by check mark whether the registrant: is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes      No   

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

On October 28, 2020 there were 77,778,688 shares of common stock outstanding.



CoreLogic, Inc.
Table of Contents
 
 
Part I: Financial Information
1
   
Item 1. Financial Statements (unaudited)
   
  A. Condensed Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019
1
   
  B. Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2020 and 2019
2
   
  C. Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2020 and 2019
3
   
  D. Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2020 and 2019
4
   
  E. Condensed Consolidated Statements of Stockholders' Equity for the three and nine months ended September 30, 2020 and 2019
7
   
  F. Notes to Condensed Consolidated Financial Statements
8
   
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
33
   
Item 3. Quantitative and Qualitative Disclosures About Market Risk
46
   
Item 4. Controls and Procedures
43
   
Part II: Other Information
47
   
Item 1. Legal Proceedings
47
   
Item 1A. Risk Factors
47
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
49
Item 6. Exhibits
50




PART I: FINANCIAL INFORMATION
Item 1.  Financial Statements.

CoreLogic, Inc.
Condensed Consolidated Balance Sheets
(Unaudited) 
(in thousands, except par value) September 30, December 31,
Assets 2020 2019
Current assets:    
Cash and cash equivalents $ 302,329  $ 104,162 
Accounts receivable (less allowance for credit losses of $9,188 and $6,937 as of September 30, 2020 and December 31, 2019, respectively)
279,492  247,683 
Prepaid expenses and other current assets 84,595  53,105 
Assets of discontinued operations 207,791  201,986 
Total current assets 874,207  606,936 
Property and equipment, net 407,228  424,670 
Operating lease assets 86,489  65,825 
Goodwill, net 2,298,876  2,286,896 
Other intangible assets, net 334,363  375,629 
Capitalized data and database costs, net 314,399  308,409 
Investment in affiliates, net 1,121  16,666 
Other assets 76,787  74,250 
Total assets $ 4,393,470  $ 4,159,281 
Liabilities and Equity    
Current liabilities:    
Accounts payable and other accrued expenses $ 190,997  $ 139,511 
Accrued salaries and benefits 91,763  83,418 
Dividends payable —  17,374 
Contract liabilities, current 401,986  320,634 
Liabilities of discontinued operations 50,497  42,708 
Current portion of long-term debt 21,382  56,022 
Operating lease liabilities, current 16,245  18,058 
Total current liabilities 772,870  677,725 
Long-term debt, net of current 1,548,785  1,610,538 
Contract liabilities, net of current 584,907  563,190 
Deferred income tax liabilities 67,171  92,783 
Operating lease liabilities, net of current 103,293  85,139 
Other liabilities 193,705  178,696 
Total liabilities 3,270,731  3,208,071 
Stockholders' equity:    
Preferred stock, $0.00001 par value; 500 shares authorized, no shares issued or outstanding
—  — 
Common stock, $0.00001 par value; 180,000 shares authorized; 79,545 and 78,972 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively
Additional paid-in capital 135,267  111,000 
Retained earnings 1,185,904  1,006,992 
Accumulated other comprehensive loss (198,433) (166,783)
Total stockholders' equity 1,122,739  951,210 
Total liabilities and equity $ 4,393,470  $ 4,159,281 
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
1


CoreLogic, Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
For the Three Months Ended For the Nine Months Ended
September 30, September 30,
(in thousands, except per share amounts) 2020 2019 2020 2019
Operating revenues $ 436,727  $ 375,571  $ 1,174,733  $ 1,088,032 
Cost of services (excluding depreciation and amortization shown below) 154,192  164,715  439,032  486,973 
Selling, general and administrative expenses 165,742  106,600  393,247  348,788 
Depreciation and amortization 43,610  42,389  130,639  132,767 
Impairment loss —  —  1,228  47,834 
Total operating expenses 363,544  313,704  964,146  1,016,362 
Operating income 73,183  61,867  210,587  71,670 
Interest expense:        
Interest income 100  349  611  1,728 
Interest expense 17,021  19,852  52,958  59,137 
Total interest expense, net (16,921) (19,503) (52,347) (57,409)
Gain/(loss) on investments and other, net 35,674  227  37,154  (2,116)
Tax indemnification release —  —  —  (13,394)
Income/(loss) from continuing operations before equity in earnings of affiliates and income taxes 91,936  42,591  195,394  (1,249)
(Benefit)/provision for income taxes (9,560) 11,530  19,433  (8,976)
Income from continuing operations before equity in earnings of affiliates 101,496  31,061  175,961  7,727 
Equity in earnings of affiliates, net of tax 971  607  1,859  498 
Net income from continuing operations 102,467  31,668  177,820  8,225 
Income/(loss) from discontinued operations, net of tax 10,679  (8,485) 28,149  11,073 
Net income $ 113,146  $ 23,183  $ 205,969  $ 19,298 
Basic income per share:
Net income from continuing operations $ 1.29  $ 0.40  $ 2.24  $ 0.10 
Income/(loss) from discontinued operations, net of tax 0.13  (0.11) 0.35  0.14 
Net income $ 1.42  $ 0.29  $ 2.59  $ 0.24 
Diluted income per share:        
Net income from continuing operations $ 1.26  $ 0.39  $ 2.19  $ 0.10 
Income/(loss) from discontinued operations, net of tax 0.13  (0.10) 0.35  0.14 
Net income $ 1.39  $ 0.29  $ 2.54  $ 0.24 
Weighted-average common shares outstanding:        
Basic 79,467  79,761  79,300  80,138 
Diluted 81,402  80,914  81,136  81,205 

The accompanying notes are an integral part of these condensed consolidated financial statements.
2


CoreLogic, Inc.
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
For the Three Months Ended For the Nine Months Ended
September 30, September 30,
(in thousands) 2020 2019 2020 2019
Net income $ 113,146  $ 23,183  $ 205,969  $ 19,298 
Other comprehensive income/(loss)        
Market value adjustments on interest rate swaps, net of tax 7,905  (8,121) (30,475) (41,415)
Reclassification adjustment for gain on terminated interest rate swap included in net income —  —  —  (67)
Foreign currency translation adjustments 10,799  (13,529) (1,211) (9,007)
Supplemental benefit plans adjustments, net of tax (76) (149) 36  (448)
Total other comprehensive income/(loss) 18,628  (21,799) (31,650) (50,937)
Comprehensive income/(loss) $ 131,774  $ 1,384  $ 174,319  $ (31,639)
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
3


CoreLogic, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
For the Nine Months Ended September 30,
(in thousands) 2020 2019
Cash flows from operating activities:    
Net income $ 205,969  $ 19,298 
Less: Income from discontinued operations, net of tax 28,149  11,073 
Net income from continuing operations 177,820  8,225 
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities:    
Depreciation and amortization 130,639  132,767 
Amortization of debt issuance costs 3,710  3,836 
Amortization of operating lease assets 11,067  11,675 
Impairment loss 1,228  47,834 
Provision for bad debt and claim losses 14,020  10,998 
Share-based compensation 33,898  26,018 
Equity in earnings of affiliates, net of taxes (1,859) (498)
Gain on sale of property and equipment 1,360  (3)
Loss on early extinguishment of debt —  1,453 
Deferred income tax 56  (10,642)
Impairment loss on investment in affiliates —  1,511 
Gain on investments and other, net (37,154) (847)
Tax indemnification release —  13,394 
Change in operating assets and liabilities, net of acquisitions:    
Accounts receivable (33,159) (23,218)
Prepaid expenses and other current assets (2,104) (7,201)
Accounts payable and other accrued expenses 54,847  (19,894)
Contract liabilities 102,302  19,899 
Income taxes (32,815) 31,239 
Dividends received from investments in affiliates 109  — 
Other assets and other liabilities (45,550) (29,122)
Net cash provided by operating activities - continuing operations 378,415  217,424 
Net cash provided by operating activities - discontinued operations 40,687  29,669 
Total cash provided by operating activities $ 419,102  $ 247,093 
Cash flows from investing activities:    
Purchases of property and equipment $ (40,187) $ (52,807)
Purchases of capitalized data and other intangible assets (28,717) (25,845)
Cash paid for acquisitions, net of cash acquired (12,045) (13,280)
Purchases of investments (1,315) (658)
Cash received from sale of business-lines —  4,109 
Proceeds from sale of property and equipment — 
Proceeds from investments and other 48,035  5,591 
Net cash used in investing activities - continuing operations (34,229) (82,887)
Net cash used in investing activities - discontinued operations (9,259) (13,987)
Total cash used in investing activities $ (43,488) $ (96,874)
Cash flows from financing activities:    
Proceeds from long-term debt $ —  $ 1,770,000 
Debt issuance costs —  (9,621)
Repayment of long-term debt (102,461) (1,844,155)
Proceeds from issuance of shares in connection with share-based compensation 8,487  8,391 
Payment of tax withholdings related to net share settlements (9,816) (9,645)
Shares repurchased and retired (9,273) (61,607)
Dividends paid (61,062) — 
Contingent consideration payments subsequent to acquisitions —  (600)
Net cash used in financing activities - continuing operations (174,125) (147,237)
Net cash used in financing activities - discontinued operations (6) (12)
Total cash used in financing activities $ (174,131) $ (147,249)
Effect of exchange rate on cash, cash equivalents, and restricted cash (2,042) 637 
Net change in cash, cash equivalents, and restricted cash 199,441  3,607 
Cash, cash equivalents, and restricted cash at beginning of period 114,679  94,679 
Less: Change in cash, cash equivalents, and restricted cash - discontinued operations 31,422  15,670 
Plus: Cash swept from discontinued operations 30,135  17,697 
Cash, cash equivalents, and restricted cash at end of period $ 312,833  $ 100,313 
Supplemental disclosures of cash flow information:    
Cash paid for interest $ 48,419  $ 53,202 
Cash paid for income taxes $ 59,538  $ 11,558 
Cash refunds from income taxes $ 449  $ 16,812 
Non-cash investing activities:
Capital expenditures included in accounts payable and other accrued expenses $ 10,695  $ 10,322 

The accompanying notes are an integral part of these condensed consolidated financial statements.
4


CoreLogic, Inc.
Condensed Consolidated Statement of Stockholders' Equity (Quarter-to-Date)
(Unaudited)
Common Stock Shares Common Stock Amount Additional Paid-in Capital Retained Earnings Accumulated Other Comprehensive Loss Total
(in thousands)
For the Three Months Ended September 30, 2020
Balance as of June 30, 2020 79,459  $ $ 120,029  $ 1,099,154  $ (217,061) $ 1,002,123 
Net income —  —  —  113,146  —  113,146 
Shares issued in connection with share-based compensation 86  —  2,702  —  —  2,702 
Payment of tax withholdings related to net share settlements —  —  (470) —  —  (470)
Share-based compensation —  —  12,833  —  —  12,833 
Shares repurchased and retired —  —  —  —  —  — 
Dividends on common shares —  —  173  (26,396) —  (26,223)
Other comprehensive income —  —  —  —  18,628  18,628 
Balance as of September 30, 2020 79,545  $ $ 135,267  $ 1,185,904  $ (198,433) $ 1,122,739 
For the Three Months Ended September 30, 2019
Balance as of June 30, 2019 80,133  $ $ 146,887  $ 971,490  $ (164,886) $ 953,492 
Net income —  —  —  23,183  —  23,183 
Shares issued in connection with share-based compensation 86  —  1,832  —  —  1,832 
Payment of tax withholdings related to net share settlements —  —  (378) —  —  (378)
Share-based compensation —  —  9,108  —  —  9,108 
Shares repurchased and retired (700) —  (32,577) —  —  (32,577)
Other comprehensive loss —  —  —  —  (21,799) (21,799)
Balance as of September 30, 2019 79,519  $ $ 124,872  $ 994,673  $ (186,685) $ 932,861 

The accompanying notes are an integral part of these condensed consolidated financial statements.
5


CoreLogic, Inc.
Condensed Consolidated Statement of Stockholders' Equity (Year-to-Date)
(Unaudited)
Common Stock Shares Common Stock Amount Additional Paid-in Capital Retained Earnings Accumulated Other Comprehensive Loss Total
(in thousands)
For the Nine Months Ended September 30, 2020
Balance as of December 31, 2019 78,972  $ $ 111,000  $ 1,006,992  $ (166,783) $ 951,210 
Adoption of new accounting standards —  —  —  16,827  —  16,827 
Net income —  —  —  205,969  —  205,969 
Shares issued in connection with share-based compensation 773  —  8,487  —  —  8,487 
Payment of tax withholdings related to net share settlements —  —  (9,816) —  —  (9,816)
Share-based compensation —  —  34,671  —  —  34,671 
Shares repurchased and retired (200) —  (9,273) —  —  (9,273)
Dividend on common shares —  —  198  (43,884) —  (43,686)
Other comprehensive loss —  —  —  —  (31,650) (31,650)
Balance as of September 30, 2020 79,545  $ $ 135,267  $ 1,185,904  $ (198,433) $ 1,122,739 
For the Nine Months Ended September 30, 2019
Balance as of December 31, 2018 80,092  $ $ 160,870  $ 975,375  $ (135,748) $ 1,000,498 
Net income —  —  —  19,298  —  19,298 
Shares issued in connection with share-based compensation 827  —  8,391  —  —  8,391 
Payment of tax withholdings related to net share settlements —  —  (9,645) —  —  (9,645)
Share-based compensation —  —  26,863  —  —  26,863 
Shares repurchased and retired (1,400) —  (61,607) —  —  (61,607)
Other comprehensive loss —  —  —  —  (50,937) (50,937)
Balance as of September 30, 2019 79,519  $ $ 124,872  $ 994,673  $ (186,685) $ 932,861 

The accompanying notes are an integral part of these condensed consolidated financial statements.

6



Note 1 – Basis of Condensed Consolidated Financial Statements

CoreLogic, Inc., together with its subsidiaries (collectively “the Company”, “we”, “us” or “our”), is a leading global property information, insight, analytics and data-enabled solutions provider operating in North America, Western Europe and Asia Pacific. Our combined data from public, contributory, and proprietary sources provides detailed coverage of property, mortgages and other encumbrances, property risk and replacement cost, location, hazard risk and related performance information. The markets we serve include real estate and mortgage finance, insurance, capital markets, and the public sector. We deliver value to clients through unique data, analytics, workflow technology, advisory and managed solutions. Clients rely on us to help identify and manage growth opportunities, improve performance, and mitigate risk.

Our condensed consolidated financial information included in this report has been prepared in accordance with accounting principles generally accepted (“GAAP”) in the United States ("US") for interim financial information pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The 2019 year-end condensed consolidated balance sheet was derived from the Company’s audited financial statements for the year ended December 31, 2019. Interim financial information does not require the inclusion of all the information and footnotes required by GAAP for complete financial statements. Therefore, these financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2019.

The accompanying unaudited condensed consolidated interim financial statements reflect all adjustments, consisting of only normal recurring items which, in the opinion of management, are necessary for a fair statement of the results of operations for the periods shown. The results of operations for such periods are not necessarily indicative of the results expected for the full year or for any future periods.

Unsolicited Proposal and Proxy Contest

On June 26, 2020, we received an unsolicited proposal from Senator Investment Group, LP (“Senator”) and Cannae Holdings, Inc. (“Cannae”) to acquire the Company for $65.00 per share in cash, which initial proposal was revised by Senator and Cannae on September 14, 2020 by $1.00 per share to $66.00 per share in cash (the “Unsolicited Proposal”). Our Board of Directors, in consultation with its independent financial and legal advisors, unanimously determined to reject the Unsolicited Proposal. On August 9, 2020, the Board of Directors determined to call a special meeting of stockholders in order to allow our stockholders to consider and vote upon Senator and Cannae's proposal for the removal and replacement of up to nine members of our Board of Directors and to amend certain provisions of our Bylaws (the “Proxy Contest”). The Board of Directors set the special meeting for November 17, 2020, with a record date of September 18, 2020. In connection with the Unsolicited Proposal and Proxy Contest, we have accrued expenses of approximately $36.9 million for the three and nine months ended September 30, 2020.

Divestiture of Non-Core Businesses

In July 2020, we announced our intention to exit our reseller operations focused on mortgage credit and borrower verification and multi-family tenant screening. Although market leaders in their respective business areas, these reseller businesses are not compatible with our long-term strategic imperatives. The divestiture of these operations is expected to improve our revenue growth trends, revenue mix, and significantly enhance profit margins. As a result of this strategic decision, the businesses have been reflected in our consolidated financial statements as discontinued operations for all periods presented. Please refer to Note 14 - Discontinued Operations for further information.

Client Concentration

We generate the majority of our operating revenues from clients with operations in the US residential real estate, mortgage origination, and mortgage servicing markets. Approximately 37% and 29% of our operating revenues for the three months ended September 30, 2020 and 2019, respectively, were generated from our top ten clients, who consist of the largest US mortgage originators and servicers. None of our clients individually accounted for greater than 10% of our operating revenues during these periods. Approximately 35% and 26% of our operating revenues for the nine months ended September 30, 2020 and 2019, respectively, were generated from our top ten clients. None of our clients individually accounted for greater than 10% of our operating revenues during these periods.
7



Cash, Cash Equivalents, and Restricted Cash

We deem the carrying value of cash, cash equivalents, and restricted cash to be a reasonable estimate of fair value due to the nature of these instruments. Restricted cash is comprised of deposits that are pledged for various letters of credit/bank guarantees secured by us, escrow accounts due to acquisitions and divestitures, as well as short-term investments within our deferred compensation plan trust. The following table provides a reconciliation of cash, cash equivalents, and restricted cash to amounts shown in the statement of cash flows:
(in thousands) September 30, 2020 September 30, 2019
Cash and cash equivalents $ 302,329  $ 86,695 
Restricted cash included in other assets 10,129  11,616 
Restricted cash included in prepaid expenses and other current assets 375  2,002 
Total cash, cash equivalents, and restricted cash $ 312,833  $ 100,313 

Operating Revenue Recognition

We derive our operating revenues primarily from US mortgage lenders, servicers, and insurance companies with good creditworthiness. Operating revenue arrangements are written and specify the products or services to be delivered, pricing, and payment terms. Operating revenue is recognized when the distinct good or service (also referred as "performance obligation"), is delivered and control has been transferred to the client. Generally, clients contract with us to provide products and services that are highly interrelated and not separately identifiable. Therefore, the entire contract is accounted for as one performance obligation. At times, some of our contracts have multiple performance obligations where we allocate the total price to each performance obligation based on the estimated relative standalone selling price using observable sales or the cost-plus-margin approach.

For products or services where delivery occurs at a point in time, we recognize operating revenue when the client obtains control of the products upon delivery. When delivery occurs over time, we generally recognize operating revenue ratably over the service period, once initial delivery has occurred. For certain of our products or services, clients may also pay upfront fees, which we defer and recognize as operating revenue over the longer of the contractual term or the expected client relationship period.

Licensing arrangements that provide our clients with the right to access or use our intellectual property are considered functional licenses for which we generally recognize operating revenue based on usage. For arrangements that provide a stand-ready obligation or substantive updates to the intellectual property which the client is contractually or practically required to use, we recognize operating revenue ratably over the contractual term.

Client payment terms are standard with no significant financing components or extended payment terms granted. In limited cases, we allow for client cancellations for which we estimate a reserve at the point-of-sale.

See further discussion in Note 7 - Operating Revenues.

Comprehensive Loss

Comprehensive loss includes all changes in equity except those resulting from investments by stockholders and distributions to stockholders. Specifically, foreign currency translation adjustments, amounts related to supplemental benefit plans, unrealized gains and losses on interest rate swap transactions and investments are recorded in other comprehensive loss. The following table shows the components of accumulated other comprehensive loss, net of taxes, as of September 30, 2020 and December 31, 2019:
(in thousands) 2020 2019
Cumulative foreign currency translation $ (123,714) $ (122,503)
Cumulative supplemental benefit plans (8,881) (8,917)
Net unrecognized losses on interest rate swaps (65,838) (35,296)
Reclassification adjustment for gain on terminated interest rate swap included in net income —  (67)
Accumulated other comprehensive loss $ (198,433) $ (166,783)
8



Investment in Affiliates, net

Investments in affiliates are accounted for under the equity method of accounting when we are deemed to have significant influence over the affiliate but do not control or have a majority voting interest in the affiliate. Investments are carried at the cost of acquisition, including subsequent impairments, capital contributions and loans from us, plus our equity in undistributed earnings or losses since inception of the investment, less dividends received.

As of September 30, 2020 and December 31, 2019, we had insignificant revenue, expense, accounts receivable, and accounts payable related to our investments in these affiliates.

During the three months ended September 30, 2020, we sold our investment in an equity related investment for $45.8 million in cash which resulted in a gain of $35.1 million and is reflected within gain/(loss) on investments and other, net, in our condensed consolidated statement of operations for the three and nine months ended September 30, 2020.

In January 2020, we completed the acquisition of the remaining 66% of Location, Inc. ("Location") for $11.5 million, subject to certain working capital adjustments. In connection with this transaction, we remeasured our pre-existing 34% investment balance of $5.6 million to fair value based on the purchase price, resulting in a $0.6 million step-up gain which is reflected within gain/(loss) on investments and other, net, in our condensed consolidated statement of operations for the nine months ended September 30, 2020. See Note 12 - Acquisitions for additional information. Prior to the acquisition of the remaining interest, we accounted for Location under the equity method and received dividends of $0.7 million in the first quarter of 2020.

Leases

We determine if an arrangement contains a lease at inception and determine the classification of the lease, as either operating or finance, at commencement.

Operating and finance lease assets and liabilities are recorded based on the present value of future lease payments over the lease term which factors in certain qualifying initial direct costs incurred as well as any lease incentives received. If an implicit rate is not readily determinable, we utilize our incremental borrowing rate and inputs from third-party lenders to determine the appropriate discount rate. Lease expense for operating lease payments are recognized on a straight-line basis over the lease term, which, if applicable, may factor in renewal or termination options. Finance leases incur interest expense using the effective interest method in addition to amortization of the leased asset on a straight-line basis, both over the applicable lease term. Lease terms may factor in options to extend or terminate the lease.

We adhere to the short-term lease recognition exemption for all classes of assets (i.e. facilities and equipment). As a result, leases with an initial term of twelve months or less are not recorded on the balance sheet and are recognized on a straight-line basis over the lease term. In addition, for certain equipment leases, we account for lease and non-lease components, such as services, as a single lease component as permitted.

Dividends

We record cash dividends as reductions to retained earnings upon declaration, with a corresponding increase to current liabilities, based on common shares outstanding on the record date. In addition, as part of our share-based compensation program, the terms of our restricted stock units (“RSUs”) and performance-based restricted stock units (“PBRSUs”) stipulate that holders of these awards are credited with dividend equivalent units on each date that a cash dividend is paid to holders of common stock. These dividend equivalents are subject to the same vesting and performance requirements of the underlying units and therefore are forfeitable (i.e. non-participating). Upon declaration of a dividend, we record dividend equivalents as a reduction to retained earnings, derived from the number of eligible unvested shares, with a corresponding increase to additional paid-in-capital.

In December 2019, we announced that our Board of Directors approved the initiation of a quarterly cash dividend to common stockholders. In connection with this announcement, in December 2019, our Board of Directors initiated and declared a cash dividend of $0.22 per common share. As a result, as of December 31, 2019, we recorded a liability of $17.4 million within accounts payable and other accrued expenses, as well as $0.4 million in dividend equivalents reflected in additional paid-in-capital within our accompanying consolidated balance sheets. The dividend declared was paid in January 2020. In April 2020, our Board of Directors announced a cash dividend to common stockholders of $0.22 per share of common stock which was paid in June 2020 to stockholders of record at the close of business on June 1, 2020.
9


In July 2020, our Board of Directors announced a 50% increase in our cash dividend and declared a $0.33 per share cash dividend to common stockholders, which was paid in September 2020 to stockholders of record as of September 1, 2020. In October 2020, our Board of Directors declared a cash dividend of $0.33 per share of common stock to be paid in December 2020 to shareholders of record on the close of business December 1, 2020.

Tax Escrow Disbursement Arrangements

We administer tax escrow disbursements as a service to our clients in connection with our tax services business. Funds to be disbursed are deposited and maintained in segregated accounts for the benefit of our clients and totaled $1.4 billion as of both September 30, 2020 and December 31, 2019. Because these deposits are held on behalf of our clients, they are not our funds and, therefore, are not included in the accompanying condensed consolidated balance sheets.

These deposits generally remain in the accounts for a period of two to five business days. We record credits from these activities as a reduction to related administrative expenses, including the cost of bank fees and other administration costs.

Under our contracts with our clients, if we make a payment in error or fail to pay a taxing authority when a payment is due, we could be held liable to our clients for all or part of the financial loss they suffer as a result of our act or omission. We maintained total claim reserves relating to incorrect disposition of assets of $24.8 million and $22.7 million as of September 30, 2020 and December 31, 2019, respectively. Within these amounts are $10.7 million and $9.8 million, respectively, which are short-term and are therefore reflected within accounts payable and other accrued expenses within our accompanying condensed consolidated balance sheets. The remaining reserves are reflected within other liabilities.

Recent Accounting Pronouncements

In March 2020, the Financial Accounting Standards Board (“FASB”) issued guidance to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform, in connection with the scheduled phase-out of the London interbank offering rate (“LIBOR”) as a reference interest rate. The guidance provides practical expedients and exceptions in accounting for contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. Entities electing the practical expedients will be allowed, among other topics, to account for reference rate modification of debt and receivables prospectively; to not reassess lease classifications and discount rates in reference rate lease modifications; and ease cash-flow hedge effectiveness testing guidelines for hedges affected by reference rate reform. The guidance is effective through December 2022 with adoption permitted as of any date within the aforementioned time frame from the beginning of the selected interim period on a prospective basis. We adopted the guidance in the first quarter of 2020, which has not had a material effect on our condensed consolidated financial statements.

In December 2019, as part of a simplification initiative, the FASB issued guidance to remove certain exceptions and added further guidance to simplify the accounting for income taxes. The exceptions that were removed relate to recognizing deferred taxes for investments, performing intra-period allocation, and calculating income taxes in interim periods. The guidance reduces the complexity of recognizing deferred taxes for goodwill and allocating taxes to entities of a consolidated group. The guidance is effective for fiscal years beginning after December 15, 2020 with early adoption permitted. We elected to early adopt on January 1, 2020 via the modified retrospective method with a cumulative effect adjustment at the date of initial application, resulting in an increase to retained earnings of $16.8 million. This impact results from the release of a deferred tax liability that had previously been established for the outside basis difference of an equity method investment that later became a subsidiary.

In November 2018, the FASB issued guidance to clarify the definition and interaction of collaborative arrangements with previously issued guidance on revenue recognition. This guidance is effective for fiscal years beginning after December 15, 2019 on a retrospective basis to the date of the initial adoption of the revenue standard. We adopted this guidance in the first quarter of 2020, which has not had a material impact on our condensed consolidated financial statements.

In August 2018, the FASB issued guidance that amends fair value disclosure requirements. The guidance removes disclosure requirements on the transfers between Level 1 and Level 2 of the fair value hierarchy in addition to the disclosure requirements on the policy for timing of transfers between levels and the valuation process for Level 3 fair value measurements. The guidance clarifies the measurement uncertainty disclosure and adds disclosure requirements for Level 3 unrealized gains and losses and significant unobservable inputs used to develop Level 3 fair value measurements. The guidance is effective for fiscal years beginning after December 15, 2019. Entities were permitted to early adopt any removed or modified disclosures upon issuance and delay adoption of the additional disclosures until the effective date. We early adopted the removal of disclosure provisions of the new guidance in 2018 and adopted the measurement uncertainty disclosure and additional Level 3 disclosures in the current year as required. Adoption of this guidance has not had a material impact on our condensed consolidated financial statements.
10



In June 2016, the FASB issued guidance for accounting of credit losses affecting the impairment model for most financial assets and certain other instruments. Entities are required to use a forward-looking current expected credit loss model for trade and other receivables, held-to-maturity debt securities, loans, and other instruments, which will generally lead to an earlier recognition of loss allowances. Entities will recognize expected losses on available-for-sale debt securities as allowances rather than a reduction in amortized cost of the security while the measurement process of such loss does not change. Disclosure requirements are expanded regarding an entity’s assumptions, models, and methods of estimations of the allowance. The guidance is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. In November 2018 and 2019, the FASB issued updates to this standard which, amongst other items, clarified that impairment of receivables arising from operating leases should be accounted for under applicable leasing guidance. We adopted this guidance in the first quarter of 2020, which has not had a material impact on our condensed consolidated financial statements.

Note 2 - Property and Equipment, Net

Property and equipment, net as of September 30, 2020 and December 31, 2019 consists of the following:
(in thousands) 2020 2019
Land $ 7,476  $ 7,476 
Buildings 6,487  6,487 
Furniture and equipment 68,362  74,043 
Capitalized software 843,638  819,828 
Leasehold improvements 50,334  48,811 
Construction in progress 276  3,064 
  976,573  959,709 
Less accumulated depreciation (569,345) (535,039)
Property and equipment, net $ 407,228  $ 424,670 

Depreciation expense for property and equipment, net, was approximately $21.2 million and $20.4 million for the three months ended September 30, 2020 and 2019, respectively, and $64.2 million and $63.6 million for the nine months ended September 30, 2020 and 2019, respectively.

Impairment losses for property and equipment of $1.2 million and $12.3 million were recorded for the nine months ended September 30, 2020 and 2019, respectively. See Note 6 - Fair Value for further discussion.

11


Note 3 – Goodwill, Net

A reconciliation of the changes in the carrying amount of goodwill and accumulated impairment losses, by reporting unit, for the nine months ended September 30, 2020 is as follows:
 
(in thousands) PIRM UWS Consolidated
Balance as of January 1, 2020
Goodwill $ 1,078,225  $ 1,216,196  $ 2,294,421 
Accumulated impairment losses (600) (6,925) (7,525)
Goodwill, net 1,077,625  1,209,271  2,286,896 
Measurement period adjustments — 
Acquisition 12,584  —  12,584 
Translation adjustments (612) —  (612)
Balance as of September 30, 2020
Goodwill, net $ 1,089,597  $ 1,209,279  $ 2,298,876 
In connection with our intent to exit our reseller businesses, we have reclassified $29.3 million and $79.9 million of goodwill, net, from our Property Intelligence and Risk Managements Solutions (“PIRM”) and Underwriting and Workflow Solutions (“UWS”) segments, respectively, to assets of discontinued operations as of September 30, 2020. See Note 14 - Discontinued Operations. As part of the process of marketing the sale of these businesses, we updated our long-term projections and obtained indicative fair market values from potential participants. The level of indicative values supported the net book value of the businesses being marketed and our remaining reporting units within continuing operations with no impairment.

See Note 12 - Acquisitions for discussion of current year acquisition and measurement period adjustments.

Note 4 – Other Intangible Assets, Net

Other intangible assets, net consists of the following:
September 30, 2020 December 31, 2019
(in thousands) Gross Accumulated Amortization Net Gross Accumulated Amortization Net
Client lists $ 640,155  $ (364,295) $ 275,860  $ 645,770  $ (340,168) $ 305,602 
Non-compete agreements 26,755  (20,233) 6,522  26,409  (16,249) 10,160 
Tradenames and licenses 126,913  (74,932) 51,981  126,405  (66,538) 59,867 
  $ 793,823  $ (459,460) $ 334,363  $ 798,584  $ (422,955) $ 375,629 

Amortization expense for other intangible assets, net was $14.2 million for both the three months ended September 30, 2020 and 2019, and $42.5 million and $45.9 million for the nine months ended September 30, 2020 and 2019, respectively.

Impairment losses of $35.6 million were recorded for the nine months ended September 30, 2019. For the three months ended September 30, 2019, there were no impairments. For the three and nine months ended September 30, 2020, there were no impairments. See Note 6 - Fair Value for further discussion.

12


Estimated amortization expense for other intangible assets, net is as follows:
(in thousands)  
Remainder of 2020 $ 14,294 
2021 53,770 
2022 51,953 
2023 43,642 
2024 37,303 
Thereafter 133,401 
  $ 334,363 

Note 5 – Long-Term Debt

Our long-term debt consists of the following:
September 30, 2020 December 31, 2019
(in thousands) Gross Debt Issuance Costs Net Gross Debt Issuance Costs Net
Bank debt:
Term loan facility borrowings due May 2024, weighted-average interest rate of 1.91% as of September 30, 2020
$ 1,572,000  $ (12,242) $ 1,559,758  $ 1,672,188  $ (14,868) $ 1,657,320 
Revolving line of credit borrowings due May 2024, weighted-average interest rate of 1.91% as of September 30, 2020
—  (5,342) (5,342) —  (6,425) (6,425)
Notes:        
 
7.55% senior debentures due April 2028
9,531  (24) 9,507  9,524  (26) 9,498 
Other debt:        
  Various debt instruments with maturities through March 2024 6,244  —  6,244  6,167  —  6,167 
Total long-term debt 1,587,775  (17,608) 1,570,167  1,687,879  (21,319) 1,666,560 
Less current portion of long-term debt 21,382  —  21,382  56,022  —  56,022 
Long-term debt, net of current portion $ 1,566,393  $ (17,608) $ 1,548,785  $ 1,631,857  $ (21,319) $ 1,610,538 

As of September 30, 2020 and December 31, 2019, we recorded less than $0.1 million and $0.4 million, respectively, of accrued interest expense on our debt-related instruments within accounts payable and other accrued expenses.

Credit Agreement

In May 2019, we amended and restated our credit agreement (the “Credit Agreement”) with Bank of America, N.A., as the administrative agent, and other financial institutions. The Credit Agreement provides for a $1.8 billion 5-year term loan facility (the “Term Facility”), and a $750.0 million 5-year revolving credit facility (the “Revolving Facility”). The Term Facility matures, and the Revolving Facility expires, in May 2024. The Revolving Facility includes a $100.0 million multi-currency revolving sub-facility and a $50.0 million letter of credit sub-facility. The Credit Agreement also provides for the ability to increase the Term Facility and Revolving Facility by up to $300.0 million in the aggregate; however, the lenders are not obligated to do so. As of September 30, 2020, we had a remaining borrowing capacity of $750.0 million under the Revolving Facility and we were in compliance with all financial and restrictive covenants under the Credit Agreement.

Debt Issuance Costs

In connection with the amendment and restatement of the Credit Agreement, in May 2019, we incurred approximately $9.7 million of debt issuance costs of which $9.6 million were initially capitalized within long-term debt, net of current, in the accompanying condensed consolidated balance sheets. In addition, when we amended and restated the Credit Agreement, we wrote-off previously unamortized debt issuance costs of $1.5 million within gain/(loss) on investments and other, net, in the accompanying condensed consolidated statements of operations for the nine months ended September 30, 2019, which resulted
13


in a remaining $14.6 million of previously unamortized costs. We are amortizing these costs over the term of the Credit Agreement. For both the three months ended September 30, 2020 and 2019, $1.2 million was recognized in the accompanying condensed consolidated statements of operations related to the amortization of debt issuance costs. For the nine months ended September 30, 2020 and 2019, $3.7 million and $3.8 million, respectively, were recognized in the accompanying condensed consolidated statements of operations related to the amortization of debt issuance costs.

7.55% Senior Debentures

In April 1998, we issued $100.0 million in aggregate principal amount of 7.55% senior debentures due 2028. The indentures governing these debentures, as amended, contain limited restrictions on us.

Interest Rate Swaps

We have entered into amortizing interest rate swaps (“Swaps”) in order to convert a portion of our interest rate exposure on the Term Facility floating rate borrowings from variable to fixed. Under the Swaps, we agree to exchange floating rate for fixed rate interest payments periodically over the life of the agreement. The floating rates in our Swaps are based on the one-month LIBOR. The notional balances, terms and maturities of our Swaps are designed to have the effect of fixing the rate of interest on at least 50% of the principal balance of our senior term debt.

As of September 30, 2020, the Swaps have a combined remaining notional balance of $1.2 billion, a weighted average fixed interest rate of 2.40% (rates range from 0.66% to 2.98%), and scheduled terminations through December 2025. Notional balances under our Swaps are scheduled to increase and decrease based on our expectations of the level of variable rate debt to be in effect in future periods. Currently, we have scheduled notional amounts of approximately $1.2 billion through September 2021, then $1.1 billion and $1.0 billion through August 2022, and $496.8 million and $465.0 million through December 2025. Approximate weighted average fixed interest rates for the aforementioned time periods are 2.59%, 2.77%, and 2.64%, respectively.

We have designated the Swaps as cash flow hedges. The estimated fair values of these cash flow hedges are recorded in prepaid expenses and other current assets or other assets as well as accounts payable and other accrued expenses or other liabilities in the accompanying condensed consolidated balance sheets. As of September 30, 2020, the estimated fair value of these cash flow hedges resulted in a liability of $87.7 million, of which $3.5 million was recorded within accounts payable and other accrued expenses. As of December 31, 2019, the estimated fair value of these cash flow hedges resulted in an asset of $0.6 million which was recorded within prepaid expenses and other current assets, as well as a liability of $47.7 million recorded within other liabilities.

Unrealized gains of $7.9 million (net of $2.6 million in deferred taxes) and unrealized losses of $8.1 million (net of $2.7 million in deferred taxes) for the three months ended September 30, 2020 and 2019, respectively, were recognized in other comprehensive loss related to the Swaps. Unrealized losses of $30.5 million (net of $10.1 million in deferred taxes) and $41.4 million (net of $13.8 million in deferred taxes) for the nine months ended September 30, 2020 and 2019, respectively, were recognized in other comprehensive loss related to the Swaps.

As a result of our Swap activity, for the three months ended September 30, 2020 and 2019, included within interest expense, on a pre-tax basis, we recognized interest expense of $7.1 million and interest income of $0.7 million, respectively. For the nine months ended September 30, 2020 and 2019, included within interest expense, on a pre-tax basis, we recognized interest expense of $14.3 million and interest income of $4.0 million, respectively. Estimated net losses included in accumulated other comprehensive loss related to the Swaps as of September 30, 2020, that will be reclassified into earnings as interest expense over the next 12 months, utilizing September 30, 2020 LIBOR, is estimated to be $16.0 million, on a pre-tax basis.

14


Note 6 – Fair Value

Fair value is the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We utilize market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable.

The market approach is applied for recurring fair value measurements and endeavors to utilize the best available information. Accordingly, we utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. Fair value balances are classified based on the observability of those inputs.

A fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). Level 2 measurements utilize observable inputs in active markets for similar assets and liabilities, or, quoted prices in markets that are not active.

In estimating fair value, we used the following methods and assumptions:

Cash and Cash Equivalents

For cash and cash equivalents, the carrying value is a reasonable estimate of fair value due to the short-term nature of the instruments.

Restricted Cash

Restricted cash is comprised of deposits that are pledged for various letters of credit/bank guarantees secured by us, escrow accounts due to acquisitions and divestitures, as well as short-term investments within our deferred compensation plan trust. We deem the carrying value to be a reasonable estimate of fair value due to the nature of these instruments.

Other Investments

Other investments are currently comprised of a minority equity investment in a foreign enterprise which we measure at cost and adjust to fair value on a quarterly basis when there are observable price changes in orderly transactions for the identical, or similar, investments. Changes in fair value are recorded within gain/(loss) on investments and other, net, in our condensed consolidated statements of operations.

Contingent Consideration

The fair value of our contingent consideration was estimated using the Monte-Carlo simulation model, which relies on significant assumptions and estimates including discount rates and future market conditions, among others.

Long-Term Debt

The fair value of debt was estimated based on the current rates available to us for similar debt of the same remaining maturities and consideration of our default and credit risk.

Swaps

The fair values of the Swaps were estimated based on market-value quotes received from the counterparties to the agreements.

15


The fair values of our financial instruments as of September 30, 2020 are presented in the following table:
(in thousands) Fair Value Measurements Using
As of September 30, 2020 Level 1 Level 2 Level 3 Fair Value
Financial Assets:
Cash and cash equivalents $ 302,329  $ —  $ —  $ 302,329 
Restricted cash 8,719  1,785  —  10,504 
Other investments —  3,279  —  3,279 
Total $ 311,048  $ 5,064  $ —  $ 316,112 
Financial Liabilities:
Total debt $ —  $ 1,590,260  $ —  $ 1,590,260 
Total $ —  $ 1,590,260  $ —  $ 1,590,260 
Derivatives:
Liability for Swaps $ —  $ 87,725  $ —  $ 87,725 
As of December 31, 2019
Financial Assets:
Cash and cash equivalents $ 104,162  $ —  $ —  $ 104,162 
Restricted cash 9,791  726  —  10,517 
Other investments —  1,898  —  1,898 
Total $ 113,953  $ 2,624  $ —  $ 116,577 
Financial Liabilities:
Total debt $ —  $ 1,690,731  $ —  $ 1,690,731 
Total $ —  $ 1,690,731  $ —  $ 1,690,731 
Derivatives:
Asset for Swaps $ —  $ 572  $ —  $ 572 
Liability for Swaps $ —  $ 47,691  $ —  $ 47,691 

For the nine months ended September 30, 2020, we recorded non-cash impairment charges of $1.2 million in property and equipment, net, related to capitalized software within our UWS segment. For the nine months ended September 30, 2019, we recorded non-cash impairment charges of $35.6 million in other intangible assets, net, as well as $12.3 million in property and equipment, net. For both the three months ended September 30, 2020, and 2019, there were no impairments. Both impairments are due to ongoing business transformation activities of our appraisal management company within our UWS segment. The impairments within other intangible assets, net include $32.3 million for client lists and $3.3 million for licenses. The impairments within property and equipment, net relate to capitalized software. All impairments were derived using an undiscounted cash flow methodology.

In connection with the 2019 acquisition of National Tax Search, LLC (“NTS”), we entered into a contingent consideration agreement for up to $7.5 million in cash based upon certain revenue targets in fiscal years 2020 and 2021. This contingent consideration has been assessed with no fair value as of September 30, 2020 using the Monte-Carlo simulation model.

Due to observable price changes in an inactive market, in the first half of 2019, we recorded a combined unfavorable fair value adjustment of $6.6 million to a minority equity investment, which was recorded within gain/(loss) on investments and other, net in our condensed consolidated statement of operations for the nine months ended September 30, 2019. No adjustments were necessary for the three and nine months ended September 30, 2020.

16


In connection with certain acquisitions in 2017 related to our discontinued operations, we entered into contingent consideration agreements for up to $17.5 million in cash by 2022 upon the achievement of certain revenue targets ending in fiscal year 2021. This contingent payment was originally recorded at a fair value of $4.4 million using the Monte-Carlo simulation model. The contingent payments are remeasured at fair value quarterly, and changes are recorded within income/(loss) from discontinued operations, net of tax, in our condensed consolidated statements of operations. During the three months ended September 30, 2020 we decreased the fair value of our contingent consideration by $1.2 million and recorded the gain in our condensed consolidated statements of operations. During the three months ended September 30, 2019, there were no adjustments to our contingent consideration. During the nine months ended September 30, 2020 and 2019, we decreased the fair value of our contingent consideration by $3.8 million and $0.2 million, respectively, and recorded the gain in our condensed consolidated statements of operations.

17


Note 7 – Operating Revenues

Operating revenues by solution type consist of the following:
(in thousands) PIRM UWS Corporate and Eliminations Consolidated
For the Three Months Ended September 30, 2020
Property insights $ 126,325  $ —  $ —  $ 126,325 
Insurance and spatial solutions 49,923  —  —  49,923 
Flood data solutions —  34,351  —  34,351 
Valuation solutions —  58,434  —  58,434 
Property tax solutions —  166,858  —  166,858 
Other —  3,699  (2,863) 836 
Total operating revenue $ 176,248  $ 263,342  $ (2,863) $ 436,727 
For the Three Months Ended September 30, 2019
Property insights $ 120,340  $ —  $ —  $ 120,340 
Insurance and spatial solutions 48,739  —  —  48,739 
Flood data solutions —  22,983  —  22,983 
Valuation solutions —  77,426  —  77,426 
Property tax solutions —  103,671  —  103,671 
Other —  5,058  (2,646) 2,412 
Total operating revenue $ 169,079  $ 209,138  $ (2,646) $ 375,571 
For the Nine Months Ended September 30, 2020
Property insights $ 359,175  $ —  $ —  $ 359,175 
Insurance and spatial solutions 145,204  —  —  145,204 
Flood data services —  91,931  —  91,931 
Valuation solutions —  182,637  —  182,637 
Property tax solutions —  394,799  —  394,799 
Other —  11,088  (10,101) 987 
Total operating revenue $ 504,379  $ 680,455  $ (10,101) $ 1,174,733 
For the Nine Months Ended September 30, 2019
Property insights $ 359,278  $ —  $ —  $ 359,278 
Insurance and spatial solutions 142,576  —  —  142,576 
Flood data services —  61,572  —  61,572 
Valuation solutions —  230,891  —  230,891 
Property tax solutions —  282,724  —  282,724 
Other —  17,988  (6,997) 10,991 
Total operating revenue $ 501,854  $ 593,175  $ (6,997) $ 1,088,032 

18


Property Insights

Our property insights solutions combine our patented predictive analytics with our proprietary and contributed data to enable our clients to improve customer acquisition and retention, detect and prevent fraud, improve mortgage transaction cycle time and cost efficiency, identify real estate trends and neighborhood characteristics, track market performance, and increase market share. Our data is comprised of real estate information, incorporating crime, site inspection, neighborhood, document images, and other information from proprietary sources. We also offer verification of applicant income, identity and employment services. We typically license data in one of two forms: bulk data licensing and transactional licensing. Operating revenue for bulk data licensing contracts that provide a stand-ready obligation or include substantive updates to the intellectual property is recognized ratably over the contractual term; otherwise, operating revenue is recognized upon delivery. For transactional licensing, we recognize operating revenue based on usage.

Insurance and Spatial Solutions

Our insurance and spatial solutions provide originators and property and casualty insurers the ability to more effectively locate, assess and manage property-level assets and risks through location-based data and analytics. We also provide cloud-based property claims workflow technology for property and casualty insurers. The licensed intellectual property data is generally provided to our clients on a subscription or usage basis. For subscription contracts, operating revenue is recognized ratably over the contractual term once initial delivery has occurred. For contracts to provide a license to data which is delivered via report or data file, operating revenue is recognized when the client obtains control of the products, which is upon delivery.

Property Tax Solutions

Our property tax solutions are built from aggregated property tax information from over 20,000 taxing authorities. We use this information to advise mortgage lenders and servicers of the property tax payment status of loans in their portfolio and to monitor that status over the life of the loans. If a mortgage lender or servicer requires tax payments to be impounded on behalf of its borrowers, we can also facilitate the transfer of these funds to the taxing authorities and provide the lender or servicer with payment confirmation. Property tax processing revenues are primarily comprised of periodic loan fees and life-of-loan fees. For periodic fee arrangements, we generate monthly fees at a contracted rate for as long as we service the loan. For life-of-loan fee arrangements, we charge a one-time fee when the loan is set-up in our tax servicing system. Life-of-loan fees are deferred and recognized ratably over the expected service period of 10 years and adjusted for early loan cancellation. Revenue recognition rates of loan portfolios are regularly analyzed and adjusted monthly to reflect current trends.

Valuation Solutions

Our valuation solutions represent property valuation-related data driven services and analytics combined with collateral valuation workflow technologies which assist our clients in assessing risk of loss using both traditional and alternative forms of property valuation, driving process efficiencies as well as ensuring compliance with lender and governmental regulations. We provide collateral information technology and solutions that automate property appraisal ordering, tracking, documentation and review for lender compliance with government regulations. Revenue for the property appraisal service is recognized when the appraisal service is performed and delivered to the client. In addition, to the extent that we provide continuous access to the hosted software platform, we recognize operating revenue over the term of the arrangement.

Flood Data Solutions

Our flood data solutions provide flood zone determinations primarily to mortgage lenders in accordance with US Federal legislation passed in 1994, which requires that most lenders obtain a determination of the current flood zone status at the time each loan is originated and obtain applicable updates during the life of the loan if contracted to do so. We also provide flood zone determinations to insurance companies. We generally recognize operating revenue upon delivery of the initial determination. If contracted for life of loan monitoring, we recognize operating revenue over the estimated service period, as adjusted for early loan cancellation.
Contract Costs

Incremental costs to obtain or fulfill client contracts are recognized as an asset. As of September 30, 2020, we had $13.0 million of current deferred contract costs which are presented in prepaid expenses and other current assets, as well as $23.4 million of long-term deferred contract costs which are presented in other assets in our condensed consolidated balance sheet. As of December 31, 2019, we had $9.8 million of current deferred contract costs which are presented in prepaid expenses and other current assets as well as $23.1 million of long-term deferred contract costs which are presented in other assets in our
19


consolidated balance sheet. Our deferred contract costs primarily include certain set-up and acquisition costs related to property tax solutions, which amortize ratably over an expected 10-year life, adjusted for early loan cancellations. For the three months ended September 30, 2020 and 2019, we recorded amortization associated with deferred contract costs of $5.6 million and $3.4 million, respectively, and $13.9 million and $9.8 million, respectively, for the nine months ended September 30, 2020 and 2019.

Contract Liabilities

We record a contract liability when amounts are invoiced, which is generally prior to the satisfaction of the performance obligation. For property tax solutions, we invoice upfront fees to clients for services to be performed over time. For property insights and insurance and spatial solutions we invoice quarterly and annually, commencing upon execution of the contracts or at the beginning of the license term, as applicable.

As of September 30, 2020, we had $986.9 million in contract liabilities compared to $883.8 million as of December 31, 2019. The overall change of $103.1 million in contract liability balances is primarily due to $632.4 million of new deferred billings in the current year, partially offset by $530.2 million of operating revenue recognized, of which $292.8 million related to contracts previously deferred, and other increases of $0.9 million.

Remaining Performance Obligations

The majority of our arrangements are between one and three years with a significant portion being one year or less. For the remaining population of non-cancellable and fixed arrangements greater than one year, as of September 30, 2020 we had $1.2 billion of remaining performance obligations. We expect to recognize approximately 11% percent of this remaining revenue backlog in 2020, 31% in 2021, 21% in 2022 and 37% thereafter. See further discussion of performance obligations in Note 1 - Basis for Condensed Consolidated Financial Statements.

Note 8 – Share-Based Compensation

We currently issue equity awards under the CoreLogic, Inc. 2018 Performance Incentive Plan (the “Plan”), which was approved by our stockholders at our Annual Meeting held in May 2018. The Plan includes the ability to grant share-based instruments such as RSUs, PBRSUs, and stock options. Prior to the approval of the Plan, we issued share-based awards under the CoreLogic, Inc. 2011 Performance Incentive Plan, as amended, which was preceded by the CoreLogic, Inc. 2006 Incentive Plan. The Plan provides for up to 15,139,084 shares of the Company's common stock to be available for award grants.

We have primarily utilized RSUs and PBRSUs as our share-based compensation instruments for employees and directors. The fair value of any share-based compensation instrument grant is based on the market value of our common stock on the date of grant and is recognized as compensation expense over its vesting period.

Restricted Stock Units

For the nine months ended September 30, 2020 and 2019, we awarded 777,139 and 640,339 RSUs, respectively, with an estimated grant-date fair value of $28.8 million and $23.5 million, respectively. The RSU awards will vest ratably over 3 years. RSU activity for the nine months ended September 30, 2020 is as follows:
Number of Shares Weighted-Average
Grant-Date Fair Value
(in thousands, except weighted-average fair value prices)
Unvested RSUs outstanding at December 31, 2019 1,032  $ 39.84 
RSUs granted 777  $ 37.10 
RSUs vested (524) $ 40.51 
RSUs forfeited (47) $ 36.53 
Unvested RSUs outstanding at September 30, 2020 1,238  $ 37.98 

As of September 30, 2020, there was $29.7 million of total unrecognized compensation cost related to unvested RSUs that is expected to be recognized over a weighted-average period of 1.7 years. The fair value of RSU awards is based on the market value of our common stock on the date of grant.

20


Performance-Based Restricted Stock Units

For the nine months ended September 30, 2020 and 2019, we awarded 321,014 and 203,464 PBRSUs, respectively, with an estimated grant-date fair value of $13.0 million and $7.5 million, respectively. These awards are generally subject to service-based, performance-based, and market-based vesting conditions. 

The service and performance period for the 2020 PBRSU grants is from January 2020 to December 2022 and the performance metric is adjusted earnings per share, subject to modification based on relative total stockholder return, a market-based vesting condition. The performance and service period for the 2019 PBRSUs is from January 2019 to December 2021 and the performance metric is adjusted earnings per share, subject to modification based on relative total stockholder return, a market-based vesting condition.

The fair value of PBRSU awards are based on the market value of our common stock on the date of grant. For PBRSUs with market-based vesting conditions, we also use the Monte-Carlo simulation with the following weighted-average assumptions:
For the Nine Months Ended September 30,
2020 2019
Expected dividend yield (1)
—  % —  %
Risk-free interest rate (2)
0.60  % 2.44  %
Expected volatility (3)
32.53  % 28.24  %
Average total stockholder return (3)
(21.47) % 17.15  %
(1) Since PBRSU participants are credited with dividend equivalent shares when dividends are paid, 0.00% was used in the Monte-Carlo simulation which is mathematically equivalent to paying dividend equivalents upon vesting. Please see Note 1 - Basis for Condensed Consolidated Financial Statements for further information regarding dividends.
(2) The risk-free interest rate for the periods within the contractual term of the PBRSUs is based on the US Treasury yield curve in effect at the time of the grant.
(3) The expected volatility and average total stockholder return are measures of the amount by which a stock price has fluctuated or is expected to fluctuate based primarily on our and our peers' historical data.

Additionally, within our outstanding unvested PBRSUs shown in the table below, there are prior year grants which do not include market-based conditions, but instead have adjusted EBITDA margin or organic revenue growth rate as the performance metric.

PBRSU activity for the nine months ended September 30, 2020 is as follows:
Number of Shares Weighted-Average
Grant-Date Fair Value
(in thousands, except weighted-average fair value prices)
Unvested PBRSUs outstanding at December 31, 2019 636  $ 42.62 
PBRSUs granted 321  $ 40.64 
PBRSUs vested (184) $ 39.50 
PBRSUs forfeited (29) $ 44.77 
Unvested PBRSUs outstanding at September 30, 2020 744  $ 42.58 

As of September 30, 2020, there was $20.1 million of total unrecognized compensation cost related to unvested PBRSUs that is expected to be recognized over a weighted-average period of 1.7 years.

Stock Options

Prior to 2015, we issued stock options as incentive compensation for certain employees. Option activity for the nine months ended September 30, 2020 is as follows:
21


(in thousands, except weighted-average price) Number of
Shares
Weighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual Term
Aggregate
Intrinsic
Value
Options outstanding at December 31, 2019 479  $ 19.59     
Options exercised (82) $ 18.34     
Options outstanding at September 30, 2020 397  $ 19.84  1.9 $ 19,024 

As of September 30, 2020, there was no unrecognized compensation cost related to unvested stock options.

The intrinsic value of options exercised was $2.9 million and $1.4 million for the nine months ended September 30, 2020 and 2019, respectively. This intrinsic value represents the difference between the fair market value of our common stock on the date of exercise and the exercise price of each option.

Employee Stock Purchase Plan

The employee stock purchase plan allows eligible employees to purchase our common stock at 85.0% of the lesser of the closing price on the first day or the last day of each quarter. Our employee stock purchase plan was approved by our stockholders at our 2012 annual meeting of stockholders and the first offering period commenced in October 2012. We recognize an expense for the amount equal to the estimated fair value of the discount during each offering period.

The following table sets forth the share-based compensation expense recognized for the three and nine months ended September 30, 2020 and 2019:
For the Three Months Ended For the Nine Months Ended
September 30, September 30,
(in thousands) 2020 2019 2020 2019
RSUs $ 6,378  $ 4,521  $ 17,446  $ 17,063 
PBRSUs 5,468  3,893  14,264  7,390 
Stock options —  —  —  — 
Employee stock purchase plan 700  392  2,188  1,565 
  $ 12,546  $ 8,806  $ 33,898  $ 26,018 

The table above includes $1.1 million and $0.5 million of share-based compensation expense within cost of services in the accompanying condensed consolidated statements of operations for the three months ended September 30, 2020 and 2019, respectively, and $2.2 million and $1.7 million for the nine months ended September 30, 2020 and 2019, respectively. Additionally, we recognized $0.3 million of share-based compensation expense for both the three months ended September 30, 2020 and 2019, and $0.8 million for both the nine months ended September 30, 2020 and 2019, reported within income/(loss) from discontinued operations.

Note 9 – Litigation and Regulatory Contingencies

We have been named in various lawsuits and we are from time to time subject to audit or investigation by governmental agencies arising in the ordinary course of business.

With respect to matters where we determine that a loss is both probable and reasonably estimable, we record a liability representing our best estimate of the financial exposure based on known facts. For matters where a settlement has been reached, we record the expected amount of such settlements. With respect to audits, investigations or lawsuits that are ongoing, although their final dispositions are not yet determinable, we do not believe that the ultimate resolution of such matters, either individually or in the aggregate, will have a material adverse effect on our financial condition, results of operations or cash flows. The ability to predict the ultimate outcome of such matters involves judgments, estimates and inherent uncertainties. The actual outcome of such matters could differ materially from management’s estimates. We record expenses for legal fees as incurred. As of September 30, 2020 our accrual for litigation and regulatory contingencies was immaterial.

22


Fair Credit Reporting Act Class Actions

In July 2017, Rental Property Solutions, LLC (“RPS”) was named as a defendant in Claudinne Feliciano, et. al., v. CoreLogic SafeRent, LLC, a putative class action lawsuit in the US District Court for the Southern District of New York. The named plaintiff alleges that RPS prepared a background screening report about her that contained a record of a New York Housing Court action without noting that the action had previously been dismissed. On this basis, she seeks damages under the Fair Credit Reporting Act and the New York Fair Credit Reporting Act on behalf of herself and a class of similarly situated consumers with respect to reports issued during the period of July 2015 to the present. In July 2019, the District Court issued an order certifying a class of approximately 2,000 consumers. In June 2020, we reached an agreement to resolve the case. The settlement has been preliminarily approved by the District Court, and a final approval hearing is scheduled for February 23, 2021. The settlement amount was recorded during the quarter ended June 30, 2020.

In May 2020, Rental Property Solutions, LLC (“RPS”) was named as a defendant in Terry Brown v. CoreLogic Rental Property Solutions, LLC, a putative class action lawsuit filed in the US District Court for the Eastern District of Virginia. The named plaintiff alleges that RPS prepared a background screening report about him that included a sex offender record that did not relate to him. He seeks damages under the Fair Credit Reporting Act on behalf of himself and a class of similarly situated consumers, as well as a subclass of consumers for whom misattributed sex offender records were removed following a dispute. The Company intends to vigorously defend itself in the litigation.

In June 2020, CoreLogic Credco, LLC (“Credco”) was named as a defendant in Marco Fernandez v. CoreLogic Credco, LLC, a putative class action lawsuit filed in California Superior Court in San Diego County. The named plaintiff alleges that Credco provided a lender with a consumer report about him that erroneously indicated he is on the Office of Foreign Asset Control’s list of Specially Designated Nationals and Blocked Persons (“OFAC List”). He further alleges that Credco failed to provide him with a copy of the OFAC List designation upon request, failed to notify him of what entities had received such a notification in the past, and failed to respond to his effort to dispute the item. He seeks to represent three classes and four subclasses based upon these allegations, and asserts seven claims under the Fair Credit Reporting Act, the California Credit Reporting Agencies Act, and California’s Unfair Competition law. The Company has removed the case to the US District Court for the Southern District of California, and intends to vigorously defend itself in the litigation.

Separation

Following the separation of the financial services businesses of our predecessor company, The First American Corporation (“FAC”) on June 1, 2010 (the “Separation”), we are responsible for a portion of First American Financial Corporation's ("FAFC") contingent and other corporate liabilities. In the Separation and Distribution Agreement we entered into in connection with the Separation, we agreed with FAFC to share equally in the cost of resolution of a small number of corporate-level lawsuits, including certain consolidated securities litigation matters from which we have since been dropped. There were no liabilities incurred in connection with the consolidated securities matters. Responsibility to manage each case has been assigned to either FAFC or us, with the managing party required to update the other party regularly and consult with each other prior to certain important decisions, such as settlement. The managing party will also have primary responsibility for determining the ultimate total liability, if any, related to the applicable case. We will record our share of any such liability when the responsible party determines a reserve is necessary. As of September 30, 2020, no reserves were considered necessary.

In addition, the Separation and Distribution Agreement provides for cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of FAC's financial services business with FAFC, and financial responsibility for the obligations and liabilities of FAC's information solutions business with us. Specifically, each party will, and will cause its subsidiaries and affiliates to, indemnify, defend and hold harmless the other party, its respective affiliates and subsidiaries and each of its respective officers, directors, employees and agents for any losses arising out of or otherwise in connection with the liabilities each such party assumed or retained pursuant to the Separation.

Note 10 – Income Taxes

The effective income tax rate for income taxes as a percentage of income from continuing operations before equity in earnings of affiliates and income taxes was a benefit of 10.4% and and provision of 27.1% for the three months ended September 30, 2020 and 2019, respectively, and a provision of 10.0% and a benefit of 718.7% for the nine months ended September 30, 2020 and 2019, respectively.

During the quarter ended September 30, 2020, the Internal Revenue Service ("IRS") concluded their examination of our 2010 to 2012 income tax returns resulting in the recognition of a discrete tax benefit of approximately $24 million, inclusive of anticipated interest and state taxes.

23


For the three months ended September 30, 2020, when compared to the same period for 2019, the change in the effective income tax rate was primarily due to the benefit recorded in relation to the settlement of the IRS examination in 2020. For the nine months ended September 30, 2020, when compared to the same period for 2019, the change in the effective income tax rate was primarily due to the benefit recorded in relation to the settlement of the IRS examination in 2020 as compared to a smaller nonrecurring benefit recorded in 2019 related to the reversal of state tax reserves.     

We are currently under examination for the year 2016 by the IRS, our primary taxing authority, and for other years by various other taxing authorities. It is reasonably possible the amount of the unrecognized benefits could be significantly impacted which would have an impact on net income.

Note 11 – Earnings Per Share

The following is a reconciliation of net income per share:
For the Three Months Ended September 30, For the Nine Months Ended Sep 30,
  2020 2019 2020 2019
(in thousands, except per share amounts)        
Numerator for basic and diluted net income per share:        
Net income from continuing operations $ 102,467  $ 31,668  $ 177,820  $ 8,225 
Income/(loss) from discontinued operations, net of tax 10,679  (8,485) 28,149  11,073 
Net income $ 113,146  $ 23,183  $ 205,969  $ 19,298 
Denominator:        
Weighted-average shares for basic income/(loss) per share 79,467  79,761  79,300  80,138 
Dilutive effect of stock options and RSUs 1,935  1,153  1,836  1,067 
Weighted-average shares for diluted income/(loss) per share 81,402  80,914  81,136  81,205 
Income/(loss) per share        
Basic:        
Net income from continuing operations $ 1.29  $ 0.40  $ 2.24  $ 0.10 
Income/(loss) from discontinued operations, net of tax 0.13  (0.11) 0.35  0.14 
Net income $ 1.42  $ 0.29  $ 2.59  $ 0.24 
Diluted:  
Net income from continuing operations $ 1.26  $ 0.39  $ 2.19  $ 0.10 
Income/(loss) from discontinued operations, net of tax 0.13  (0.10) 0.35  0.14 
Net income $ 1.39  $ 0.29  $ 2.54  $ 0.24 

The dilutive effect of share-based compensation awards has been calculated using the treasury-stock method. For both the three and nine months ended September 30, 2020 and 2019 an aggregate of less than 0.1 million of RSUs and PBRSUs were excluded from the weighted-average diluted common shares outstanding due to their anti-dilutive effect.
24


Note 12 – Acquisitions

In January 2020, we acquired the remaining 66% of Location for $11.5 million, subject to certain working capital adjustments. Location is a leading provider of geographic location indicators for crime and non-weather related events connected to underwriting risk assessment. This acquisition further progresses our long-term strategic plan by adding scale to our insurance and spatial businesses. Location is included as a component of our PIRM segment. The purchase price was allocated to the assets acquired and liabilities assumed using a variety of valuation techniques including discounted cash flow analysis, which included significant unobservable inputs. We have preliminarily recorded proprietary technology of $6.0 million with an estimated useful life of 10 years, client lists of $0.3 million with an estimated useful life of 5 years, trademarks of $0.8 million with an estimated useful life of 8 years, non-compete agreements of $0.4 million with an estimated useful life of 5 years, and goodwill of $12.6 million. For the nine months ended September 30, 2020, goodwill increased by $0.3 million as a result of a change in the purchase price allocation for certain working capital adjustments. In connection with this acquisition, we remeasured our then-existing 34% investment ownership in Location which resulted in a $0.6 million step-up gain that we recorded within gain/(loss) on investments and other, net, in our condensed consolidated statement of operations for the nine months ended September 30, 2020.

In August 2019, we completed the acquisition of NTS for $15.0 million, subject to certain working capital adjustments, and up to $7.5 million to be paid in cash by 2022, contingent upon the achievement of certain revenue targets in fiscal years 2020 and 2021 (see Note 6 - Fair Value for further details). NTS is a leading provider of commercial property tax payment services and specializes in identifying potential collateral loss related to unpaid property tax, homeowners association fees, and inaccurate flood zone determinations. The NTS acquisition increases our commercial property information offerings and is expected to drive future growth in the US. NTS is included as a component of our UWS segment. The purchase price was allocated to the assets acquired and liabilities assumed using a variety of valuation techniques including discounted cash flow analysis, which included significant unobservable inputs. We recorded client lists of $5.0 million with an estimated useful life of 10 years, proprietary technology of $3.3 million with an estimated useful life of 7 years, trademarks of $1.0 million with an estimated useful life of 7 years, non-compete agreements of $0.3 million with an estimated useful life of 5 years, contract liabilities of $2.5 million, and goodwill of $5.5 million, all of which is deductible for tax purposes. For the nine months ended September 30, 2020, goodwill increased by less than $0.1 million as a result of a change in the purchase price allocation for certain working capital adjustments.

These business combinations did not have a material impact on our condensed consolidated statements of operations.

There was $0.1 million of acquisition-related costs within selling, general and administrative expenses on our condensed consolidated statements of operations for both the three months ended September 30, 2020 and 2019, and $0.1 million and $0.3 million of these costs for the nine months ended September 30, 2020 and 2019, respectively.

Note 13 – Segment Information

We have organized into two reportable segments: PIRM and UWS.

Property Intelligence & Risk Management Solutions. Our PIRM segment combines property information, mortgage information, and consumer information to deliver unique housing market and property-level insights, predictive analytics and risk management capabilities. We have also developed proprietary technology and software platforms to access, automate, and track this information and assist our clients with decision-making and compliance tools in the real estate industry, and insurance industry. We deliver this information directly to our clients in a standard format over the web, through hosted software platforms, or in bulk data form. Our PIRM solutions include property insights and insurance and spatial solutions in North America, Western Europe, and Asia Pacific. The segment's primary clients are commercial banks, mortgage lenders and brokers, investment banks, fixed-income investors, real estate agents, MLS companies, property and casualty insurance companies, title insurance companies, government agencies, and government-sponsored enterprises.

The operating results of our PIRM segment included intercompany revenues of $2.3 million and $1.9 million for the three months ended September 30, 2020 and 2019, respectively, and $8.2 million and $4.4 million for the nine months ended September 30, 2020 and 2019, respectively. The segment also included intercompany expenses of $0.6 million and $0.8 million for the three months ended September 30, 2020 and 2019, respectively, and $1.9 million and $2.6 million for the nine months ended September 30, 2020 and 2019, respectively.

25


Underwriting & Workflow Solutions. Our UWS segment combines property and mortgage to provide comprehensive mortgage origination and monitoring solutions, including, underwriting-related solutions, and data-enabled valuations and appraisals. We have also developed proprietary technology and software platforms to access, automate, and track this information, and assist our clients with vetting and onboarding prospects, meeting compliance regulations and understanding, evaluating, and monitoring property values. Our UWS solutions include property tax solutions, valuation solutions, and flood data solutions in North America. The segment’s primary clients are large, national mortgage lenders and servicers, but we also serve regional mortgage lenders and brokers, credit unions, commercial banks, fixed-income investors, government agencies, and property and casualty insurance companies.

The operating results of our UWS segment included intercompany revenues of $0.6 million and $0.8 million for the three months ended September 30, 2020 and 2019, respectively, and $1.9 million and $2.6 million for the nine months ended September 30, 2020 and 2019, respectively. The segment also included intercompany expenses of $0.9 million and $1.0 million for the three months ended September 30, 2020 and 2019, respectively, and $2.7 million and $3.5 million for the nine months ended September 30, 2020 and 2019, respectively.

We also separately report on our corporate and eliminations. Corporate consists primarily of corporate personnel and other expenses associated with our corporate functions and facilities, investment gains and losses, equity in earnings/(losses) of affiliates, net of tax, and interest expense. The results of our Corporate segment included intercompany expenses of $1.5 million and $5.6 million for the three and nine months ended September 30, 2020, respectively, and $0.9 million for both the three and nine months ended September 30, 2019.

26


Selected financial information by reportable segment related to our continuing operations is as follows:
(in thousands) Operating Revenues Depreciation and Amortization Operating Income/(Loss) Equity in Earnings/(Losses) of Affiliates, Net of Tax Net Income/(Loss) From Continuing Operations Capital Expenditures
For the Three Months Ended September 30, 2020
PIRM $ 176,248  $ 23,474  $ 22,670  $ 1,013  $ 58,325  $ 16,957 
UWS 263,342  12,017  124,699  —  124,834  2,366 
Corporate —  8,119  (74,186) (42) (80,692) 5,768 
Eliminations (2,863) —  —  —  —  — 
Consolidated (excluding discontinued operations) $ 436,727  $ 43,610  $ 73,183  $ 971  $ 102,467  $ 25,091 
For the Three Months Ended September 30, 2019        
PIRM $ 169,079  $ 23,061  $ 18,375  $ 762  $ 19,366  $ 10,706 
UWS 209,138  11,800  70,831  (4) 70,642  1,942 
Corporate —  7,528  (27,339) (151) (58,340) 13,766 
Eliminations (2,646) —  —  —  —  — 
Consolidated (excluding discontinued operations) $ 375,571  $ 42,389  $ 61,867  $ 607  $ 31,668  $ 26,414 
For the Nine Months Ended September 30, 2020        
PIRM $ 504,379  $ 69,833  $ 65,249  $ 2,483  $ 102,451  $ 42,813 
UWS 680,455  36,091  281,567  —  281,717  5,891 
Corporate —  24,715  (136,229) (624) (206,348) 20,200 
Eliminations (10,101) —  —  —  —  — 
Consolidated (excluding discontinued operations) $ 1,174,733  $ 130,639  $ 210,587  $ 1,859  $ 177,820  $ 68,904 
For the Nine Months Ended September 30, 2019        
PIRM $ 501,854  $ 72,135  $ 44,110  $ 720  $ 38,382  $ 36,767 
UWS 593,175  39,391  121,946  (12) 121,745  8,472 
Corporate —  21,241  (94,386) (210) (151,902) 33,413 
Eliminations (6,997) —  —  —  —  — 
Consolidated (excluding discontinued operations) $ 1,088,032  $ 132,767  $ 71,670  $ 498  $ 8,225  $ 78,652 
(in thousands)
Assets September 30, 2020 December 31, 2019
PIRM $ 1,851,655  $ 1,932,643 
UWS 2,019,299  2,008,233 
Corporate 6,185,679  5,950,472 
Eliminations (5,870,954) (5,934,053)
Consolidated (excluding discontinued operations) $ 4,185,679  $ 3,957,295 
27


Note 14 – Discontinued Operations

In July 2020, we announced our intentions to pursue the sale of our reseller businesses as these are lower-margin businesses that are highly influenced by vendor pricing. These businesses are comprised of our Credit Solutions and Rental Property Solutions operations. We expect to sell these businesses to unrelated third parties within one year of the quarter ended September 30, 2020. These reseller business were included within the PIRM and UWS segments.

For both the three and nine months ended September 30, 2020, we recorded $0.6 million in costs directly related to the sale of these reseller businesses. Each of these businesses is reflected in our accompanying condensed consolidated financial statements as discontinued operations.

In September 2014, we completed the sale of our collateral solutions and field services businesses, which were included in the former reporting segment Asset Management and Processing Solutions ("AMPS"). In connection with the sale of our Employer and Litigation Services businesses (“ELI”) in December 2010, we retained certain liabilities and, in September 2016, a jury returned an unfavorable verdict against this discontinued operating unit, which we appealed. In August 2019, the verdict was upheld on appeal. We were unable to secure further review of the appellate decision and paid $23.0 million to satisfy the judgement in December 2019.

In October 2020, we consummated the sale of a component of the reseller operations for $9.0 million.

Summarized below are certain assets and liabilities classified as discontinued operations as of September 30, 2020 and December 31, 2019:

28


(in thousands)
As of September 30, 2020 PIRM UWS AMPS ELI Total
Cash and cash equivalents $ 941  $ 1,369  $ —  $ —  $ 2,310 
Accounts receivable 4,304  39,689  —  —  43,993 
Property and equipment, net 5,257 22,960 —  —  28,217 
Goodwill, net 29,269 79,931 —  —  109,200 
Capitalized data and database costs, net 16,643 941 —  —  17,584 
Other assets 537 5,682 268 —  6,487 
Total assets $ 56,951  $ 150,572  $ 268  $ —  $ 207,791 
Accounts payable and accrued expenses $ 2,460  $ 24,590  $ 240  $ —  $ 27,290 
Accrued salaries and benefits 487 3,073 —  —  3,560 
Deferred income tax liabilities 8,206  9,637 —  393  18,236 
Other liabilities 389 1,022 —  —  1,411 
Total liabilities $ 11,542  $ 38,322  $ 240  $ 393  $ 50,497 
As of December 31, 2019
Cash and cash equivalents $ 711  $ 313  $ —  $ —  $ 1,024 
Accounts receivable 3,538  30,171  —  —  33,709 
Income tax receivable —  —  —  6,166 6,166 
Property and equipment, net 4,831 21,520 —  —  26,351 
Goodwill, net 29,269 79,931 —  —  109,200 
Capitalized data and database costs, net 17,781 888 —  —  18,669 
Other assets 598 5,981 268 20 6,867 
Total assets $ 56,728  $ 138,804  $ 268  $ 6,186  $ 201,986 
Accounts payable and accrued expenses $ 987  $ 15,881  $ 240  $ 22  $ 17,130 
Accrued salaries and benefits 785 2,395 —  —  3,180
Deferred income tax liabilities 8,206 9,637 —  393  18,236
Other liabilities 456 3,706 —  —  4,162
Total liabilities $ 10,434  $ 31,619  $ 240  $ 415  $ 42,708 

    
Summarized below are the components of our income/(loss) from discontinued operations, net of tax for the three and nine months ended September 30, 2020 and 2019:
29


(in thousands)
For the Three Months September 30, 2020 PIRM UWS AMPS ELI Total
Operating revenues $ 9,904  $ 93,262  $ —  $ —  $ 103,166 
Cost of services (exclusive of depreciation and amortization) 4,711  75,732  —  —  80,443 
Selling, general and administrative expenses 2,989  4,539  —  (1) 7,527 
Depreciation and amortization 1,204  957  —  —  2,161 
Gain on investments and other, net —  (1,194) —  —  (1,194)
Income from discontinued operations before income taxes 1,000  13,228  —  14,229 
Provision for income taxes 250  3,300  —  —  3,550 
Income from discontinued operations, net of tax $ 750  $ 9,928  $ —  $ $ 10,679 
For the Three Months September 30, 2019
Operating revenues $ 11,066  $ 72,317  $ —  $ —  $ 83,383 
Cost of services (exclusive of depreciation and amortization) 5,112  58,359  —  —  63,471 
Selling, general and administrative expenses 2,763  1,913  23,129  27,810 
Depreciation and amortization 1,953  1,375  —  —  3,328 
Impairment Loss (1) 78  —  —  77 
Loss on investments and other, net —  —  — 
Income/(loss) from discontinued operations before income taxes 1,239  10,589  (5) (23,129) (11,306)
Provision/(benefit) for income taxes 309  2,642  (1) (5,771) (2,821)
Income/(loss) from discontinued operations, net of tax $ 930  $ 7,947  $ (4) $ (17,358) $ (8,485)
30


(in thousands)
For the Nine Months Ended September 30, 2020 PIRM UWS AMPS ELI Total
Operating revenues $ 28,452  $ 258,058  $ —  $ —  $ 286,510 
Cost of services (exclusive of depreciation and amortization) 14,054  211,604  —  —  225,658 
Selling, general and administrative expenses 9,674  8,816  (19) 18,472 
Depreciation and amortization 4,906  3,770  —  —  8,676 
(Gain)/loss on investments and other, net —  (3,803) —  —  (3,803)
Income from discontinued operations before income taxes (182) 37,671  (1) 19  37,507 
Provision for income taxes (45) 9,398  —  9,358 
Income from discontinued operations, net of tax $ (137) $ 28,273  $ (1) $ 14  $ 28,149 
For the Nine Months Ended September 30, 2019
Operating revenues $ 35,348  $ 212,822  $ —  $ —  $ 248,170 
Cost of services (exclusive of depreciation and amortization) 16,009  171,475  —  —  187,484 
Selling, general and administrative expenses 8,139  5,373  23,252  36,770 
Depreciation and amortization 5,791  3,484  —  —  9,275 
Impairment Loss —  78  —  —  78 
Gain on investments and other, net —  (191) —  —  (191)
Income/(loss) from discontinued operations before income taxes 5,409  32,603  (6) (23,252) 14,754 
Provision/(benefit) for income taxes 1,350  8,133  (1) (5,801) 3,681 
Income/(loss) from discontinued operations, net of tax $ 4,059  $ 24,470  $ (5) $ (17,451) $ 11,073 
31


Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
 
This Quarterly Report on Form 10-Q and certain information incorporated herein by reference contain forward-looking statements within the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. All statements included or incorporated by reference in this Quarterly Report, other than statements that are purely historical, are forward-looking statements. Words such as “anticipate,” “expect,” “intend,” “plan,” “believe,” “seek,” “estimate,” “will,” “should,” “would,” “could,” “may,” and similar expressions also identify forward-looking statements. The forward-looking statements include, without limitation, statements regarding our future operations, financial condition and prospects, operating results, revenues and earnings liquidity, our estimated income tax rate, unrecognized tax positions, amortization expenses, impact of recent accounting pronouncements, our cost management program, our acquisition strategy and our growth plans, expectations regarding our recent acquisitions, share repurchases, the level of aggregate US mortgage originations, the reasonableness of the carrying value related to specific financial assets and liabilities, the near and long-term consequences of the unsolicited proposal from Senator Investment Group, L.P. ( “Senator”) and Cannae Holdings, Inc. (“Cannae”) to acquire the Company for $66.00 per share in cash (the “Unsolicited Proposal”), and the outcome and consequences of certain proposals, including the removal and replacement of up to nine members of our Board of Directors, that Senator and Cannae have requested be presented to our stockholders and that will be voted upon at a special meeting of stockholders on November 17, 2020 (the “Proxy Contest”).

Our expectations, beliefs, objectives, intentions and strategies regarding future results are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results to differ materially from results contemplated by our forward-looking statements. These risks and uncertainties include, but are not limited to:

the potential impact of, and any potential developments related to, the Unsolicited Proposal and the Proxy Contest;
the impact of our adoption of a shareholder rights plan;
the potential impact that the COVID-19 pandemic, or the perception of its effects, may have on our business;
compromises in the security or stability of our data and systems, including from cyber-based attacks, the unauthorized transmission of confidential information or systems interruptions;
changes in prices at which we are able to repurchase our shares and limitations on our ability to repurchase our shares;
limitations on access to, or increase in prices for, data from external sources, including government and public record sources;
interruptions which could impair the delivery of our products and services;
changes in applicable government legislation, regulations and the level of regulatory scrutiny affecting our clients or us, including with respect to consumer financial services and the use of public records and consumer data;
difficult or uncertain conditions in the mortgage and consumer lending industries and the economy generally;
reliance on our top ten clients for a significant portion of our revenue and profit;
intense competition in the market against third parties and the in-house capabilities of our clients;
risks related to the outsourcing of services and international operations;
our ability to realize the anticipated benefits of certain acquisitions and the timing thereof;
our ability to operate in international markets;
our ability to protect proprietary technology rights and avoid infringement of others’ proprietary technology rights;
the level of our indebtedness, our ability to service our indebtedness and the restrictions in our various debt agreements;
our ability to attract and retain qualified management; and
the remaining tax sharing arrangements and other obligations associated with the spin-off of First American Financial Corporation (“FAFC”).

We urge you to carefully consider risks and uncertainties and review the additional disclosures we make concerning risks and uncertainties that may materially affect the outcome of our forward-looking statements and our future business and operating results, including those made in Item 1A of Part II of this Quarterly Report on Form 10-Q, Item 1A of Part II of our Quarterly Reports on Forms 10-Q for the quarters ended March 31, 2020 and June 30, 2020, and Item 1A of Part I of our Annual Report on Form 10-K for the year ended December 31, 2019, as such risk factors may be amended, supplemented, or superseded from time to time by other reports we file with the Securities and Exchange Commission. We assume no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of the filing of this Quarterly Report on Form 10-Q.

32


Business Overview

We are a leading global property information, analytics and data-enabled software platforms and services provider operating in North America, Western Europe and Asia Pacific. Our combined data from public, contributory and proprietary sources provides detailed coverage of property, mortgages, other encumbrances, property risk and replacement cost, location, hazard risk and related performance information. We have more than one million users who rely on our data and predictive decision analytics to reduce risk, enhance transparency and improve the performance of their businesses.

We offer our clients a comprehensive national database covering real property and mortgage information, judgments and liens, building and replacement costs, parcel and geospatial data, and tax information, among other data types. Our structured property-specific data consisting of over 150 million parcel records covers 99% of the United States ("US"), includes both residential and commercial real estate data and is enriched by over 1 billion historical sales, mortgage, and pre-foreclosure transactions. Our consortium data covers loan level mortgage performance, appraisal, as well as mortgage application data and is in excess of 300 million records. We are also the industry's first parcel-based geocoder and have developed a proprietary spatial database covering more than 150 million parcel polygons across the US. We believe the quality of the data we offer is distinguished by our broad range of data sources and our experience in aggregating, organizing, normalizing, processing, and delivering data to our clients.

With our data as a foundation, we have built strong analytics capabilities and a variety of value-added business services to meet our clients’ needs for property tax processing, property valuation, hazard risk, property risk and replacement cost, flood plain location determination, other geospatial data analytics, and related services.

Reportable Segments

We have organized into the following two reportable segments:

Our Property Intelligence & Risk Management (“PIRM”) segment combines property information, mortgage information, and consumer information to deliver unique housing market and property-level insights, predictive analytics and risk management capabilities. We have also developed proprietary technology and software platforms to access, automate or track this information and assist our clients with decision-making and compliance tools in the real estate industry and insurance industry. We deliver this information directly to our clients in a standard format over the web, through hosted software platforms or in bulk data form. Our solutions include property insights as well as insurance and spatial solutions in North America, Western Europe and Asia Pacific.

Our Underwriting & Workflow Solutions (“UWS”) segment combines property information and mortgage information to provide comprehensive mortgage origination and monitoring solutions, including underwriting-related solutions and data-enabled valuations and appraisals. We have also developed proprietary technology and software platforms to access, automate or track this information and assist our clients with vetting and on-boarding prospects, meeting compliance regulations and understanding, diagnosing and monitoring property values. Our solutions include property tax solutions, valuation solutions, and flood services in North America.

33


Results of Operations

Overview of Business Environment and Company Developments

COVID-19

The global coronavirus ("COVID-19") pandemic and the mitigation efforts by governments to attempt to control its spread have adversely impacted the global economy, leading to disruptions and volatility in the global financial markets. Most states and many countries have issued policies intended to stop or slow the further spread of the disease. Our first priority remains ensuring the safety and health of our employees, clients, and others with whom we partner in conducting our business. We have deployed risk mitigation activities, safety practices, and business continuity strategies so that we can continue offering our clients consistent service offerings while continuing to protect our employees.

The volume of US mortgage loan originations serves as a key market driver for more than half of our business. We believe the volume and related volatility of real estate and mortgage transactions is primarily affected by real estate prices, the availability of funds for mortgage loans, mortgage interest rates, housing supply, employment levels, actions by the Federal Reserve, and the overall state of the US economy. Mortgage interest rates are extremely low by historical standards, and are resulting in higher demand for refinance activity, while the purchase market has been adversely impacted by reduced construction and sales of new and existing homes, and more recently, the COVID-19 pandemic and resulting economic instability. For the three and nine months ended September 30, 2020, our continuing operations experienced unfavorable business and revenue impacts of approximately $4.3 million and $16.1 million, respectively, related to the COVID-19 pandemic, exclusive of the increased mortgage refinance volumes. We have also incurred COVID-19 related expenses of $0.6 million and $2.3 million for the three and nine months ended September 30, 2020, respectively. As of September 30, 2020, the impact we have experienced as a result of the COVID-19 pandemic has not had a significant impact on our financial condition, cash flows, control environment, or any related disclosures.

We will continue to monitor our business trends, financial condition, and liquidity, and are taking steps to manage our operating cash flows, by prioritizing our investments, and evaluating our capital needs and activities. Our liquidity as of September 30, 2020 consisted primarily of $302.3 million of cash and cash equivalents, and $750.0 million of unused committed capacity under our revolving credit facility, and we are in compliance with all financial covenants.

Business Environment

We believe mortgage origination unit volumes increased by approximately 35% to 40% in the third quarter of 2020 relative to the same period in 2019, primarily due to higher mortgage refinance volumes resulting from lower interest rates. For 2020, we expect total mortgage unit volumes to increase by approximately 35% relative to 2019 levels, with historically low interest rates benefiting refinance volumes and increasing purchase activity. Further, we anticipate that short-term rates will remain near zero for the foreseeable future and we expect mortgage rates will also remain at near historically low levels. Given this favorable rate environment and the significant population of existing loans that are in the money and meet broad-based eligibility criteria for refinance, we expect refinance volumes to remain at elevated levels through the foreseeable future.

We generate the majority of our operating revenues from clients with operations in the US residential real estate, mortgage origination, and mortgage servicing markets. Approximately 37% and 29% of our operating revenues for the three months ended September 30, 2020 and 2019, respectively, were generated from our top ten clients, who consist of the largest US mortgage originators and servicers. None of our clients individually accounted for greater than 10% of our operating revenues for the three months ended September 30, 2020 or 2019. Approximately 35% and 26% of our operating revenues for the nine months ended September 30, 2020 and 2019, respectively, were generated from our top ten clients. None of our clients individually accounted for greater than 10% of our operating revenues during the nine months ended September 30, 2020 or 2019.

While the majority of our revenues are generated in the US, foreign exchange translation impacted our financial results from our international operating revenues favorably by $1.4 million and unfavorably by $3.0 million for the three and nine months ended September 30, 2020, respectively.

34


Capital Return

In July 2020, our Board of Directors authorized the repurchase up to $1.0 billion of outstanding shares of our common stock. The authorization has no expiration date and supersedes our previous share repurchase authorization. We expect to repurchase approximately $1 billion worth of outstanding shares by the end of 2022, inclusive of at least $500.0 million of shares in 2020.

In July 2020, our Board of Directors announced a 50% increase to the quarterly cash dividend, declaring a cash dividend of $0.33 per share of common stock which was paid in September 2020 to stockholders of record as of the close of business on September 1, 2020. In October 2020, our Board of Directors declared a cash dividend of $0.33 per share of common stock to be paid in December 2020 to shareholders of record on the close of business December 1, 2020.

Acquisitions

In January 2020, we acquired the remaining 66% of Location, Inc. ("Location") for $11.5 million, subject to certain working capital adjustments. Location is included as a component of our PIRM segment. See Note 12 - Acquisitions for further discussion.

Technology Transformation

In September 2018, we announced the adoption of the Google Cloud Platform (“GCP”) as a foundational element of our ongoing technology transformation program to further expand infrastructure capabilities and drive efficiencies. We successfully completed the initial transformation phase, and will continue transitioning our technology over the foreseeable future on an opportunistic basis. The transition to GCP allows us to leverage the capabilities of the cloud platform to achieve best-in-class system performance and reliability and to facilitate the deployment of unique business insights fueled by gold-standard data, information, and analytics. Additionally, we expect to realize cost efficiencies and enhanced security as we continue the transition.

Divestiture of Non-Core Businesses & Transformations

In July 2020, we announced our intention to exit our reseller operations focused on mortgage credit and borrower verification and multi-family tenant screening. Although market leaders in their respective business areas, these reseller businesses are not compatible with our long-term strategic imperatives. The divestiture of these operations is expected to improve the Company’s revenue growth trends, revenue mix, and significantly enhance profit margins. As a result of this strategic decision, the businesses have been reflected in our consolidated financial statements as discontinued operations for all periods presented. For the three and nine months ended September 30, 2020, these businesses generated revenues of $103.2 million and $286.5 million, respectively, and operating income of $14.2 million and $37.5 million, respectively. Please refer to Note 14 - Discontinued Operations for further information.

In December 2018, we announced our intent to exit a loan origination software unit and its remaining legacy default management related platforms, as well as accelerate an appraisal management company ("AMC") transformation program. We believe these actions have expanded our overall profit margins and provide for enhanced long-term organic growth trends. In September 2019, we divested our default management related platforms and received proceeds of $3.8 million. The AMC transformation concluded in December 2019. Operating revenues attributable to the aforementioned business exits and AMC transformation were $17.0 million and $65.6 million for three and nine months ended September 30, 2019, respectively.

Unsolicited Proposal and Proxy Contest

On June 26, 2020, we received the Unsolicited Proposal from Senator and Cannae to acquire the Company for $65.00 per share in cash, which initial proposal was revised by Senator and Cannae on September 14, 2020 by $1.00 per share to $66.00 per share in cash. Our Board of Directors, in consultation with its independent financial and legal advisors, unanimously determined to reject the Unsolicited Proposal, as it significantly undervalues the Company, raises serious regulatory concerns and is not in the best interests of the Company and its stockholders. On July 14, 2020, we received written notification from the Federal Trade Commission (the “FTC”) that the FTC is conducting an investigation (the “FTC Investigation”) of the proposed acquisition of the Company by Senator and Cannae and requesting that we produce information in connection with that investigation. On August 7, 2020, we received a Civil Investigative Demand from the FTC in connection with the FTC Investigation into Senator and Cannae, requesting that the Company produce additional information in connection with that investigation.

35


On July 29, 2020, in connection with the Unsolicited Proposal, Senator and Cannae issued a press release announcing their initiation of the Proxy Contest. Although our Board of Directors opposes the actions being pursued by Senator and Cannae because they believe these proposals are not in the best interests of the Company’s stockholders, on August 9, 2020, the Board of Directors determined to call a special meeting to provide stockholders the opportunity to vote and express their views. The Board of Directors set the special meeting for November 17, 2020, with a record date of September 18, 2020.

On October 28, 2020, we issued a press release confirming that we are engaging with third parties that have indicated interest in a potential acquisition of the Company at a value at or above $80 per share. On November 3, 2020, we issued a press release announcing that our Board of Directors is conducting a thorough strategic review (the “Strategic Review”) to maximize shareholder value.

The outcome of the Unsolicited Proposal, the Proxy Contest, the FTC Investigation, the Strategic Review and related circumstances are uncertain. These events have required us, and will continue to require us, to incur significant legal and advisory fees and expenses, and require significant time and attention by management and our Board of Directors. For a further discussion of risks, uncertainties and other factors relating to the Unsolicited Proposal, the Proxy Contest, the FTC Investigation and the Strategic Review that could impact our business and operating results, see the section entitled “Risk Factors” in Item 1A of Part I of this Quarterly Report on Form 10-Q as well as in Item 1A of Part II in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2020. The Company can offer no assurance that it will enter into any transaction with respect to a potential acquisition of the Company in the future or, if entered into, what the terms of any such transaction would be.

In connection with the Unsolicited Proposal and Proxy Contest, we accrued expenses of $36.9 million for the three and nine months ended September 30, 2020.

Unless otherwise indicated, the Management’s Discussion and Analysis of Financial Condition and Results of Operations in this Quarterly Report on Form 10-Q relate solely to the discussion of our continuing operations.
36


Consolidated Results of Operations
 
Three Months Ended September 30, 2020 Compared to the Three Months Ended September 30, 2019

Operating Revenues

Our consolidated operating revenues were $436.7 million for the three months ended September 30, 2020, an increase of $61.2 million, or 16.3% when compared to the comparable period in 2019, and consisted of the following:
(in thousands, except percentages) 2020 2019 $ Change % Change
PIRM $ 176,248  $ 169,079  $ 7,169  4.2  %
UWS 263,342  209,138  54,204  25.9 
Corporate and eliminations (2,863) (2,646) (217) 8.2 
Operating revenues $ 436,727  $ 375,571  $ 61,156  16.3  %

Our PIRM segment operating revenues increased by $7.2 million, or 4.2%, for the three months ended September 30, 2020, when compared to 2019. Excluding acquisition activity of $1.0 million, operating revenues increased $6.2 million primarily due to our property insights and insurance solutions business gaining market-share of approximately $6.4 million and increased market volumes & pricing and favorable foreign exchange impacting property insights by an additional $2.7 million and $1.4 million, respectively. These gains were partially offset COVID-19 impacts totaling $4.3 million across our solution groups.

Our UWS segment revenues increased by $54.2 million, or 25.9%, for the three months ended September 30, 2020, when compared to 2019. Excluding acquisition activity of $1.2 million, operating revenues increased $53.0 million due to higher property tax solutions revenues of $62.0 million, and higher flood data solutions revenues of $11.4 million primarily related to increased volumes, market share gains, and pricing. These increases were partially offset by lower valuation solutions revenue of $19.0 million due to the impacts of our AMC transformation program, and lower other revenues of $1.4 million. Operating revenues attributable to the aforementioned business exits and AMC transformation were $17.0 million for the quarter ended September 30, 2019. Refer to "Business Exits & Transformation" discussion above for further details. Additionally, the UWS segment did not experience significant adverse impacts related to COVID-19 during the current period.

Our corporate and eliminations were comprised of intercompany revenue eliminations between our operating segments.

Cost of Services (excluding depreciation and amortization)

Our consolidated cost of services was $154.2 million for the three months ended September 30, 2020, a decrease of $10.5 million, or 6.4%, when compared to 2019. Excluding acquisition activity of $1.4 million, the decrease of $11.9 million was primarily due to favorable product mix.

Selling, General and Administrative Expenses

Our consolidated selling, general and administrative expenses were $165.7 million for the three months ended September 30, 2020, an increase of $59.1 million, or 55.5%, when compared to 2019. Excluding acquisition activity of $1.1 million, the increase of $58.0 million was primarily due to higher costs as a result of the Unsolicited Proposal and the Proxy Contest of $36.9 million, higher other external services costs of $13.9 million, and $11.5 million in compensation, primarily due to higher variable compensation costs relating to operating performance, partially offset by lower travel costs of $3.1 million and lower other expenses of $1.2 million.

Depreciation and Amortization

Our consolidated depreciation and amortization expense was $43.6 million for the three months ended September 30, 2020, an increase of $1.2 million, or 2.9%, when compared to 2019. Excluding acquisition activity of $0.3 million, the increase of $0.9 million was primarily due to the addition of completed software projects and increased licenses in the current period.

37


Operating Income

Our consolidated operating income was $73.2 million for the three months ended September 30, 2020, an increase of $11.3 million, or 18.3%, when compared to 2019, and consisted of the following:
(in thousands, except percentages) 2020 2019 $ Change % Change
PIRM $ 22,670  $ 18,375  $ 4,295  23.4  %
UWS 124,699  70,831  53,868  76.1 
Corporate and eliminations (74,186) (27,339) (46,847) 171.4 
Operating income $ 73,183  $ 61,867  $ 11,316  18.3  %

Our PIRM segment operating income increased by $4.3 million, or 23.4%, for the three months ended September 30, 2020 when compared to 2019. Acquisitions lowered operating income by $0.3 million primarily due to investments in data and technology capabilities and the amortization of acquisition-related intangible assets. Excluding acquisition activity, operating income increased by $4.6 million and margins increased by 220 basis points, primarily due to higher revenues and the impact of our ongoing operational efficiency programs.

Our UWS segment operating income increased by $53.9 million, or 76.1%, for the three months ended September 30, 2020 when compared to 2019. Acquisitions lowered operating income by $0.4 million primarily due to investments in data and technology capabilities and the amortization of acquisition-related intangible assets. Excluding acquisition activity, operating income increased by $54.3 million and margins increased by 1,380 basis points, primarily driven by higher revenues, favorable product mix, and the impact of our ongoing operational efficiency programs.

Corporate and eliminations had an unfavorable variance of $46.8 million, or 171.4%, for the three months ended September 30, 2020 when compared to 2019, primarily due to higher costs associated with the Unsolicited Proposal and the Proxy Contest and higher variable compensation costs relating to operating performance.

Total Interest Expense, net

Our consolidated total interest expense, net was $16.9 million for the three months ended September 30, 2020, a decrease of $2.6 million, or 13.2%, when compared to 2019. The decrease was primarily due to lower interest rates as well as lower average outstanding principal balances.

Gain/(Loss) on Investments and Other, net

Our consolidated gain on investments and other, net was $35.7 million for the three months ended September 30, 2020, a favorable variance of $35.4 million, when compared to 2019. The variance is primarily due to a $35.1 million gain from the sale of an equity method investment and higher gains of $1.7 million related to supplemental benefit plans, offset by a loss of $1.4 million related to the impairment of an equity method investment.

Provision/(Benefit) for Income Taxes

Our consolidated provision/(benefit) for income taxes from continuing operations before equity in earnings of affiliates and income taxes was a benefit of $9.6 million and a provision of $11.5 million for the three months ended September 30, 2020 and 2019, respectively. The effective tax rate was a benefit of 10.4% and a provision of 27.1% for the three months ended September 30, 2020 and 2019, respectively. The change in the effective income tax rate was primarily due to a $24 million discrete tax benefit recorded in relation to the settlement of an IRS examination in 2020.

Equity in Earnings of Affiliates, net of tax

Our consolidated equity in earnings of affiliates, net of tax was $1.0 million for the three months ended September 30, 2020, a favorable variance of $0.4 million when compared to 2019. We have equity interests in various affiliates which had higher earnings in the current period compared to the prior year period.

38


Income/(loss) from Discontinued Operations, Net of Tax

Our consolidated income/(loss) from discontinued operations, net of tax was $10.7 million for the three months ended September 30, 2020, a favorable variance of $19.2 million when compared to 2019. The increase is primarily due to higher gains from our reseller businesses related to increased market volumes and a prior year loss principally related to the impact of an appellate court decision in August 2019 for which we recorded a liability of $21.7 million as of September 30, 2019. See Note 14 - Discontinued Operations for further information.
39


Consolidated Results of Operations

Nine Months Ended September 30, 2020 Compared to Nine Months Ended September 30, 2019

Operating Revenues

Our consolidated operating revenues were $1.2 billion for the nine months ended September 30, 2020, an increase of $86.7 million, or 8.0%, when compared to 2019, and consisted of the following:
(in thousands, except percentages) 2020 2019 $ Change % Change
PIRM $ 504,379  $ 501,854  $ 2,525  0.5  %
UWS 680,455  593,175  87,280  14.7 
Corporate and eliminations (10,101) (6,997) (3,104) 44.4 
Operating revenues $ 1,174,733  $ 1,088,032  $ 86,701  8.0  %

Our PIRM segment revenues increased by $2.5 million, or 0.5%, for the nine months ended September 30, 2020, when compared to 2019. Excluding acquisition activity of $2.4 million, the increase of $0.1 million primarily due higher revenues of $14.9 million from property insights and insurance and spatial solutions due to increased market volumes, market-share gains and pricing. The increase was offset by the impact of COVID-19 totaling $11.8 million across our solution groups. Additionally, included within our property insights revenues is unfavorable foreign exchange of $3.0 million.

Our UWS segment revenues increased by $87.3 million, or 14.7%, for the nine months ended September 30, 2020, when compared to 2019. Excluding acquisition activity of $4.5 million, the increase of $82.8 million was primarily due to higher property tax solutions revenues of $107.6 million, and higher flood data solutions revenues of $30.4 million primarily related to increased market volumes, market-share gains, and pricing. These increases were partially offset by lower valuation solutions revenue of $48.3 million due to the impacts of our AMC transformation program and lower other revenues of $6.9 million. Operating revenues attributable to the aforementioned business exits and AMC transformation were $65.6 million for the nine months ended September 30, 2019. Additionally, the UWS segment revenues reflected a total adverse impact of $4.3 million related to COVID-19.

Our corporate and eliminations were comprised of intercompany revenue eliminations between our operating segments.

Cost of Services (excluding depreciation and amortization)

Our consolidated cost of services was $439.0 million for the nine months ended September 30, 2020, a decrease of $47.9 million, or 9.8%, when compared to 2019. Excluding acquisition activity of $4.7 million, the decrease of $52.6 million was primarily due to favorable product mix.

Selling, General and Administrative Expenses

Our consolidated selling, general and administrative expenses were $393.2 million for the nine months ended September 30, 2020, an increase of $44.5 million, or 12.8%, when compared to 2019. Excluding acquisition activity of $2.9 million, the increase of $41.6 million was primarily due to higher costs as a result of the Unsolicited Proposal and the Proxy Contest of $36.9 million and higher other external services costs of $13.6 million, partially offset by lower travel costs of $7.3 million and lower compensation costs of $1.6 million.

Depreciation and Amortization

Our consolidated depreciation and amortization expense was $130.6 million for the nine months ended September 30, 2020, a decrease of $2.1 million, or 1.6%, when compared to 2019. Excluding acquisition activity of $1.4 million, the decrease of $3.5 million is primarily due to assets that were fully impaired during the prior year.

Impairment Loss

Our consolidated impairment loss was $1.2 million for the nine months ended September 30, 2020, a decrease of $46.6 million, or 97.4%, when compared to 2019, primarily due to prior year write-offs of clients lists of $32.3 million, software of $12.3 million, and licenses of $3.3 million related to the transformation of our AMC business, offset by current year impairment charges related to software.
40



Operating Income

Our consolidated operating income was $210.6 million for the nine months ended September 30, 2020, an increase of $138.9 million, or 193.8%, when compared to 2019, and consisted of the following:
(in thousands, except percentages) 2020 2019 $ Change % Change
PIRM $ 65,249  $ 44,110  $ 21,139  47.9  %
UWS 281,567  121,946  159,621  130.9 
Corporate and eliminations (136,229) (94,386) (41,843) 44.3 
Operating income $ 210,587  $ 71,670  $ 138,917  193.8  %

Our PIRM segment operating income increased by $21.1 million, or 47.9%, for the nine months ended September 30, 2020, when compared to 2019. Acquisitions lowered operating income by $0.9 million primarily due to investments in data and technology capabilities and the amortization of acquisition-related intangible assets. Excluding acquisition activity, operating income increased by $22.0 million and margins increased by 440 basis points primarily due to higher revenue, favorable product mix and the impact of our ongoing operational efficiency programs.

Our UWS segment operating income increased by $159.6 million, or 130.9%, for the nine months ended September 30, 2020, when compared to 2019. Acquisitions lowered operating income by $1.3 million primarily due to investments in data and technology capabilities and the amortization of acquisition-related intangible assets. Excluding acquisition activity, operating income increased by $160.9 million and margins increased by 2,130 basis points, primarily impacted by lower impairment loss, higher revenues, improved product mix, and the impact of our ongoing operational efficiency programs.

Corporate and eliminations had an unfavorable variance of $41.8 million, or 44.3%, for the nine months ended September 30, 2020, primarily due to higher costs associated with the Unsolicited Proposal and Proxy Contest.

Total Interest Expense, net

Our consolidated total interest expense, net, was $52.3 million for the nine months ended September 30, 2020, a decrease of $5.1 million, or 8.8%, when compared to 2019. The decrease was primarily due to lower interest rates as well as lower average outstanding principal balances.

Gain/(Loss) on Investments and Other, net

Our consolidated gain on investments and other, net, was $37.2 million for the nine months ended September 30, 2020, a favorable variance of $39.3 million, when compared to 2019. The variance is due to a gain of $35.1 million from the sale of an equity method investment, a prior year loss of $6.6 million related to revaluation of an equity investment, a prior year loss of $1.5 million from unamortized debt issuance cost write-offs due to financing activities, and other gains of $0.6 million; partially offset by higher losses of $3.1 million related to supplemental benefit plans and a loss of $1.4 million related to the impairment of an equity method investment.

Tax Indemnification Release

In the prior year, we recorded a $13.4 million loss related to the release of a tax indemnification receivable due to the expiration of the statutes of limitations in our principal state jurisdictions. Associated state tax reserves of $15.3 million were also released and recognized, in the prior year, as income tax benefit through the provision for income taxes.

Provision/(Benefit) for Income Taxes

Our consolidated provision/(benefit) for income taxes from continuing operations before equity in earnings of affiliates and income taxes was a provision of $19.4 million and a benefit of $9.0 million for the nine months ended September 30, 2020 and 2019, respectively. The effective tax rate was a provision of 10.0% and a benefit of 718.7% for the nine months ended September 30, 2020 and 2019, respectively. The change in the effective income tax rate was primarily due to the benefit recorded in relation to the settlement of an IRS examination in 2020 as compared to a smaller nonrecurring benefit recorded in 2019 related to the reversal of state tax reserves.

41


Equity in Earnings of Affiliates, net of tax

Our consolidated equity in earnings of affiliates, net of tax was $1.9 for the nine months ended September 30, 2020, a favorable variance of $1.4 when compared to 2019. We have equity interests in various affiliates which had higher earnings in the current period compared to prior year.

Income/(loss) from Discontinued Operations, Net of Tax

Our consolidated income/(loss) from discontinued operations, net of tax was $28.1 million for the nine months ended September 30, 2020, a favorable variance of $17.1 million when compared to 2019. The is primarily due to higher gains from our reseller businesses related to increased market volumes and a prior year loss principally related to the impact of an appellate court decision in August 2019 pertaining to a discontinued operating unit, for which we recorded a liability of $21.7 million as of September 30, 2019. See Note 14 - Discontinued Operations for further information.
Item 4.  Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Our principal executive officer and principal financial officer have concluded that, as of the end of the quarterly period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures, as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended, were effective, based on the evaluation of these controls and procedures required by Rule 13a-15(b).

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended) that occurred during the quarter ended September 30, 2020, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

42


Liquidity and Capital Resources

Cash and cash equivalents as of September 30, 2020 totaled $302.3 million, an increase of $198.2 million from December 31, 2019. As of September 30, 2020, our cash balances held in foreign jurisdictions totaled $61.0 million and are primarily related to our international operations. We plan to maintain significant cash balances outside of the US for the foreseeable future.

Restricted cash of $10.5 million as of both September 30, 2020 and December 31, 2019 is comprised of deposits that are pledged for various letters of credit/bank guarantees secured by us, escrow accounts due to acquisitions and divestitures, as well as short-term investments within our deferred compensation plan trust.

Cash Flow

Operating Activities. Cash provided by operating activities reflects net income adjusted for certain non-cash items and changes in operating assets and liabilities. Total cash provided by operating activities was approximately $419.1 million and $247.1 million for the nine months ended September 30, 2020 and 2019, respectively. Cash used in discontinued operating activities was $40.7 million and $29.7 million for the nine months ended September 30, 2020 and 2019, respectively. The increase in cash provided by continuing and discontinued operations were primarily due to higher net income as adjusted for non-cash activities and favorable changes in working capital items.

Investing Activities. Total cash used in investing activities was approximately $43.5 million and $96.9 million during the nine months ended September 30, 2020 and 2019, respectively. Cash used in discontinued operating activities was $9.3 million and $14.0 million for the nine months ended September 30, 2020 and 2019, respectively, which decrease was driven by lower investments in technology and innovation. The decrease in cash used in continuing operations was primarily related higher proceeds from the sale of investments and other of $42.4 million, lower investments in technology and innovation of $9.7 million, and lower net cash paid for acquisitions of $1.2 million, partially offset by lower cash received from a prior year sale of a business line of $4.1 million.

Financing Activities. Total cash used in financing activities was approximately $174.1 million for the nine months ended September 30, 2020, which was primarily comprised of dividends paid of $61.1 million, net outflows from share-based compensation-related transactions of $1.3 million, share repurchases of $9.3 million, and repayments of long-term debt of $102.5 million. Total cash used in financing activities was approximately $147.2 million for the nine months ended September 30, 2019, which was primarily comprised of net repayment of long-term debt of $83.8 million, share repurchases of $61.6 million, net outflows from share-based compensation-related transactions of $1.3 million, and contingent consideration payments of $0.6 million.

Financing and Financing Capacity

We had total debt outstanding of $1.5 billion and $1.6 billion as of September 30, 2020 and December 31, 2019, respectively. Our significant debt instruments and borrowing capacity are described below.

Credit Agreement

The Credit Agreement provides for a $1.8 billion term loan facility (the “Term Facility”), and a $750.0 million revolving credit facility (the “Revolving Facility”). The Term Facility matures and the Revolving Facility expires in May 2024. As of September 30, 2020, we had borrowing capacity under the Revolving Facility of $750.0 million and were in compliance with the financial and restrictive covenants of the Credit Agreement. See Note 5 - Long-Term Debt for further discussion.

43


Interest Rate Swaps
 
We have entered into amortizing interest rate swaps (“Swaps”) in order to convert a portion of our interest rate exposure on the Term Facility floating rate borrowings from variable to fixed. Under the Swaps, we agree to exchange floating rate for fixed rate interest payments periodically over the life of the agreement. The floating rates in our Swaps are based on the one-month London interbank offering rate. The notional balances, terms and maturities of our Swaps are designed to have the effect of fixing the rate of interest on at least 50% of the principal balance of our senior term debt.

As of September 30, 2020, the Swaps have a combined remaining notional balance of $1.2 billion, a weighted average fixed interest rate of 2.40% (rates range from 0.66% to 2.98%), and scheduled terminations through December 2025. Notional balances under our Swaps are scheduled to increase and decrease based on our expectations of the level of variable rate debt to be in effect in future periods. Currently, we have scheduled notional amounts approximately $1.2 billion through September 2021, then $1.1 billion and $1.0 billion through August 2022, and $496.8 million and $465.0 million through December 2025. Approximate weighted average fixed interest rates for the aforementioned time periods are 2.59%, 2.77%, and 2.64%, respectively.

Liquidity and Capital Strategy

We expect that cash flow from operations and current cash balances, together with available borrowings under our Revolving Facility, will be sufficient to meet operating requirements through the next twelve months. Cash available from operations, however, could be affected by any general economic downturn, such as financial impacts related to COVID-19, or any decline or adverse changes in our business such as a loss of clients, challenges collecting payments from clients, competitive pressures, or other significant change in our business environment.

We strive to pursue a balanced approach to capital allocation and initiated a regular dividend in December 2019. We will also continue to evaluate the repurchase of shares, management of outstanding debt, and the pursuit of strategic acquisitions and investments on an opportunistic basis.

In July 2020, our Board of Directors canceled all prior repurchase authorizations and established a new share repurchase authorization of up to $1.0 billion. During the nine months ended September 30, 2020, we repurchased 0.2 million shares of our common stock for $9.3 million. The Company expects to fully utilize such repurchase authorization by the end of 2022, inclusive of $500.0 million of shares by the end of 2020. Purchases may be made from time to time in the open market at prevailing market prices or in privately negotiated transactions, and may be made according to a plan adopted pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. See Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds - Purchases of Equity Securities by the Issuer and Affiliated Purchasers for further discussion.

For the nine months ended September 30, 2020, we paid cash dividends of $61.1 million. In July 2020, our Board of Directors announced a 50% increase to the quarterly cash dividend, declaring a cash dividend of $0.33 per share of common stock which was paid in September 2020. We expect to make regular quarterly dividend payments for the foreseeable future. The timing, declaration, and payment of future dividends, however, falls within the discretion of our Board of Directors and will depend upon many factors, including the Company’s financial condition and earnings, the capital requirements of our businesses, restrictions imposed by applicable law, and any other factors our Board of Directors deems relevant from time to time.

Availability of Additional Capital

Our access to additional capital fluctuates as market conditions change. There may be times when the private capital markets and the public debt or equity markets lack sufficient liquidity or when our securities cannot be sold at attractive prices, in which case we would not be able to access capital from these sources. Based on current market conditions and our financial condition (including our ability to satisfy the conditions contained in our debt instruments that are required to be satisfied to permit us to incur additional indebtedness), we believe that we have the ability to effectively access these liquidity sources for new borrowings. However, continued general economic instability, such as financial impacts resulting from COVID-19 which has caused, and may continue to cause, disruptions in the financial markets or a weakening of our financial condition, including a significant decrease in our profitability, or cash flows, or a material increase in our leverage, could adversely affect our ability to access these markets on acceptable terms or at all and/or increase our cost of borrowings.

44


Critical Accounting Policies and Estimates

For additional information with respect to our critical accounting policies, which are those that could have the most significant effect on our reported results and require subjective or complex judgments by management, see Item 7, “Management's Discussion and Analysis of Financial Condition and Results of Operations,” of our Annual Report on Form 10-K for the year ended December 31, 2019. Management believes there have been no material changes to this information.

Item 3.  Quantitative and Qualitative Disclosures about Market Risk.

Our primary exposure to market risk relates to interest-rate risk associated with certain financial instruments. We monitor our risk associated with fluctuations in interest rates and currently use derivative financial instruments to hedge some of these risks.

As of September 30, 2020, we had approximately $1.5 billion in gross, long-term debt outstanding, predominately all of which was variable-interest-rate debt. An increase in interest rates could increase the costs of our variable-interest-rate debt obligations. Rising interest rates could also limit our ability to refinance our debt when it matures or cause us to pay higher interest rates upon refinancing and increase interest expense on refinanced indebtedness.

To manage our interest rate risk we have entered into Swaps in order to convert a portion of our interest rate exposure on the Term Facility floating rate borrowings from variable to fixed. Under the Swaps, we agree to exchange floating rate for fixed rate interest payments periodically over the life of the agreement. The notional balances, terms and maturities of our Swaps are designed to have the effect of fixing the rate of interest on at least 50% of the principal balance of our senior term debt. As of September 30, 2020, the combined remaining notional balance of the Swaps was $1.2 billion, with a weighted average fixed interest rate of 2.40% (rates range from 0.66% to 2.98%), and scheduled terminations through December 2025. Notional balances under our Swaps are scheduled to increase and decrease over their contract lengths based on our expectations of the level of variable rate debt to be in effect in future periods. After giving effect to the Swaps, a hypothetical 1% increase or decrease in interest rates would result in an approximately $0.9 million change to interest expense on our existing indebtedness as of September 30, 2020, on a quarterly basis.

Although we are subject to foreign currency exchange rate risk as a result of our operations in certain foreign countries, the foreign exchange exposure related to these operations, in the aggregate, is not material to our financial condition or results of operations.

45


PART II: OTHER INFORMATION

Item  1.  Legal Proceedings.

For a description of our legal proceedings, see Note 9 – Litigation and Regulatory Contingencies of our condensed consolidated financial statements, which is incorporated by reference in response to this item.

Item  1A.  Risk Factors.

We have described in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and in Part II, Item 1A of our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020, the primary risks related to our business, and we may periodically update those risks for material developments. Those risks are not the only ones we face, but do represent those risks that we believe are material to us. Our business is also subject to the risks that affect many other companies, such as general economic conditions, geopolitical events and employment relations. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also harm our business. Please read the cautionary notice regarding forward-looking statements under the heading “Management's Discussion and Analysis of Financial Condition and Results of Operations.” You should carefully consider the risks and uncertainties our business faces. We are including two supplemental risk factors below, which disclosures should be read in conjunction with the risk factors described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020.

The Unsolicited Proposal and Proxy Contest being pursued by Senator and Cannae could cause us to incur substantial costs, divert management’s attention and resources and be disruptive to, and have an adverse effect on, our business.

On June 26, 2020, we received the Unsolicited Proposal from Senator and Cannae to acquire all of the outstanding shares of the Company’s common stock for $65.00 per share in cash, which initial proposal was revised by Senator and Cannae on September 14, 2020 by $1.00 per share to $66.00 per share in cash. Our Board of Directors carefully reviewed the Unsolicited Proposal and unanimously concluded, in consultation with its independent financial and legal advisors, to reject the Unsolicited Proposal, as it significantly undervalues the Company, raises serious regulatory concerns and is not in the best interests of the Company and its stockholders. On July 14, 2020, we received written notification from the FTC that the FTC is conducting an investigation of the proposed acquisition of the Company by Senator and Cannae, and on August 7, 2020, the Company received a Civil Investigative Demand and subpoena from the FTC in connection with the FTC’s investigation into Senator and Cannae, requiring that the Company produce information in connection with that investigation.

On July 29, 2020, in connection with the Unsolicited Proposal, Senator and Cannae issued a press release, and subsequently filed a Schedule 13D/A with the SEC, announcing their initiation of a process to call a special meeting of stockholders in order to, among other things, remove nine current members of our Board of Directors and nominate nine new directors to serve on our Board of Directors. Although our Board of Directors opposes the actions being pursued by Senator and Cannae because they believe these proposals are not in the best interests of the Company’s stockholders, on August 9, 2020, the Board of Directors determined to call a special meeting to provide stockholders the opportunity to vote and express their views. For more information, see above under Management’s Discussion and Analysis of Financial Condition and Results of Operations - Results of Operations - Overview of Business Environment and Company Developments - Unsolicited Proposal and Proxy Contest.

On October 28, 2020, we issued a press release confirming that we are engaging with third parties that have indicated interest in a potential acquisition of the Company at a value at or above $80 per share. On November 3, 2020, we issued a press release announcing that our Board of Directors is conducting the Strategic Review to maximize shareholder value.

The events surrounding the Unsolicited Proposal and related circumstances, including the pending Proxy Contest being pursued by Senator and Cannae and the Strategic Review, have required, and are likely to continue to require, significant time and attention of management and our Board of Directors and our incurrence of significant legal and advisory fees and expenses. Actions taken by Senator and Cannae or other third parties as a result of the Unsolicited Proposal and the Proxy Contest could disrupt our business, divert the time and attention of management and our employees away from our business operations, cause us to incur substantial additional expense, create perceived uncertainties among current and potential customers, clients, suppliers, employees and other constituencies as to our future direction as a consequence thereof that may result in lost sales or other business arrangements and the loss of potential business opportunities, and make it more difficult to attract and retain qualified personnel and business partners. Actions that our Board of Directors has taken, and may take in the future, in response to any offer or other related actions by Senator and Cannae, including the Unsolicited Proposal and the Proxy Contest, or any other offer or proposal, may result in litigation against us, which could also be a significant distraction for our management and employees and may require us to incur significant costs or otherwise result in an adverse effect on the Company.
46



If Senator and Cannae's nominees were to be appointed to the Board of Directors at the special meeting of stockholders to be held on November 17, 2020, it may adversely affect our ability to effectively and timely implement our business strategy to create additional value for our stockholders and, while there is no assurance that any transaction will occur, may facilitate an acquisition of the Company by Senator and Cannae, or otherwise, at a price and on terms comparable to the Unsolicited Proposal, which our Board of Directors has determined significantly undervalues the Company, raises serious regulatory concerns and is not in the best interests of the Company‘s stockholders. Furthermore, if Senator and Cannae are successful in replacing at least a majority of the members of our Board of Directors, a change in control of the Board of Directors may be deemed to have occurred under certain of our contracts and agreements, and trigger change in control provisions under employment and change in control agreements with our named executive officers, our equity compensation and deferred compensation plans, and our revolving credit facility and indentures (although the Board of Directors has approved the nomination of Senator and Cannae’s nine director nominees solely for purposes of the revolving credit facility and as a result, the Company believes the nomination for appointment of such nominees will not trigger the change in control provision under the revolving credit facility or indentures). These change in control provisions may cause us to incur significant additional expense and/or tax liabilities.

As a result of numerous factors including those identified above, the future trading price of our common stock could be subject to price fluctuations based on uncertainty associated with the Unsolicited Proposal, the outcome of the proxy contest and other temporary or speculative market perceptions.

47


Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities

During the quarter ended September 30, 2020, we did not issue any shares of our common stock in any transaction that was not registered under the Securities Act of 1933, as amended.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

In July 2020, our Board of Directors canceled all prior repurchase authorizations and established a new share repurchase authorization of up to $1.0 billion. As of September 30, 2020, we had $1.0 billion in value of shares of common stock (inclusive of commissions and fees) available to be repurchased under the repurchase authorization. The stock repurchase authorization has no expiration date and repurchases may be made from time to time in the open market, in privately negotiated transactions or pursuant to a Rule 10b5-1 plan.

Under our Credit Agreement, our stock repurchase capacity is restricted to $150.0 million per fiscal year, with the ability to undertake an additional amount of repurchases in such fiscal year provided that, on a pro forma basis after giving effect to the stock repurchase, our total leverage ratio does not exceed 3.5 to 1.0. While we are currently prioritizing capital return to our stockholders through stock repurchases, we continue to pursue a balanced approach to capital allocation and will consider the repurchase of shares of our common stock, the retirement of outstanding debt and the pursuit of strategic acquisitions on an opportunistic basis.

We did not repurchase any shares of our common stock during the quarter ended September 30, 2020.
48


Item 6.  Exhibits.
Exhibit
Number
Description
3.1
3.2
3.3
4.1
10.1
10.2
10.3
10.4
10.5
10.6
31.1
31.2
32.1
32.2
101
The following unaudited consolidated financial statements for the quarter ended September 30, 2020 included in this quarterly report on Form 10-Q formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Stockholders' Equity, and (v) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tagsü
104
Cover Page Interactive Data File (formatted in Inline XBRL and included in the interactive data files submitted as Exhibit 101)ü
49


ü Filed herewith.
** Furnished herewith.
50



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
  CoreLogic, Inc.
  (Registrant)
   
  By: /s/   Frank D. Martell
  Frank D. Martell
  President and Chief Executive Officer
  (Principal Executive Officer)
   
  By: /s/  James L. Balas
  James L. Balas
  Chief Financial Officer
(Principal Financial Officer)
By: /s/  John K. Stumpf
John K. Stumpf
Controller
(Principal Accounting Officer)
Date: November 3, 2020  

51

EXHIBIT 10.1
EMPLOYMENT AGREEMENT
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into this 28th day of October, 2020, by and between CoreLogic, Inc., a Delaware corporation (the Company”), and Patrick Dodd (the “Executive”).
RECITALS
THE PARTIES ENTER THIS AGREEMENT on the basis of the following facts, understandings and intentions:
A.  The Company desires that the Executive be employed by the Company to carry out the duties and responsibilities described below, all on the terms and conditions hereinafter set forth, effective as of September 1, 2020 (the “Effective Date”).
B.  The Executive desires to accept such employment on such terms and conditions.
AGREEMENT
NOW, THEREFORE, in consideration of the above recitals incorporated herein and the mutual covenants and promises contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby expressly acknowledged, the parties agree as follows:
1.    Retention and Duties.
  1.1
Retention.  The Company does hereby hire, engage and employ the Executive for the Period of Employment (as such term is defined in Section 2) on the terms and conditions expressly set forth in this Agreement.  The Executive does hereby accept and agree to such hiring, engagement and employment, on the terms and conditions expressly set forth in this Agreement.
  1.2
Duties.  During the Period of Employment, the Executive shall serve the Company as its Chief Operating and Growth Officer and shall have such other duties and responsibilities as the Chief Executive Officer of the Company (the “CEO”) shall determine from time to time.  The Executive shall be subject to the corporate policies of the Company as they are in effect from time to time throughout the Period of Employment (including, without limitation, the Company’s Code of Conduct, as it may change from time to time).  During the Period of Employment, the Executive shall report solely to the CEO.
  1.3
No Other Employment; Minimum Time Commitment.  During the Period of Employment, the Executive shall (i) devote substantially all of the Executive’s business time, energy and skill to the performance of the Executive’s duties for the Company, (ii) perform such duties in a faithful, effective and efficient manner to the best of his abilities, and (iii) hold no other employment.  The Executive’s service on the boards of directors (or similar body) of other business entities is subject to the approval of the CEO or the Company’s Board of Directors (the “Board”).  The Company shall have the right to require the Executive to resign from any board or similar body (including, without limitation, any association, corporate, civic or charitable board or similar body) which he may then serve if the Board reasonably determines that the Executive’s service on such board or body interferes with the effective discharge of the Executive’s duties and responsibilities to the Company or that any business related to such service is then in competition with any business of the Company or any of its affiliates, successors or assigns.
1




   1.4
No Breach of Contract.  The Executive hereby represents to the Company and agrees that: (i) the execution and delivery of this Agreement by the Executive and the Company and the performance by the Executive of the Executive’s duties hereunder do not and shall not constitute a breach of, conflict with, or otherwise contravene or cause a default under, the terms of any other agreement or policy to which the Executive is a party or otherwise bound or any judgment, order or decree to which the Executive is subject; (ii) the Executive will not enter into any new agreement that would or reasonably could contravene or cause a default by the Executive under this Agreement; (iii) the Executive has no information (including, without limitation, confidential information and trade secrets) relating to any other Person (as such term is defined in Section 5.5) which would prevent, or be violated by, the Executive entering into this Agreement or carrying out his duties hereunder; (iv) the Executive is not bound by any employment, consulting, non-compete, confidentiality, trade secret or similar agreement (other than this Agreement and the Confidentiality Agreement) with any other Person; (v) to the extent the Executive has any confidential or similar information that he is not free to disclose to the Company, he will not disclose such information to the extent such disclosure would violate applicable law or any other agreement or policy to which the Executive is a party or by which the Executive is otherwise bound; and (vi) the Executive understands the Company will rely upon the accuracy and truth of the representations and warranties of the Executive set forth herein and the Executive consents to such reliance.
   1.5
Location.  The Executive’s principal place of employment shall be the Company’s principal executive office as it may be located from time to time.  The Executive agrees that he will be regularly present at that office.  The Executive acknowledges that he will be required to travel from time to time in the course of performing his duties for the Company.
   1.6
Confidentiality Agreement.  In connection with entering into this Agreement, the Executive has executed and delivered to the Company a Confidential Information and Inventions Agreement (as it may be amended from time to time and together with any similar successor agreement, the “Confidentiality Agreement”).  The Executive agrees to abide by the Confidentiality Agreement.
2.
Period of Employment.  The “Period of Employment” shall commence on the Effective Date and shall end at the close of business on December 31, 2021 (the “Termination Date”); provided, however, that this Agreement shall be automatically renewed, and the Period of Employment shall be automatically extended for one (1) additional year on the Termination Date and each anniversary of the Termination Date thereafter, unless either party gives written notice at least sixty (60) days prior to the expiration of the Period of Employment (including any renewal thereof) of such party’s desire to terminate the Period of Employment (such notice to be delivered in accordance with Section 18).  The term “Period of Employment” shall include any extension thereof pursuant to the preceding sentence. Provision of notice that the Period of Employment shall not be extended or further extended, as the case may be, shall not constitute a breach of this Agreement and shall not give rise to an obligation to pay severance benefits pursuant to Section 5.3(b). Notwithstanding the foregoing, the Period of Employment is subject to earlier termination as provided below in this Agreement.
3.    Compensation.
  3.1
Base Salary.  The Executive’s base salary (the “Base Salary”) shall be paid in accordance with the Company’s regular payroll practices in effect from time to time, but not less frequently than in monthly installments.  The Executive’s initial Base Salary shall be at an annualized rate of Six Hundred Fifty Thousand Dollars ($650,000).  The Company will review the Executive’s Base Salary at least annually and may increase the Executive’s Base Salary from the rate then in effect based on such review.
2




   3.2
Annual Performance Bonus.  For each fiscal year of the Company that ends during the Period of Employment, the Executive shall be eligible to receive an annual incentive bonus (“Incentive Bonus”) in an amount to be determined by the Company’s Compensation Committee in its sole discretion, based on the performance objectives established for that particular period and subject to the terms and conditions of any applicable bonus plan. Subject to the Compensation Committee’s discretion to determine the final bonus amount each year, the Executive’s target annual incentive bonus amount is One Hundred Percent (100%) of the Executive’s Base Salary, with a range of 0 to 200%. Incentive Bonus awards at target performance are determined annually based on Company performance targets and market data for similarly situated executives at peer companies. Notwithstanding the foregoing, the Executive’s Incentive Bonus with respect to the Company’s 2020 fiscal year shall not be less than Five Hundred Thousand Dollars ($500,000).
  3.3
Long Term Incentives.  The Executive shall also be eligible to receive long-term incentive awards annually in an amount to be determined by the Company’s Compensation Committee in its sole discretion (“LTI Awards”).  Subject to the Compensation Committee’s discretion to determine the annual LTI Award each year, the Executive’s target annual LTI Award is Two Hundred Fifty Percent (250%) of the Executive’s Base Salary. LTI Awards at target performance are determined annually based on Company performance goals and market data for similarly situated executives at peer companies, in the form of a mix of equity vehicles, including but not limited to Performance Based Restricted Stock Units (“PBRSUs”) and Time-Vested Restricted Stock Units (“RSUs”).
  4.    Benefits.
  4.1
Retirement, Welfare and Fringe Benefits.  During the Period of Employment, the Executive shall be entitled to participate in all employee pension and welfare benefit plans and programs, and fringe benefit plans and programs, made available by the Company to the Company’s employees generally, in accordance with the eligibility and participation provisions of such plans and as such plans or programs may be in effect from time to time.
   4.2
Reimbursement of Business Expenses.  The Executive is authorized to incur reasonable expenses in carrying out the Executive’s duties for the Company under this Agreement and shall be entitled to reimbursement for all reasonable business expenses the Executive incurs during the Period of Employment in connection with carrying out the Executive’s duties for the Company, subject to the Company’s expense reimbursement policies and any pre-approval policies in effect from time to time.  The Executive agrees to promptly submit and document any reimbursable expenses in accordance with the Company’s expense reimbursement policies to facilitate the timely reimbursement of such expenses.
   4.3
Paid Time Off.  During the Period of Employment, the Executive will be covered by the Company’s Executive Paid Time Off Policy as in effect from time to time.
4.4
Relocation Expenses.  In connection with the Executive’s relocation from Switzerland to a location in reasonable proximity to the Company’s principal executive office, the Executive will be entitled to receive reimbursement for his reasonable expenses related to his relocation, including the Executive’s temporary living expenses, house hunting, travel and other related expenses incurred by the Executive and his family in connection with the relocation, up to a maximum aggregate total amount of Five Hundred Thousand Dollars ($500,000). Such relocation expenses shall be paid in accordance with a relocation agreement to be entered into by the Company and the Executive.
3




5.    Termination.
  5.1
Termination by the Company.  The Executive’s employment with the Company, and the Period of Employment, may be terminated at any time by the Company: (i) with Cause (as such term is defined in Section 5.5), or (ii) without Cause, or (iii) in the event of the Executive’s death, or (iv) in the event that the Board determines in good faith that the Executive has a Disability (as such term is defined in Section 5.5).
  5.2
Termination by the Executive. The Executive’s employment with the Company, and the Period of Employment, may be terminated by the Executive with no less than thirty (30) days advance written notice to the Company (such notice to be delivered in accordance with Section 18).
  5.3
Benefits upon Termination.  If the Executive’s employment by the Company is terminated during the Period of Employment for any reason by the Company or by the Executive, or upon or following the expiration of the Period of Employment (in any case, the date that the Executive’s employment by the Company terminates is referred to as the “Severance Date”), the Company shall have no further obligation to make or provide to the Executive, and the Executive shall have no further right to receive or obtain from the Company, any payments or benefits except as follows:
(a)    The Company shall pay the Executive (or, in the event of his death, the Executive’s estate) any Accrued Obligations (as such term is defined in Section 5.5);
(b)    If, during the Period of Employment and prior to the date on which a Change in Control (as defined in Section 5.5) occurs, the Executive’s employment with the Company terminates as a result of an Involuntary Termination (as such term is defined in Section 5.5), the Executive shall be entitled to the following benefits:
(i)    The Company shall pay the Executive (in addition to the Accrued Obligations), subject to tax withholding and other authorized deductions, an amount equal to Two (2) (the “Applicable Multiple”) times the sum of (x) the Executive’s Base Salary at the annualized rate in effect on the Severance Date plus (y) the target annual Incentive Bonus amount for the Executive as established by the Company and as in effect on the Severance Date (the “Severance Benefit.”)  In the seventh (7th) month following the month in which the Executive’s Separation from Service (as such term is defined in Section 5.5) occurs, the Company shall pay the Executive a fraction of the aggregate Severance Benefit, where the numerator of such fraction is seven (7) and the denominator of such fraction is the Number of Severance Months.  For purposes of this Agreement, the “Number of Severance Months” equals eighteen (18) multiplied by the Applicable Multiple.  For each month thereafter, commencing with the eighth (8th) month following the month in which the Executive’s Separation from Service occurs and continuing through and ending with the month which is the Number of Severance Months following the month in which the Executive’s Separation from Service occurs, the Company shall pay the Executive a fraction of the aggregate Severance Benefit, where the numerator of such fraction is one (1) and the denominator of such fraction is the Number of Severance Months.  Any fractional payment shall be rounded down to the nearest whole cent.
(ii)    The Company will pay or reimburse the Executive for his premiums charged to continue medical coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act (“COBRA”), at the same or reasonably equivalent medical
4




coverage for the Executive (and, if applicable, the Executive’s eligible dependents) as in effect immediately prior to the Severance Date, to the extent that the Executive elects such continued coverage; provided that the Company’s obligation to make any payment or reimbursement pursuant to this clause (ii) shall, subject to Section 21(b), commence with continuation coverage for the month following the month in which the Executive’s Separation from Service occurs and shall cease with continuation coverage for the twenty-fourth (24th) month following the month in which the Executive’s Separation from Service occurs (or, if earlier, shall cease upon the first to occur of the Executive’s death, the date the Executive becomes eligible for coverage under the health plan of a future employer, or the date the Company ceases to offer group medical coverage to its active executive employees or the Company is otherwise under no obligation to offer COBRA continuation coverage to the Executive).  If the Company is not able to provide continuation coverage under COBRA for any month during the continuation period, the Company shall pay the Executive a cash payment equal to its portion of the applicable COBRA premiums on an after-tax basis, with such payment to be made in the same month for which the continuation coverage was otherwise to be provided. To the extent the Executive elects COBRA coverage, he shall notify the Company in writing of such election prior to such coverage taking effect and complete any other continuation coverage enrollment procedures the Company may then have in place;
(iii)    The Company shall promptly pay to the Executive any Incentive Bonus that would otherwise be paid to the Executive had his employment by the Company not terminated with respect to any fiscal year that ended before the Severance Date, to the extent not theretofore paid; and
(iv)    At the time the Company pays bonuses with respect to the fiscal year in which the Severance Date occurs (and in all events not later than two and one-half (2 ½) months after the end of such fiscal year), the Company shall pay the Executive the Incentive Bonus that would otherwise have been paid to the Executive with respect to that fiscal year had his employment with the Company not terminated, multiplied by a fraction, the numerator of which is the total number of days in such fiscal year the Executive was employed with the Company and the denominator of which is the total number of days in such fiscal year.
(c)    If, during the Period of Employment, the Executive’s employment with the Company terminates as a result of the Executive’s death or Disability, the Company shall pay the Executive the amounts contemplated by Section 5.3(b)(iii) and (iv).
(d)    Notwithstanding the foregoing provisions of this Section 5.3, if the Executive breaches his obligations under Section 6 of this Agreement, or any obligation under the Confidentiality Agreement, at any time, from and after the date of such breach and not in any way in limitation of any right or remedy otherwise available to the Company, the Executive will no longer be entitled to, and the Company will no longer be obligated to pay, any remaining unpaid portion of the Severance Benefit or any remaining unpaid amount contemplated by Section 5.3(b)(iii), 5.3(b)(iv), or 5.3(c), or to any continued Company-paid or reimbursed coverage pursuant to Section 5.3(b)(ii); provided that, if the Executive provides the Release contemplated by Section 5.4, in no event shall the Executive be entitled to benefits pursuant to Section 5.3(b) or 5.3(c), as applicable, of less than $5,000 (or the amount of such benefits, if less than $5,000), which amount the
5




parties agree is good and adequate consideration, in and of itself, for the Executive’s Release contemplated by Section 5.4.
(e)    The foregoing provisions of this Section 5.3 shall not affect: (i) the Executive’s receipt of benefits otherwise due terminated employees under group insurance coverage consistent with the terms of the applicable Company welfare benefit plan; (ii) the Executive’s rights under COBRA to continue participation in medical, dental, and hospitalization; or (iii) the Executive’s receipt of benefits otherwise due in accordance with the terms of the Company’s 401(k) plan (if any).
(f)    If a Change in Control occurs, Section 5.3 shall no longer apply as of the date of the Change in Control (other than to the extent Executive’s employment had already terminated prior to such date), and the Executive’s right to receive any severance benefits in connection with a termination of employment upon or after the date of such Change in Control shall be governed by the Change in Control Agreement (as defined in Section 5.5); provided, however, that if the Executive is entitled to any severance benefits under the Change in Control Agreement in connection with a Termination (as such term is defined in the Change in Control Agreement) that occurs within six (6) months prior to a Change in Control as provided in Section 5 of the Change in Control Agreement (a “Pre-CIC Termination”), then (i) any severance benefits otherwise payable to Executive pursuant to Section 6(a)(ii) and (iii) of the Change in Control Agreement shall be reduced on a dollar-for-dollar basis by the amount of any severance benefits Executive becomes entitled to in connection with such termination under Section 5.3(b)(i), (ii) any benefits due to the Executive pursuant to Section 6(b) of the Change in Control Agreement shall be reduced for the number of months (if any) the Executive was provided benefits under Section 5(b)(ii) and Section 5(b)(ii) shall cease to apply with the month in which the Change in Control occurs, and (iii) if the Executive is entitled in connection with such termination to the benefit provided for in Section 5(b)(iv), such provision shall apply and the Executive shall not be entitled to the benefit provided for in Section 6(a)(i) of the Change in Control Agreement.  By executing this Agreement, the Executive and the Company agree that the Change in Control Agreement is amended (i) as provided to effect the foregoing provisions of this Section 5(f), and (ii) if the Executive becomes entitled to cash severance as provided in Section 6(a) of the Change in Control Agreement (including cash severance pursuant to the Change in Control Agreement in connection with a Pre-CIC Termination), such cash severance shall be paid in installments in accordance with the schedule set forth in Section 5.3(b)(i) above (but determined applying the Applicable Multiple provided for in the Change in Control Agreement).  In addition, the parties hereby agree that if the Executive becomes entitled to payment by the Company of his COBRA premiums as provided in Section 6(b) of the Change in Control Agreement in connection with a Pre-CIC Termination and was not entitled to the benefit provided in Section 5(b)(iv) of this Agreement in connection with such a Pre-CIC Termination, such benefit under Section 6(b) of the Change in Control Agreement shall commence with the month following the month in which the Change in Control occurs.
   5.4
Release; Exclusive Remedy.
(a)    This Section 5.4 shall apply notwithstanding anything else contained in this Agreement or any stock option or other equity-based award agreement to the contrary.  As a condition precedent to any Company obligation to the Executive pursuant to Section 5.3(b) or 5.3(c) or any other obligation to accelerate vesting of any equity-based award in connection with the termination of the Executive’s employment, the Executive shall, upon or promptly following his last day of employment with the Company (and in all events within twenty-one (21) days after his last day of employment with the Company),
6




provide the Company with a valid, executed Release, and such Release shall have not been revoked by the Executive pursuant to any revocation rights afforded by applicable law.  For these purposes, “Release” means a written release agreement in substantially the form attached as Exhibit A to this Agreement, provided that the Company may make technical changes to such form and may revise such form to reflect changes in law, rules and regulations or otherwise to help ensure that the Release is maximally enforceable under applicable law.
(b)    The Executive agrees that the payments and benefits contemplated by Section 5.3 (and any applicable acceleration of vesting of an equity-based award in accordance with the terms of such award in connection with the termination of the Executive’s employment) shall constitute the exclusive and sole remedy for any termination of his employment and the Executive covenants not to assert or pursue any other remedies, at law or in equity, with respect to any termination of employment.  The Executive agrees to resign, on the Severance Date, as an officer and director of the Company and each of its subsidiaries, and as a fiduciary of any benefit plan of the Company or any of its subsidiaries, and to promptly execute and provide to the Company any further documentation, as requested by the Company, to confirm such resignation.
  5.5
Certain Defined Terms.
(a)    As used herein, “Accrued Obligations” means:
(i)    any Base Salary that had accrued but had not been paid on or before the Severance Date; and
(ii)    any reimbursement due to the Executive pursuant to Sections 4.2 or 4.4 for expenses reasonably incurred by the Executive on or before the Severance Date and documented and pre-approved, to the extent applicable, in accordance with the Company’s expense reimbursement policies in effect at the applicable time.
(b)    As used herein, “Cause” shall mean, as reasonably determined by the Board (excluding the Executive, if he is then a member of the Board) based on the information then known to it, that one or more of the following has occurred:
(i)    the Executive has committed a felony or any crime of moral turpitude (under the laws of the United States or any relevant state, or a similar crime or offense under the applicable laws of any relevant foreign jurisdiction);
(ii)    the Executive has engaged in acts of fraud, dishonesty or other acts of misconduct in the course of his duties hereunder;
(iii)    the Executive has willfully failed to perform or uphold his duties under this Agreement, has been negligent in performing such duties, and/or has willfully failed to comply with reasonable directives of the Board or any superior officer of the Company; or
(iv)    the Executive has breached any Company policy applicable to the Executive, the Confidentiality Agreement, any provision of Section 6, and/or any other contract to which the Executive is a party to with the Company or any of its subsidiaries.
(c)    As used herein, “Change of Control” shall have the meaning given to such term in the Change in Control Agreement.
7




(d)    As used herein, “Change in Control Agreement” shall mean the Change in Control Agreement by and between the Executive and the Company dated [September ___, 2020].
(e)    As used herein, “Disability” shall mean a physical or mental impairment which, as reasonably determined by the Board, renders the Executive unable to perform the essential functions of his employment with the Company, even with reasonable accommodation that does not impose an undue hardship on the Company, for more than 90 days in any 180-day period, unless a longer period is required by federal or state law, in which case that longer period would apply.
(f)    As used herein, “Involuntary Termination” shall mean a termination of the Executive’s employment by the Company without Cause (and other than due to Executive’s death or in connection with a good faith determination by the Board that the Executive has a Disability).
(g)    As used herein, the term “Person” shall be construed broadly and shall include, without limitation, an individual, a partnership, a limited liability company, a corporation, an association, a joint stock company, a trust, a joint venture, an unincorporated organization and a governmental entity or any department, agency or political subdivision thereof.
(h)    As used herein, a “Separation from Service” occurs when the Executive dies, retires, or otherwise has a termination of employment with the Company that constitutes a “separation from service” within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative definitions available thereunder.
  5.6.
Notice of Termination.  Any termination of the Executive’s employment under this Agreement shall be communicated by written notice of termination from the terminating party to the other party.  This notice of termination must be delivered in accordance with Section 18 and must indicate the specific provision(s) of this Agreement relied upon in effecting the termination.
  5.7
Limitation on Benefits; Company Clawback Policy.  Notwithstanding anything else in this Agreement to the contrary, benefits and payments under this Section 5 are subject to Section 7 of the Change in Control Agreement. Any Incentive Bonus paid, as well as any other compensation provided, to Executive will be subject, to the extent applicable in accordance with its terms, to the Company’s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law.
6.
Protective Covenants.  For purposes of clarity, the provisions of this Section 6 are in addition to, not in lieu of, any obligations set forth in the Confidentiality Agreement.
8




6.1
Cooperation. Following the Executive’s last day of employment by the Company, the Executive shall reasonably cooperate with the Company and its subsidiaries in connection with: (a) any internal or governmental investigation or administrative, regulatory, arbitral or judicial proceeding involving the Company and any subsidiaries with respect to matters relating to the Executive’s employment with or service as a member of the Board or the board of directors of any subsidiary (collectively, “Litigation”); or (b) any audit of the financial statements of the Company or any subsidiary with respect to the period of time when the Executive was employed by the Company or any subsidiary (“Audit”).  The Executive acknowledges that such cooperation may include, but shall not be limited to, the Executive making himself available to the Company or any subsidiary (or their respective attorneys or auditors) upon reasonable notice for: (i) interviews, factual investigations, and providing declarations or affidavits that provide truthful information in connection with any Litigation or Audit; (ii) appearing at the request of the Company or any subsidiary to give testimony without requiring service of a subpoena or other legal process; (iii) volunteering to the Company or any subsidiary pertinent information related to any Litigation or Audit; (iv) providing information and legal representations to the auditors of the Company or any subsidiary, in a form and within a time frame requested by the Board, with respect to the Company’s or any subsidiary’s opening balance sheet valuation of intangibles and financial statements for the period in which the Executive was employed by the Company or any subsidiary; and (v) turning over to the Company or any subsidiary any documents relevant to any Litigation or Audit that are or may come into the Executive’s possession.  The Company shall reimburse the Executive for reasonable travel expenses incurred in connection with providing the services under this Section 6.1, including lodging and meals, upon the Executive’s submission of receipts.
9




6.2
Further Condition of Any Severance.  The Executive agrees that if the Executive were to become employed by, or substantially involved in, the business of a competitor of the Company or any of its subsidiaries during the twelve (12) month period following the Severance Date, it would be very difficult for the Executive not to rely on or use the Company’s and its subsidiaries’ trade secrets and confidential information. Accordingly, the Company shall have no obligation to pay any Severance Benefit (or any further Severance Benefit, as the case may be, and in each case that may otherwise be or become due) in the event that, during the Period of Employment or at any time in the twelve (12) months after the Severance Date, the Executive, directly or indirectly through any other Person engages in, enters the employ of, renders any services to, has any ownership interest in, or participates in the financing, operation, management or control of, any Competing Business. The Executive agrees that he will not hold any such position or engage in any such activity during the Period of Employment. Compliance with this Section 6.2 is a condition precedent to any Severance Benefit that might otherwise be or become due. For avoidance of doubt, the Company shall not be entitled to monetary damages or injunctive relief in the event of any breach by the Executive of this Section 6.2 following the Severance Date. For purposes of this Agreement, the phrase “directly or indirectly through any other Person engage in” shall include, without limitation, any direct or indirect ownership or profit participation interest in such enterprise, whether as an owner, stockholder, member, partner, joint venturer or otherwise, and shall include any direct or indirect participation in such enterprise as an employee, consultant, director, officer, licensor of technology or otherwise. For purposes of this Agreement, “Competing Business” means a Person anywhere in the continental United States and elsewhere in the world where the Company and its subsidiaries engage in business, or reasonably anticipate engaging in business, on the Severance Date (the “Restricted Area”) that at any time during the Period of Employment has competed, or at any time during the twelve (12) month period following the Severance Date competes, with the Company or any of its subsidiaries in any business engaged in by the Company or any of its subsidiaries (or which any of them had plans to in the future engage in, which plans were known by or reasonably should have been known by the Executive) as of the Severance Date. Nothing herein shall prohibit the Executive from being a passive owner of not more than 2% of the outstanding stock of any class of a corporation which is publicly traded, so long as the Executive has no active participation in the business of such corporation.
7.
Withholding Taxes.  Notwithstanding anything else herein to the contrary, the Company may withhold (or cause there to be withheld, as the case may be) from any amounts otherwise due or payable under or pursuant to this Agreement such federal, state and local income, employment, or other taxes as may be required to be withheld pursuant to any applicable law or regulation.
8.
Successors and Assigns.
(a)    This Agreement is personal to the Executive and without the prior written consent of the Company shall not be assignable by the Executive otherwise than by will or the laws of descent and distribution.  This Agreement shall inure to the benefit of and be enforceable by the Executive’s legal representatives.
(b)    This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.  Without limiting the generality of the preceding sentence, the Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.  As used in this Agreement, “Company” shall mean the Company as hereinbefore defined and any successor or assignee, as applicable, which assumes and agrees to perform this Agreement by operation of law or otherwise.
10




9.
Number and Gender; Examples.  Where the context requires, the singular shall include the plural, the plural shall include the singular, and any gender shall include all other genders.  Where specific language is used to clarify by example a general statement contained herein, such specific language shall not be deemed to modify, limit or restrict in any manner the construction of the general statement to which it relates.
 10.
Section Headings.  The section headings of, and titles of paragraphs and subparagraphs contained in, this Agreement are for the purpose of convenience only, and they neither form a part of this Agreement nor are they to be used in the construction or interpretation thereof.
11.
Governing Law.  This Agreement will be governed by and construed in accordance with the laws of the state of California, without giving effect to any choice of law or conflicting provision or rule (whether of the state of California or any other jurisdiction) that would cause the laws of any jurisdiction other than the state of California to be applied.  In furtherance of the foregoing, the internal law of the state of California will control the interpretation and construction of this Agreement, even if under such jurisdiction’s choice of law or conflict of law analysis, the substantive law of some other jurisdiction would ordinarily apply.
12.
Severability.  It is the desire and intent of the parties hereto that the provisions of this Agreement be enforced to the fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought.  Accordingly, if any particular provision of this Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, prohibited or unenforceable under any present or future law, and if the rights and obligations of any party under this Agreement will not be materially and adversely affected thereby, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction, and to this end the provisions of this Agreement are declared to be severable; furthermore, in lieu of such invalid or unenforceable provision there will be added automatically as a part of this Agreement, a legal, valid and enforceable provision as similar in terms to such invalid or unenforceable provision as may be possible.  Notwithstanding the foregoing, if such provision could be more narrowly drawn (as to geographic scope, period of duration or otherwise) so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction.
13.
Entire Agreement.  This Agreement, together with the attached exhibit, the Confidentiality Agreement and the Change in Control Agreement (together, the “Integrated Document”), embodies the entire agreement of the parties hereto respecting the matters within its scope.  The Integrated Document supersedes all prior and contemporaneous agreements of the parties hereto that directly or indirectly bears upon the subject matter hereof.  Any prior negotiations, correspondence, agreements, proposals or understandings relating to the subject matter hereof shall be deemed to have been merged into the Integrated Document, and to the extent inconsistent with the Integrated Document, such negotiations, correspondence, agreements, proposals, or understandings shall be deemed to be of no force or effect.  There are no representations, warranties, or agreements, whether express or implied, or oral or written, with respect to the subject matter hereof, except as expressly set forth in the Integrated Document.
 14.
Modifications.  This Agreement may not be amended, modified or changed (in whole or in part), except by a formal, definitive written agreement expressly referring to this Agreement, which agreement is executed by both of the parties hereto.
11




15.
Waiver.  Neither the failure nor any delay on the part of a party to exercise any right, remedy, power or privilege under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege preclude any other or further exercise of the same or of any right, remedy, power or privilege, nor shall any waiver of any right, remedy, power or privilege with respect to any occurrence be construed as a waiver of such right, remedy, power or privilege with respect to any other occurrence.  No waiver shall be effective unless it is in writing and is signed by the party asserted to have granted such waiver.
16.
Arbitration.  Except as provided in Section 6.2 and Section 17, the Executive and the Company agree that any controversy arising out of or relating to this Agreement, its enforcement or interpretation, or because of an alleged breach, default, or misrepresentation in connection with any of its provisions, or any other controversy arising out of the Executive’s employment, including, but not limited to, any state or federal statutory claims, shall be submitted to arbitration in Orange County, California, before a sole arbitrator (the “Arbitrator”) selected from the American Arbitration Association, as the exclusive forum for the resolution of such dispute; provided, however, that provisional injunctive relief may, but need not, be sought by either party to this Agreement in a court of law while arbitration proceedings are pending, and any provisional injunctive relief granted by such court shall remain effective until the matter is finally determined by the Arbitrator.  Final resolution of any dispute through arbitration may include any remedy or relief which the Arbitrator deems just and equitable, including any and all remedies provided by applicable state or federal statutes.  At the conclusion of the arbitration, the Arbitrator shall issue a written decision that sets forth the essential findings and conclusions upon which the Arbitrator's award or decision is based.  Any award or relief granted by the Arbitrator hereunder shall be final and binding on the parties hereto and may be enforced by any court of competent jurisdiction.  The parties acknowledge and agree that they are hereby waiving any rights to trial by jury in any action, proceeding or counterclaim brought by either of the parties against the other in connection with any matter whatsoever arising out of or in any way connected with this Agreement or the Executive’s employment.
17.
Remedies.  Each of the parties to this Agreement and any such person or entity granted rights hereunder whether or not such person or entity is a signatory hereto shall be entitled to enforce its rights under this Agreement specifically to recover damages and costs for any breach of any provision of this Agreement and to exercise all other rights existing in its favor.  The parties hereto agree and acknowledge that money damages may not be an adequate remedy for any breach of the provisions of this Agreement and that each party may in its sole discretion apply to any court of law or equity of competent jurisdiction for specific performance, injunctive relief and/or other appropriate equitable relief (without posting any bond or deposit) in order to enforce or prevent any violations of the provisions of this Agreement.  Each party shall be responsible for paying its own attorneys’ fees, costs and other expenses pertaining to any such legal proceeding and enforcement regardless of whether an award or finding or any judgment or verdict thereon is entered against either party.
18.
Notices.  Any notice provided for in this Agreement must be in writing and must be either personally delivered, transmitted via telecopier, mailed by first class mail (postage prepaid and return receipt requested) or sent by reputable overnight courier service (charges prepaid) to the recipient at the address below indicated or at such other address or to the attention of such other person as the recipient party has specified by prior written notice to the sending party.  Notices will be deemed to have been given hereunder and received when delivered personally, when received if transmitted via telecopier, five days after deposit in the U.S. mail and one day after deposit with a reputable overnight courier service.
if to the Company:
CoreLogic, Inc.
40 Pacifica, Suite 900
Irvine, California 92618
Attention:  General Counsel
12




  if to the Executive, to the address most recently on file in the payroll records of the Company.
19.
Counterparts.  This Agreement may be executed in any number of counterparts, each of which shall be deemed an original as against any party whose signature appears thereon, and all of which together shall constitute one and the same instrument.  This Agreement shall become binding when one or more counterparts hereof, individually or taken together, shall bear the signatures of all of the parties reflected hereon as the signatories.  Photographic copies of such signed counterparts may be used in lieu of the originals for any purpose.
20.
Legal Counsel; Mutual Drafting.  Each party recognizes that this is a legally binding contract and acknowledges and agrees that they have had the opportunity to consult with legal counsel of their choice.  Each party has cooperated in the drafting, negotiation and preparation of this Agreement.  Hence, in any construction to be made of this Agreement, the same shall not be construed against either party on the basis of that party being the drafter of such language.  The Executive agrees and acknowledges that he has read and understands this Agreement, is entering into it freely and voluntarily, and has been advised to seek counsel prior to entering into this Agreement and has had ample opportunity to do so.
21.
Section 409A.
(a)    It is intended that any amounts payable under this Agreement shall either be exempt from or comply with Section 409A of the Code (including the Treasury regulations and other published guidance relating thereto) (“Code Section 409A”) so as not to subject the Executive to payment of any additional tax, penalty or interest imposed under Code Section 409A.  The provisions of this Agreement shall be construed and interpreted to avoid the imputation of any such additional tax, penalty or interest under Code Section 409A yet preserve (to the nearest extent reasonably possible) the intended benefit payable to the Executive.
(b)    If the Executive is a “specified employee” within the meaning of Treasury Regulation Section 1.409A-1(i) as of the date of the Executive’s Separation from Service, the Executive shall not be entitled to any payment or benefit pursuant to Section 5.3(b) or (c) until the earlier of (i) the date which is six (6) months after his Separation from Service for any reason other than death, or (ii) the date of the Executive’s death.  The provisions of this Section 21(b) shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty or interest pursuant to Code Section 409A.  Any amounts otherwise payable to the Executive upon or in the six (6) month period following the Executive’s Separation from Service that are not so paid by reason of this Section 21(b) shall be paid (without interest) as soon as practicable (and in all events within thirty (30) days) after the date that is six (6) months after the Executive’s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of the Executive’s death). Any installment payment payable pursuant to this Agreement shall be treated as a separate payment for purposes of Code Section 409A.
(c)    To the extent that any benefits pursuant to Section 5.3(b)(ii) or reimbursements pursuant to Section 4.2, Section 4.4 or Section 6.1 are taxable to the Executive, any reimbursement payment due to the Executive pursuant to any such provision shall be paid to the Executive on or before the last day of the Executive’s taxable year following the taxable year in which the related expense was incurred.  The benefits and reimbursements pursuant to such provisions are not subject to liquidation or exchange for another benefit and the amount of such benefits and reimbursements that the Executive receives in one taxable year shall not affect the amount of such benefits or reimbursements that the Executive receives in any other taxable year.
[The remainder of this page has intentionally been left blank.]
13




    IN WITNESS WHEREOF, the Company and the Executive have executed this Agreement as of the Effective Date.

  “COMPANY”  
       
  CoreLogic, Inc.,  
  a Delaware corporation  
       
  By: /s/ Frank Martell  
  Name:  Frank Martell  
  Title: President and Chief Executive Officer  
       
       
  “EXECUTIVE”  
       
 /s/ Patrick L. Dodd
Name: Patrick L. Dodd


14




EXHIBIT A
Form of Release
1.             Release by the Executive.  [____________] (the “Executive”), on his own behalf and on behalf of his descendants, dependents, heirs, executors, administrators, assigns and successors, and each of them, hereby acknowledges full and complete satisfaction of and releases and discharges and covenants not to sue CoreLogic, Inc. (the “Company”), its divisions, subsidiaries, parents, or affiliated corporations, past and present, and each of them, as well as its and their assignees, successors, directors, officers, stockholders, partners, representatives, attorneys, agents or employees, past or present, or any of them (individually and collectively, “Releasees”), from and with respect to any and all claims, agreements, obligations, demands and causes of action, known or unknown, suspected or unsuspected, arising out of or in any way connected with the Executive’s employment or any other relationship with or interest in the Company or the termination thereof, including without limiting the generality of the foregoing, any claim for severance pay, profit sharing, bonus or similar benefit, pension, retirement, life insurance, health or medical insurance or any other fringe benefit, or disability, or any other claims, agreements, obligations, demands and causes of action, known or unknown, suspected or unsuspected resulting from any act or omission by or on the part of Releasees committed or omitted prior to the date of this General Release Agreement (this “Agreement”) set forth below, including, without limiting the generality of the foregoing, any claim under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Family and Medical Leave Act, or any other federal, state or local law, regulation or ordinance (collectively, the “Claims”); provided, however, that the foregoing release does not apply to any obligation of the Company to the Executive pursuant to any of the following: (1) Section 5.3 of the Employment Agreement dated as of [__________, 20__] by and between the Company and the Executive (the “Employment Agreement”); (2) any equity-based awards previously granted by the Company to the Executive, to the extent that such awards continue after the termination of the Executive’s employment with the Company in accordance with the applicable terms of such awards; (3) any right to indemnification that the Executive may have pursuant to the Company’s bylaws, its corporate charter or under any written indemnification agreement with the Company (or any corresponding provision of any subsidiary or affiliate of the Company) with respect to any loss, damages or expenses (including but not limited to attorneys’ fees to the extent otherwise provided) that the Executive may in the future incur with respect to his service as an employee, officer or director of the Company or any of its subsidiaries or affiliates; (4) with respect to any rights that the Executive may have to insurance coverage for such losses, damages or expenses under any Company (or subsidiary or affiliate) directors and officers liability insurance policy; (5) any rights to continued medical and dental coverage that the Executive may have under COBRA; or (6) any rights to payment of benefits that the Executive may have under a retirement plan sponsored or maintained by the Company that is intended to qualify under Section 401(a) of the Internal Revenue Code of 1986, as amended.  In addition, this release does not cover any Claim that cannot be so released as a matter of applicable law.  The Executive acknowledges and agrees that he has received any and all leave and other benefits that he has been and is entitled to pursuant to the Family and Medical Leave Act of 1993.
     2.             Acknowledgement of Payment of Wages.  Except for accrued vacation (which the parties agree totals approximately ___ days of pay) and salary for the current pay period, the Executive acknowledges that he has received all amounts owed for his regular and usual salary (including, but not limited to, any bonus, severance, or other wages), and usual benefits through the date of this Agreement.
3.             Waiver of Civil Code Section 1542.  This Agreement is intended to be effective as a general release of and bar to each and every Claim hereinabove specified.  Accordingly, the Executive hereby expressly waives any rights and benefits conferred by Section 1542 of the California Civil Code and any similar provision of any other applicable state law as to the Claims.  Section 1542 of the California Civil Code provides:
“A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.”
15





The Executive acknowledges that he later may discover claims, demands, causes of action or facts in addition to or different from those which the Executive now knows or believes to exist with respect to the subject matter of this Agreement and which, if known or suspected at the time of executing this Agreement, may have materially affected its terms.  Nevertheless, the Executive hereby waives, as to the Claims, any claims, demands, and causes of action that might arise as a result of such different or additional claims, demands, causes of action or facts.
4.             ADEA Waiver.  The Executive expressly acknowledges and agrees that by entering into this Agreement, he is waiving any and all rights or claims that he may have arising under the Age Discrimination in Employment Act of 1967, as amended (“ADEA”), which have arisen on or before the date of execution of this Agreement.  The Executive further expressly acknowledges and agrees that:
(a)           He is hereby advised in writing by this Agreement to consult with an attorney before signing this Agreement;
(b)           He was given a copy of this Agreement on [____________] and informed that he had twenty-one (21) days within which to consider this Agreement and that if he wished to execute this Agreement prior to expiration of such 21-day period, he should execute the Acknowledgement and Waiver attached hereto as Exhibit A-1;
(c)           Nothing in this Agreement prevents or precludes the Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs from doing so, unless specifically authorized by federal law; and
(d)           He was informed that he has seven (7) days following the date of execution of this Agreement in which to revoke this Agreement, and this Agreement will become null and void if the Executive elects revocation during that time.  Any revocation must be in writing, addressed to the Company’s Chief Executive Officer and delivered in accordance with the notice provisions of the Employment Agreement, and must be received by the Company during the seven-day revocation period.  In the event that the Executive exercises his right of revocation, neither the Company nor the Executive will have any obligations under this Agreement.
 5.             Restricted Stock Unit.  As part of Executive’s employment, Executive was awarded restricted stock units pursuant to the terms of Restricted Stock Unit Award Agreements, Performance-Based Restricted Stock Unit Award Agreements and the plan in effect from time to time (collectively, the “Plan Documents”), the terms of which are incorporated herein by reference.  This Agreement shall constitute a separation agreement for purposes of determining the Period of Restriction, as defined in the Plan Documents.  If Executive signs and returns this Agreement, the Period of Restriction applicable to Executive’s outstanding, unvested restricted stock units will lapse as provided in, and subject to the provisions of, the Plan Documents.  Executive agrees that Executive will not engage in Detrimental Activity, as defined in the applicable award agreement.
6.             No Transferred Claims.  The Executive represents and warrants to the Company that he has not heretofore assigned or transferred to any person not a party to this Agreement any released matter or any part or portion thereof.
7.             Miscellaneous.  The following provisions shall apply for purposes of this Agreement:
(a)           Number and Gender. Where the context requires, the singular shall include the plural, the plural shall include the singular, and any gender shall include all other genders.
(b)           Section Headings. The section headings of, and titles of paragraphs and subparagraphs contained in, this Agreement are for the purpose of convenience only, and they neither form a part of this Agreement nor are they to be used in the construction or interpretation thereof.
16




(c)           Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of _______, without giving effect to any choice of law or conflicting provision or rule (whether of the State of ________ or any other jurisdiction) that would cause the laws of any jurisdiction other than the State of ______ to be applied.  In furtherance of the foregoing, the internal law of the State of _______ will control the interpretation and construction of this agreement, even if under such jurisdiction’s choice of law or conflict of law analysis, the substantive law of some other jurisdiction would ordinarily apply.
(d)           Severability. It is the desire and intent of the parties hereto that the provisions of this Agreement be enforced to the fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought.  Accordingly, if any particular provision of this Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, prohibited or unenforceable under any present or future law, and if the rights and obligations of any party under this Agreement will not be materially and adversely affected thereby, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction, and to this end the provisions of this Agreement are declared to be severable; furthermore, in lieu of such invalid or unenforceable provision there will be added automatically as a part of this Agreement, a legal, valid and enforceable provision as similar in terms to such invalid or unenforceable provision as may be possible.  Notwithstanding the foregoing, if such provision could be more narrowly drawn (as to geographic scope, period of duration or otherwise) so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction.
(e)           Modifications. This Agreement may not be amended, modified or changed (in whole or in part), except by a formal, definitive written agreement expressly referring to this Agreement, which agreement is executed by both of the parties hereto.
(f)           Waiver.  Neither the failure nor any delay on the part of a party to exercise any right, remedy, power or privilege under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege preclude any other or further exercise of the same or of any right, remedy, power or privilege, nor shall any waiver of any right, remedy, power or privilege with respect to any occurrence be construed as a waiver of such right, remedy, power or privilege with respect to any other occurrence.  No waiver shall be effective unless it is in writing and is signed by the party asserted to have granted such waiver.
(g)           Arbitration. The Executive and the Company agree that any controversy or claim arising out of or relating to this Agreement, its enforcement or interpretation, or because of an alleged breach, default, or misrepresentation in connection with any of its provisions, or any other controversy or claim arising out of Executive’s employment, including, but not limited to, any state or federal statutory claims, shall be submitted to arbitration in accordance with the arbitration and dispute resolution provisions set forth in the Employment Agreement.
(h)           Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original as against any party whose signature appears thereon, and all of which together shall constitute one and the same instrument.  This Agreement shall become binding when one or more counterparts hereof, individually or taken together, shall bear the signatures of all of the parties reflected hereon as the signatories.  Photographic copies of such signed counterparts may be used in lieu of the originals for any purpose.
[Remainder of page intentionally left blank]

17




The undersigned have read and understand the consequences of this Agreement and voluntarily sign it.  The undersigned declare under penalty of perjury under the laws of the State of California that the foregoing is true and correct.

EXECUTED this ________ day of ________ 20___, at ______________________ County, __________.

  “EXECUTIVE”  
     
     
     
  [___________]  


EXECUTED this ________ day of ________ 20___, at ______________________ County, __________.


  “COMPANY”
     
  CORELOGIC, INC.
     
  By:  
    [Name]
    [Title]

 

18




 
EXHIBIT A-1
ACKNOWLEDGMENT AND WAIVER

I, _______________, hereby acknowledge that I was given 21 days to consider the foregoing General Release Agreement and voluntarily chose to sign the General Release Agreement prior to the expiration of the 21-day period.
I declare under penalty of perjury under the laws of the State of California that the foregoing is true and correct.

EXECUTED this ___ day of ____________ 20___, at ___________ County, _________.


     
  [_____________]  

19


EXHIBIT 10.2
Notice of Restricted Stock Unit Grant

Participant:        [Participant Name]
Corporation:        CoreLogic, Inc.
Notice:            You have been granted the following Restricted Stock Units in accordance with the terms of the Plan and the Restricted Stock Unit Award Agreement attached hereto (this “Agreement”).
Type of Award:        Restricted Stock Units
Plan:    CoreLogic, Inc. 2018 Performance Incentive Plan
Grant:            Date of Grant: [Grant Date]
Number of Shares Underlying Bonus Restricted Stock Units: [Number of RSUs Granted]

Period of Restriction:    Subject to the terms of the Plan and this Agreement, the Period of Restriction applicable to the Restricted Stock Units shall commence on the Date of Grant and shall lapse on the date listed in the “Lapse Date” column below as to that portion of Shares underlying the Restricted Stock Units set forth below opposite each such date.


Lapse Date
Portion of Shares as to
Which Period of Restriction Lapses
Date of Grant + 1 year 1/3
Date of Grant + 2 years 1/3
Date of Grant + 3 years 1/3

For purposes of this Agreement, “Period of Restriction” means the period during which the Restricted Stock Units are subject to a substantial risk of forfeiture for reasons other than prohibited Detrimental Activities. The date on which the Period of Restriction lapses pursuant to this paragraph is referred to herein as the “Lapse Date.”

The vesting schedule set forth above requires the Participant’s continued employment or service through each applicable Lapse Date as a condition to the lapsing of the Period of Restriction on such Lapse Date. Except as provided in Section 4 or Section 5 of this Agreement, employment or service for only a portion of the Period of Restriction prior to the Lapse Date, even if a substantial portion, will not entitle the Participant to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment or services as provided in Section 4 below or under the Plan.

Rejection:        If you wish to accept this Restricted Stock Unit Award, please access Fidelity NetBenefits® at www.netbenefits.com and follow the steps outlined under the "Accept Grant" link at any time within forty-five (45) days after the Date of Grant. If you do not accept your grant via Fidelity NetBenefits® within forty-five (45) days after the Date of Grant, you will have rejected this Restricted Stock Unit Award.

- 1 -


Restricted Stock Unit Award Agreement1

This Restricted Stock Unit Award Agreement (this “Agreement”), dated as of the Date of Grant set forth in the Notice of Restricted Stock Unit Grant attached hereto (the “Grant Notice”), is made between CoreLogic, Inc. (the “Corporation”) and the Participant set forth in the Grant Notice. The Grant Notice is included in and made part of this Agreement. Participant acknowledges that acceptance of this Agreement is voluntary and is not a condition of Participant’s employment or continued employment. The Restricted Stock Unit Award is a discretionary award and not compensation for services rendered. The purpose of the award of the Restricted Stock Units provided under this Agreement is to align Participant’s interests with those of the Corporation and to secure Participant’s agreement to keep them so aligned for a reasonable period of time.
1.Definitions.
Certain capitalized terms are defined in the Grant Notice, herein or in the attached Appendix A. Capitalized terms used but not defined in the Grant Notice, herein or in the attached Appendix A shall have the meaning assigned to such terms in the Plan.
2.Grant of the Restricted Stock Units.
Subject to the provisions of this Agreement and the provisions of the Plan, the Corporation hereby grants to the Participant, pursuant to the Plan, a right to receive the number of shares of Common Stock (“Shares”) set forth in the Grant Notice (the “Restricted Stock Units”).
3.Dividend Equivalents.
Each Restricted Stock Unit shall accrue Dividend Equivalents (as defined below) with respect to dividends that would otherwise be paid on the Share underlying such Restricted Stock Unit during the period from the Grant Date to the date such Share is delivered in accordance with Section 6. As of any date in this period that the Corporation pays an ordinary cash dividend on its Common Stock, the Corporation shall credit the Participant with an additional number of Restricted Stock Units equal to (i) the per share cash dividend paid by the Corporation on its Common Stock on such date, multiplied by (ii) the total number of Restricted Stock Units subject to the award as of the related dividend payment record date (including any Dividend Equivalents previously credited hereunder), divided by (iii) the fair market value (as determined in accordance with the terms of the Plan) of a share of Common Stock on the date of payment of such dividend. Any Restricted Stock Units credited pursuant to the foregoing provisions of this Section 3 shall be subject to the same Period of Restriction, payment, delivery and other terms, conditions and restrictions as the original Restricted Stock Units to which they relate. Any such crediting of Dividend Equivalents shall be conclusively determined by the Administrator. No crediting of Restricted Stock Units shall be made pursuant to this Section 3 with respect to any Restricted Stock Units which, as of such record date, have either been delivered or terminated pursuant to the Plan or this Agreement. For purposes of this Agreement, “Dividend Equivalents” means the equivalent value (in cash or Shares) of dividends that would otherwise be paid on the Shares subject to the Restricted Stock Units but that have not been issued or delivered.
4.Period of Restriction; Termination.
The Period of Restriction with respect to the Restricted Stock Units shall be as set forth in the Grant Notice. Subject to the terms of the Plan, the remaining provisions of this Section 4 and Section 5(b), all Restricted Stock Units for which the Period of Restriction had not lapsed prior to the date of the Participant’s Termination (as defined in Appendix A attached hereto) shall be immediately forfeited. Notwithstanding the foregoing to the contrary:
(a)In the event of the Participant’s death or Disability (as defined in Appendix A attached hereto) prior to his or her Termination, the Period of Restriction as to all remaining unpaid Restricted Stock Units shall lapse in its entirety.
1 The amendments reflected in Sections 4 and 5 of this Agreement also apply to all other outstanding Restricted Stock Units.
- 2 -



(b)In the event of the Participant’s Termination due to his or her Normal Retirement (as defined below), the Period of Restriction as to all remaining unpaid Restricted Stock Units shall lapse in its entirety, provided that the Participant shall have signed a general release agreement on substantially the same form attached to the employment agreement between the Participant and the Corporation (or if the Participant is not party to an employment agreement with the Corporation, on the form attached to the most recently executed executive employment agreement entered into prior to a Change in Control) within 21 days (or such longer period of time required by applicable law) following his or her Termination and such release agreement is not subsequently revoked (the “Release Requirement”).
(c)In the event of the Participant’s involuntary Termination by the Corporation or an Affiliate (as defined in Appendix A attached hereto) without Cause (as defined in Appendix A attached hereto), the Period of Restriction as to all remaining unpaid Bonus Restricted Stock Units shall lapse in its entirety; provided that the Participant shall have satisfied the Release Requirement described in Section 4(b) of this Agreement.
For purposes of this Agreement, “Normal Retirement” means Termination of the Participant, other than for Cause, after the Participant has reached 62 years of age.
5.Change in Control.
(a)    In the event of a corporate transaction described in Section 7.2 of the Plan (which generally includes transactions that the Corporation does not survive or does not survive as a public company in respect of its Common Stock), the provisions of Section 7.2 of the Plan shall apply to the remaining unpaid Restricted Stock Units; provided, however, that the payment date of the Restricted Stock Units that are to be paid pursuant to the award shall in all cases be determined pursuant to Section 6.
(b)    In the event the Participant is Terminated by the Corporation or an Affiliate (including any successor to such entity) without Cause or, in the case of a Participant party to a Change in Control Agreement, the Participant Terminates for Good Reason (as defined in Appendix A attached hereto), in each case upon or at any time during the twelve-month period following a Change in Control (as defined in Appendix A attached hereto), the Period of Restriction as to all remaining unpaid Restricted Stock Units shall lapse in its entirety; provided that the Participant shall have satisfied the Release Requirement described in Section 4(b) of this Agreement.
6.Delivery of Shares.
The Shares underlying the Restricted Stock Units for which the Period of Restriction has lapsed according to the vesting schedule set forth in the Grant Notice, together with Shares comprising all accrued Dividend Equivalents with respect to such Restricted Stock Units, shall be delivered by the Corporation to the Participant as soon as reasonably practicable, but in no event later than 74 days following the applicable Lapse Date set forth in the Grant Notice. The Shares underlying the Restricted Stock Units for which the Period of Restriction has lapsed pursuant to Section 4 or Section 5(b) of this Agreement, together with Shares comprising all accrued Dividend Equivalents with respect to such Restricted Stock Units, shall be delivered by the Corporation to the Participant as soon as reasonably practicable, but in no event later than 74 days, following the first to occur of (i) the date of the Participant’s death or Disability, or (ii) the first anniversary of the Participant’s “separation from service” (as such term is used for purposes of Section 409A of the Code), whether such separation from service results from the Participant’s Normal Retirement, Termination by the Corporation or an Affiliate without Cause or otherwise. The Shares underlying the Restricted Stock Units for which the Period of Restriction has lapsed pursuant to Section 7.2 of the Plan, together with Shares comprising all accrued Dividend Equivalents with respect to such Restricted Stock Units, shall be delivered by the Corporation to the Participant as soon as reasonably practicable, but in no event later than 74 days following the applicable Lapse Date set forth in the Grant Notice; provided, however, that (i) if the Participant dies or incurs a Disability prior to any such Lapse Date, the related payment shall be made to the Participant as soon as reasonably practicable, but in no event later than 74 days, following the date of the Participant’s death or Disability, or (ii) if the Participant’s separation from service occurs prior to such Lapse Date, the related payment shall be made as soon as reasonably practicable, but in no event later than 74 days, following the first anniversary of the Participant’s separation from service. Notwithstanding the foregoing provisions of this
- 3 -



Section 6, the Administrator may provide for payment of any Shares underlying the Restricted Stock Units for which the Period of Restriction has lapsed in accordance with the requirements of Treasury Regulation 1.409A-3(j)(4)(ix)(A), (B) or (C) promulgated under Section 409A of the Code (or any similar successor provision), which regulation generally provides that a deferred compensation arrangement may be terminated in limited circumstances following a dissolution or change in control of the Corporation. The Participant shall have no rights to receive delivery of any Shares with respect to Restricted Stock Units that have been forfeited or cancelled, or for which Shares have previously been delivered. No fractional Shares shall be delivered, and the Shares otherwise deliverable in any payment pursuant to this Section 6 shall be rounded down to the nearest whole number of Shares.
7.No Ownership Rights Prior to Issuance of Shares.
Neither the Participant nor any other person shall become the beneficial owner of the Shares underlying the Restricted Stock Units, nor have any rights to dividends (other than rights to Dividend Equivalents pursuant to Section 3) or other rights as a shareholder with respect to any such Shares, until and after such Shares have been actually issued to the Participant and transferred on the books and records of the Corporation or its agent in accordance with the terms of the Plan and this Agreement.
8.Detrimental Activity.
(a)    Notwithstanding any other provisions of this Agreement to the contrary, if at any time prior to the delivery of Shares with respect to the Restricted Stock Units, the Participant engages in Detrimental Activity (as defined below), such Restricted Stock Units shall be cancelled and rescinded without any payment or consideration therefor. The determination of whether the Participant has engaged in Detrimental Activity shall be made by the Administrator in its good faith discretion, and lapse of the Period of Restriction and delivery of Shares with respect to the Restricted Stock Units shall be suspended pending resolution to the Administrator’s satisfaction of any investigation of the matter.
(b)    For purposes of this Agreement, “Detrimental Activity” means at any time (i) using information received during the Participant’s employment with the Corporation and/or its Subsidiaries, Affiliates and predecessors in interest relating to the business affairs of the Corporation or any such Subsidiaries, Affiliates or predecessors in interest, in breach of the Participant’s express or implied undertaking to keep such information confidential; (ii) directly or indirectly persuading or attempting to persuade, by any means, any employee of the Corporation or any of its Subsidiaries or Affiliates to breach any of the terms of his or her employment with Corporation, its Subsidiaries or its Affiliates; (iii) directly or indirectly making any statement that is, or could be, disparaging of the Corporation or any of its Subsidiaries or Affiliates, or any of their respective employees (except to the extent necessary to respond truthfully to any inquiry from applicable regulatory authorities or to provide information pursuant to legal process); (iv) directly or indirectly engaging in any illegal, unethical or otherwise wrongful activity that is, or could be, substantially injurious to the financial condition, reputation or goodwill of the Corporation or any of its Subsidiaries or Affiliates; (v) directly or indirectly engaging in an act of misconduct such as, embezzlement, fraud, dishonesty, nonpayment of any obligation owed to the Corporation or any of its Subsidiaries or Affiliates, breach of fiduciary duty or disregard or violation of rules, policies or procedures of the Corporation or any of its Subsidiaries or Affiliates, an unauthorized disclosure of any trade secret or confidential information of the Corporation or any of its Subsidiaries or Affiliates, or inducing any customer to breach a contract with the Corporation or any of its Subsidiaries or Affiliates, or (vi) threatening to engage in, engaging in, or accepting a position with duties that involve engaging in Unfair Competition; in each case as determined by the Administrator in its good faith discretion.
(c)    As a condition of receiving the Restricted Stock Unit Award applicable to this Agreement, Participant agrees not to engage in Unfair Competition. Participant engages in “Unfair Competition” if during the one (1) year period following Termination, Participant does any of the following on behalf of (or for the benefit of) a Competitor without the advance written approval of the Corporation: (i) directly or indirectly provides services to a Competitor that are the same as or similar in a material way to the services Participant provided to the Corporation in the two year period preceding Termination (the “Look Back Period”), supervises or manages such services, or participates in other activities on behalf of a Competitor that create a significant risk of unauthorized use or disclosure of the Corporation’s trade secret, confidential or proprietary information; (ii) participates in the
- 4 -



solicitation or servicing of any customer that Participant had material interaction with, supervised interaction with, or was provided confidential information about in the Look Back Period; (iii) knowingly causes or attempt to cause a customer, vendor, supplier, or referral source that Participant dealt with or gained knowledge of during employment to end or reduce business activities with the Corporation; or, (iv) for the benefit of a Competitor, solicits an employee of the Corporation that Participant worked with or was provided Confidential Information about in the Look Back Period to leave the employment of the Corporation, or assists a Competitor in hiring away any such employee of the Corporation. If Participant is offered a position with a Competitor while employed with the Corporation or within the twelve (12) month period immediately following termination of his or her employment, Participant shall provide written notice to the Corporation’s General Counsel, including adequate information about Participant’s new position to determine whether such position would likely lead to a violation of this Agreement and shall meet with the General Counsel or the General Counsel’s designee, if requested to do so, to try and resolve any disputes between the parties before beginning work in the new position.
As used above, a “Competitor” refers to any person or entity engaged in a business that provides products or services that would compete with or displace those of the Corporation. This is understood to include, by way of illustration and without limitation, any person or entity in the business of providing consumer, financial, and property data, analytics, and services to the real estate, property, mortgage, insurance, and financial services industries and government. The restrictions above are geographically limited in that they apply to activities that occur within or relate to the state where Participant resides and each additional state (or state-equivalent) within the United States and any other country where the Corporation does business or has demonstrable plans to do business as of the date of Participant’s Termination. The restrictions apply to activities undertaken by Participant on behalf of (or for the benefit of) a Competitor whether as owner, partner, participant of a joint venture, trustee, proprietor, stockholder, member, manager, director, officer, employee, independent contractor, capital investor, lender, consultant, advisor or otherwise. However, nothing in this Section 8 prohibits general advertising of a generic nature, such as “want ads” that are not targeted at the Corporation’s employees, or passive ownership of less than five percent (5%) of the equity securities of a publicly-traded company.
(d)    The avoidance of Detrimental Activities is a precondition to Participant’s entitlement to receive and retain the Restricted Stock Units awarded through this Agreement. Accordingly, unless otherwise prohibited from doing so by law, if Participant engages in Detrimental Activities the Corporation may cancel any outstanding awards and recover from Participant the Restricted Stock Units or their Fair Market Value at the time received by Participant (less taxes paid by Participant); provided, however, that the foregoing right of recovery shall expire three years after the last Lapse Date identified in the Notice of Restricted Stock Unit Grant. The foregoing shall be in addition to, and not in lieu of, the Corporation’s right to pursue and secure injunctive relief and/or an order of specific performance to enforce Participant’s agreement not to engage in Unfair Competition, and thereby prevent the irreparable harm to the Corporation that Participant acknowledges would occur if Participant engages in Unfair Competition.
(e)    A material purpose of this Agreement is to fully and finally resolve what is fair and reasonable to consider Unfair Competition. For this reason, Participant agrees not to pursue any legal claim or argument that the restrictions against Unfair Competition provided for in this Agreement are unreasonable or unenforceable as written. In the event the Unfair Competition restrictions are challenged and found unreasonable or unenforceable in any respect deemed material by the Corporation, the Corporation shall have the right to exercise an option to demand and receive the return to it of all Restricted Stock Units, or their Fair Market Value at the time received by Participant (less taxes paid by Participant), within thirty days of demand for repayment by the Corporation.
(f)    Nothing in this Agreement prohibits Participant from reporting possible violations of federal law or regulation to any governmental agency or entity, or making other disclosures that are protected under the whistleblower provisions of federal law or regulation. Participant does not need any prior authorization to make any such reports or disclosures and is not required to notify the Corporation of such reports or disclosures.
- 5 -



9.No Right to Continued Employment.
None of the Restricted Stock Units nor any terms contained in this Agreement shall confer upon the Participant any express or implied right to be retained in the employ of the Corporation or any Subsidiary or Affiliate for any period, nor restrict in any way the right of the Corporation or any Subsidiary or any Affiliate, which right is hereby expressly reserved, to terminate the Participant’s employment at any time for any reason. For the avoidance of doubt, this Section 9 is not intended to amend or modify any other agreement, including any employment agreement, that may be in existence between the Participant and the Corporation or any Subsidiary or Affiliate.
10.The Plan.
In consideration for this grant, the Participant agrees to comply with the terms of the Plan and this Agreement. This Agreement is subject to all the terms, provisions and conditions of the Plan, which are incorporated herein by reference, and to such regulations as may from time to time be adopted by the Administrator. In the event of any conflict between the provisions of the Plan and this Agreement, the provisions of the Plan shall control, and this Agreement shall be deemed to be modified accordingly, provided that the provisions of Section 6 (Delivery of Shares) of this Agreement shall control over any conflicting payment provisions of the Plan. The Plan and the prospectus describing the Plan can be found on Fidelity NetBenefits® at www.netbenefits.com under Plan Information and Documents. A paper copy of the Plan and the prospectus shall be provided to the Participant upon the Participant’s written request to the Corporation at CoreLogic, Inc., 40 Pacifica, Suite 900, Irvine, California 92618, Attention: Incentive Compensation Plan Administrator, or such other address as the Corporation may from time to time specify.
11.Compliance with Laws and Regulations.
(a)    The Restricted Stock Units and the obligation of the Corporation to sell and deliver Shares hereunder shall be subject in all respects to (i) all applicable Federal and state laws, rules and regulations and (ii) any registration, qualification, approvals or other requirements imposed by any government or regulatory agency or body which the Administrator shall, in its discretion, determine to be necessary or applicable. Moreover, the Corporation shall not deliver any certificates for Shares to the Participant or any other person pursuant to this Agreement if doing so would be contrary to applicable law. If at any time the Corporation determines, in its discretion, that the listing, registration or qualification of Shares upon any national securities exchange or under any state or Federal law, or the consent or approval of any governmental regulatory body, is necessary or desirable, the Corporation shall not be required to deliver any certificates for Shares to the Participant or any other person pursuant to this Agreement unless and until such listing, registration, qualification, consent or approval has been effected or obtained, or otherwise provided for, free of any conditions not acceptable to the Corporation.
(b)    It is intended that the Shares received in respect of the Restricted Stock Units shall have been registered under the Securities Act. If the Participant is an “affiliate” of the Corporation, as that term is defined in Rule 144 under the Securities Act (“Rule 144”), the Participant may not sell the Shares received except in compliance with Rule 144. Certificates representing Shares issued to an “affiliate” of the Corporation may bear a legend setting forth such restrictions on the disposition or transfer of the Shares as the Corporation deems appropriate to comply with Federal and state securities laws.
(c)    If, at any time, the Shares are not registered under the Securities Act, and/or there is no current prospectus in effect under the Securities Act with respect to the Shares, the Participant shall execute, prior to the delivery of any Shares to the Participant by the Corporation pursuant to this Agreement, an agreement (in such form as the Corporation may specify) in which the Participant represents and warrants that the Participant is purchasing or acquiring the Shares acquired under this Agreement for the Participant's own account, for investment only and not with a view to the resale or distribution thereof, and represents and agrees that any subsequent offer for sale or distribution of any kind of such Shares shall be made only pursuant to either (i) a registration statement on an appropriate form under the Securities Act, which registration statement has become effective and is current with regard to the Shares being offered or sold, or (ii) a specific exemption from the registration requirements of the Securities Act, but in claiming such exemption the Participant shall, prior to any offer for sale of such Shares, obtain
- 6 -



a prior favorable written opinion, in form and substance satisfactory to the Corporation, from counsel for or approved by the Corporation, as to the applicability of such exemption thereto.
12.Notices.
All notices by the Participant or the Participant’s assignees shall be addressed to CoreLogic, Inc., 40 Pacifica, Suite 900, Irvine, California 92618, Attention: Incentive Compensation Plan Administrator, or such other address as the Corporation may from time to time specify. All notices to the Participant shall be addressed to the Participant at the Participant’s address in the Corporation's records.
13.Severability.
            In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of this Agreement, and this Agreement shall be construed and enforced as if the illegal or invalid provision had not been included, except where this Agreement expressly provides to the contrary. In the event a restriction on Participant contained in this Agreement is deemed unenforceable because it is unreasonable or overbroad in time, scope, or geography, an enforcing court shall enforce the restriction to such lesser extent as would be reasonable and enforceable (and/or reform the restriction as necessary to do so), and shall not refuse to enforce the restriction in its entirety.
14.Other Plans.
The Participant acknowledges that any income derived from the Restricted Stock Units shall not affect the Participant’s participation in, or benefits under, any other benefit plan or other contract or arrangement maintained by the Corporation or any Subsidiary or Affiliate. Restricted Stock Units and Dividend Equivalents shall not be deemed to be “Covered Compensation” under any other benefit plan of the Corporation.
15.    Vesting of Restricted Stock Units Contingent on Corporation Performance.
Notwithstanding any other provisions in this Agreement, except in the event of an acceleration of vesting pursuant to Section 4(a) or Section 5 of this Agreement, the Participant’s entitlement to the receipt of any Shares hereunder is contingent upon the Corporation’s achievement of net income (as defined in accordance with generally acceptable accounting principles) for 2020 of $65 million or more. Net income shall be determined without regard to (a) amortization related to acquired intangibles, (b) asset write-downs, (c) litigation or claim judgments or settlements, (d) the effect of changes in tax laws, accounting principles, or other laws or provisions affecting reported results, (e) any transformation, reorganization and restructuring program costs, (f) non-cash stock compensation, (g) extraordinary, unusual and/or nonrecurring items of gain or loss, and (h) foreign exchange gains and losses.
16.    Adjustments.
The Restricted Stock Units and the Shares underlying the Restricted Stock Units shall be subject to adjustment and conversion pursuant to the terms of Section 7.1 of the Plan.
17.    Tax Withholding.
Any payment or delivery of Shares pursuant to this Agreement shall be subject to the Corporation’s rights to withhold applicable Federal, state, local and non-United States taxes in accordance with Section 8.5 of the Plan.
18.    Section 409A.
The provisions of this Agreement shall be construed and interpreted to comply with Section 409A of the Code so as to avoid the imposition of any penalties, taxes or interest thereunder.
- 7 -



19.    Clawback.
    The Restricted Stock Units are subject to the terms of the Corporation’s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of the Restricted Stock Units or any Shares or other cash or property received with respect to the Restricted Stock Units (including any value received from a disposition of the Shares acquired upon payment of the Restricted Stock Units).
    

    CORELOGIC, INC.

    
    By:_____________________________
     Name: Frank Martell
     Title: President and Chief Executive Officer

    Date: [Grant Date]





Acknowledged and agreed as of the Date of Grant:



Printed Name:    [Participant Name]


Date:    [Acceptance Date]


NOTE: GRANT WILL BE ACCEPTED ELECTRONICALLY
- 8 -



APPENDIX A

Certain Definitions

Affiliate” means any entity other than the Corporation and any Subsidiary that is affiliated with the Corporation through stock or equity ownership or otherwise and is designated as an Affiliate for purposes of the Plan by the Administrator.

Cause” has the same meaning as in the Participant’s Change in Control Agreement (if any), or if the Participant is not party to a Change in Control Agreement, in the Participant’s employment agreement with the Corporation, a Subsidiary or an Affiliate (if any) as in effect at the time of the Participant’s Termination, or if the Participant is not a party to such an employment agreement (or is not a party to such an employment agreement that contains a definition of “cause”), “Cause” means: (i) embezzlement, theft or misappropriation by the Participant of any property of any of the Corporation or its Affiliates; (ii) the Participant’s breach of any fiduciary duty to the Corporation or its Affiliates; (iii) the Participant’s failure or refusal to comply with laws or regulations applicable to the Corporation or its Affiliates and their businesses or the policies of the Corporation and its Affiliates governing the conduct of its employees or directors; (iv) the Participant’s gross incompetence in the performance of the Participant’s job duties; (v) commission by the Participant of a felony or of any crime involving moral turpitude, fraud or misrepresentation; (vi) the failure of the Participant to perform duties consistent with a commercially reasonable standard of care; (vii) the Participant’s failure or refusal to perform the Participant’s job duties or to perform specific directives of the Participant’s supervisor or designee, or the senior officers or Board of Directors of the Corporation; or (viii) any gross negligence or willful misconduct of the Participant resulting in loss to the Corporation or its Affiliates, or damage to the reputation of the Corporation or its Affiliates.
Change in Control” means the happening of any of the following after the date hereof:

(a)     The consummation of a merger or consolidation of the Corporation with or into another entity or any other corporate reorganization, if fifty percent (50%) or more of the combined voting power of the continuing or surviving entity’s securities outstanding immediately after such merger, consolidation, or other reorganization is owned by persons who were not shareholders of the Corporation immediately prior to such merger, consolidation, or other reorganization.
(b)     The sale, transfer, or other disposition of all or substantially all of the Corporation’s assets or the complete liquidation or dissolution of the Corporation.
(c)     A change in the composition of the Board occurring within a two (2) year period, as a result of which fewer than a majority of the directors are Incumbent Directors. “Incumbent Directors” shall mean directors who are directors of the Corporation immediately following the consummation of the transactions contemplated by the Separation and Distribution Agreement by and between the Corporation and the First American Financial Corporation dated June 1, 2010 (the “Separation Agreement”). “Incumbent Directors” shall also include directors who are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such election or nomination, but shall not include an individual not otherwise an Incumbent Director whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Corporation.
(d)     Any transaction as a result of which any person or group is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934), directly or indirectly, of securities of the Corporation representing at least thirty percent (30%) of the total voting power of the Corporation’s then outstanding voting securities. For purposes of this paragraph, the term “person” shall have the same meaning as when used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, but shall exclude: (i) a trustee or other fiduciary holding securities under an employee benefit plan of the Corporation or of a Subsidiary of the Corporation; (ii) so long as a person does not thereafter increase such
- 9 -



person’s beneficial ownership of the total voting power represented by the Corporation’s then outstanding voting securities, a person whose beneficial ownership of the total voting power represented by the Corporation’s then outstanding voting securities increases to thirty percent (30%) or more as a result of the acquisition of voting securities of the Corporation by the Corporation which reduces the number of such voting securities then outstanding; or (iii) so long as a person does not thereafter increase such person’s beneficial ownership of the total voting power represented by the Corporation’s then outstanding voting securities, a person that acquires directly from the Corporation securities of the Corporation representing at least thirty percent (30%) of the total voting power represented by the Corporation’s then outstanding voting securities.
A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Corporation’s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Corporation’s securities immediately before such transaction.
For the avoidance of doubt, the consummation of any or all of the transactions in the Separation Agreement is not considered a Change in Control for purposes of this Agreement.
Change in Control Agreement” means the Corporation’s form Change in Control Agreement entered into with certain executives of the Corporation.
Disability” means the inability to engage in any substantial gainful occupation to which the relevant individual is suited by education, training or experience, by reason of any medically determinable physical or mental impairment, which condition can be expected to result in death or continues for a continuous period of not less than twelve (12) months.
Good Reason” has the same meaning as in the Participant’s Change in Control Agreement.
Termination” means the time when the Participant ceases the performance of services for the Corporation, any Affiliate or Subsidiary, as applicable, for any reason, with or without Cause, including a Termination by resignation with or without Good Reason, discharge, retirement, death or Disability, but excluding (a) a Termination where there is a simultaneous reemployment or continuing employment of the Participant by the Corporation, any Affiliate or Subsidiary, (b) at the discretion of the Administrator, a Termination that results in a temporary severance, and (c) at the discretion of the Administrator, a Termination of an employee of the Corporation that is immediately followed by the Participant’s service as a non-employee director of the Board.  Notwithstanding any other provisions of the Plan or this Agreement to the contrary, a Termination shall not be deemed to have occurred for purposes of any provision the Plan or this Agreement providing for payment or distribution with respect to an award constituting deferred compensation subject to Code Section 409A upon or following a termination of employment or services unless such termination is also a “separation from service” within the meaning of Section 409A of the Code.




- 10 -


EXHIBIT 10.3
Notice of Performance-Based Restricted Stock Unit Grant


Participant:        [Participant Name]
Corporation:        CoreLogic, Inc.
Notice:            You have been granted the following Performance-Based Restricted Stock Units (“Performance-Based RSUs”) in accordance with the terms of the Plan and the Performance-Based Restricted Stock Unit Award Agreement attached hereto (this “Agreement”).
Type of Award:        Performance-Based RSUs
Plan:    CoreLogic, Inc. 2018 Performance Incentive Plan
Grant:            Date of Grant:  [Grant Date]
            Target Number of Performance-Based RSUs:  [Number of RSUs Granted]

Vesting:            Subject to the terms of the Plan and this Agreement, the vesting and payment of the Performance-Based RSUs shall be subject to (1) the attainment of the Performance Measures set forth below, and (2) to the extent the Performance Measures are attained, an additional time-based vesting requirement set forth below. The time-based vesting requirements set forth below require the Participant’s continued employment or service through each applicable vesting date as a condition to the vesting of any of the Shares underlying the Performance-Based RSUs. Except as provided in Sections 4 and 5 of this Agreement, employment or service for only a portion of the vesting period, even if a substantial portion, will not entitle the Participant to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment or services as provided in Section 4 below or under the Plan.

Measurement Period:    The performance period for the Performance-Based RSUs shall commence on January 1, 2020 and end on December 31, 2022 (the “Performance Period”). Each of the three calendar years occurring in the Performance Period is referred to as a “Performance Year.”
    
Performance Measures:    The Performance-Based RSUs shall be subject to a series of performance evaluations for Adjusted EPS and Relative Total Shareholder Return (TSR) (the “Performance Measures”). For each Performance Year, the number of Performance-Based RSUs that can potentially be vested (i.e., credited) is evaluated based on the Corporation’s Adjusted EPS performance (as such term is defined below and as reflected in Table 1 below), and may then be subject to potential modification based upon Relative TSR Modifier results (as such term is defined below). In addition to the evaluation in each respective Performance Year, the cumulative Adjusted EPS results for the 3-year Performance Period, before a potential Relative TSR Modifier, will be evaluated (see Table 1 below).


-1-


TABLE 1

Adjusted EPS for Performance Year or Full 3- Year Performance Period Percentage of Units Corresponding to that Year or Period to be Credited (before Relative TSR Modifier)
Less Than Threshold 0%
Threshold 50%
Target 100%
Maximum or greater 200%

Linear Interpolation. If Adjusted EPS for the applicable Performance Year or Performance Period is greater than the Threshold goal and less than the Target goal, or greater than the Target goal but less than the Maximum goal, the percentage of units corresponding to the applicable measurement period to be credited will be determined by linear interpolation between the corresponding points in Table 1 above.

The Adjusted EPS goals for each Performance Year and for the cumulative 3-year Performance Period shall be the applicable goals approved by the Compensation Committee. The percentage of the Performance-Based RSUs that will be credited based on the Adjusted EPS results in any given Performance Year, prior to a Relative TSR Modifier and subject to the provisions of this Agreement, shall be determined as set forth in Table 2.

TABLE 2
Performance Year Percentage of Target Performance-Based RSUs Potentially Credited (before Relative TSR Modifier)
2020 30%
2021 50%
2022 20%
Cumulative 100%


Relative TSR Modifier. The Performance-Based RSUs to be credited from Adjusted EPS results for any Performance Year or the full 3-year Performance Period are subject to a potential Relative TSR Modifier. The Relative TSR performance will be evaluated for each Performance Year and the full 3-year Performance Period as a percentile ranking of CoreLogic versus the Corporation Peer Group (as defined below). If Adjusted EPS for the Performance Year, or the full 3-year Performance Period, is at or greater than the 110% of Target goal but the Corporation’s Relative TSR Percentile for that Performance Year or respective Performance Period is less than the 55th percentile, the percentage of units to be credited is 150% of target (rather than the higher percentage up to 200% calculated based on Adjusted EPS results and the linear interpolation described above). If Adjusted EPS for the Performance Year or respective Performance Period is lower than the Threshold goal but the Corporation’s Relative TSR Percentile for that Performance Year or Performance Period is above median (i.e., in the top two quartiles), the percentage of units corresponding to that time period to be credited is 50% of target (rather than 0% as would have been credited based on Adjusted EPS results alone). If
- 2 -




Adjusted EPS for a Performance Year or the full 3-year Performance Period is at or greater than the applicable Threshold goal but less than 110% of the Target goal, no Relative TSR modifications will be applied to the credited Performance-Based RSUs. See Table 3 below for further illustration.
TABLE 3
Adjusted EPS Performance by Performance Year or Performance Period
Percentage of Units Credited
(before Relative TSR Modifier)
Relative TSR Modifier Treatment
Greater than 110% of Target performance

Greater than 150% of Target award (capped at 200%)
Decrease percentage of units credited to 150% of Target award if Relative TSR is less than the 55th percentile
100% of Target performance to 110% of Target performance 100% of Target award to 150% of Target award No modifier
Threshold performance to 100% of Target performance 50% of Target award to 100% of Target award No modifier
Less than Threshold performance 0% of Target award Increase percentage of units credited to 50% of Target award if Relative TSR is greater than median

Cumulative. No awards will be payable until the end of the Performance Period. At the end of the Performance Period, the number of Performance-Based RSUs that will vest will be the greater of (1) the sum of the number of units credited pursuant to Table 1 for each of the three Performance Years, and giving effect to the Relative TSR modifier for each such Performance Year discussed above (if applicable), or (2) the number of units credited pursuant to the cumulative performance for the full 3-year Performance Period, and giving effect to the Relative TSR modifier discussed above (if applicable).

Any units that have been credited pursuant to the foregoing provisions shall be subject to the time-based vesting requirement through the end of the three-year Performance Period.

Adjustments. The Administrator shall equitably and proportionately adjust Adjusted EPS or the Adjusted EPS goals set forth above, as the case may be, to preserve the intended incentives of Performance-Based RSUs and exclude or mitigate the impact of, as the case may be, the following: (a) amortization related to acquired intangibles, (b) asset write-downs, (c) litigation or claim judgments or settlements, (d) the effect of changes in tax laws, accounting principles, or other laws or provisions affecting reported results, (e) any transformation, reorganization and restructuring program effects, (f) extraordinary, unusual and/or nonrecurring items of gain or loss, (g) foreign exchange gains and losses, (h) the effects of a stock dividend, stock split or reverse stock split and (i) mergers, acquisitions, and dispositions through either sale or wind down.

Forfeiture:         Any Performance-Based RSUs that have not been credited either with respect to the individual Performance Years or the cumulative Performance Period shall be immediately forfeited effective as of the end of the Performance Period.

Time-Based Vesting:    Any Performance-Based RSUs that have become eligible for time-based vesting following the end of the applicable Performance Year based on performance as described above will be subject to the time-based vesting requirement described herein. Except as provided in Section 4 or Section 5 of this Agreement, in order to vest in and receive
- 3 -




payment of any Shares underlying the Performance-Based RSUs which have become eligible for time-based vesting based on the attainment of the performance requirements set forth above, the Participant must remain continuously employed through, and not have experienced a Termination prior to December 31, 2022. In no event, except as provided in Section 4 or Section 5 of the Performance-Based Restricted Stock Unit Award Agreement attached hereto, shall any Performance-Based RSUs be considered to have been earned unless and until such continued employment requirement is satisfied. Any Performance-Based RSUs which have not previously vested and become payable as a result of the foregoing time-based vesting requirement (and which were not previously forfeited) shall be immediately forfeited on the date of the Participant’s Termination.

Rejection:        If you wish to accept this Performance-Based RSU Award, please access Fidelity NetBenefits® at www.netbenefits.com and follow the steps outlined under the "Accept Grant" link at any time within forty-five (45) days after the Date of Grant. If you do not accept your grant via Fidelity NetBenefits® within forty-five (45) days after the Date of Grant, you will have rejected this Performance-Based RSU Award.

- 4 -




Performance-Based Restricted Stock Unit Award Agreement1

This Performance-Based Restricted Stock Unit Award Agreement (this “Agreement”), dated as of the Date of Grant set forth in the Notice of Performance-Based Restricted Stock Unit Grant attached hereto (the “Grant Notice”), is made between CoreLogic, Inc. (the “Corporation”) and the Participant set forth in the Grant Notice. The Grant Notice is included in and made part of this Agreement. Participant acknowledges that acceptance of this Agreement is voluntary and is not a condition of Participant’s employment or continued employment. The Performance-Based Restricted Stock Unit Award is a discretionary award and not compensation for services rendered. The purpose of the award of the Performance-Based Restricted Stock Units provided under this Agreement is to align Participant’s interests with those of the Corporation and to secure Participant’s agreement to keep them so aligned for a reasonable period of time.
1.Definitions.
Certain capitalized terms are defined in the Grant Notice, herein or in the attached Appendix A. Capitalized terms used but not defined in the Grant Notice, herein or in the attached Appendix A have the meaning assigned to such terms in the Plan.
2.Grant of the Performance-Based RSUs.
Subject to the provisions of this Agreement and the provisions of the Plan, the Corporation hereby grants to the Participant, pursuant to the Plan, a right to receive the number of shares of Common Stock (“Shares”) set forth in the Grant Notice (the “Performance-Based RSUs”).
3.Dividend Equivalents.
Each Performance-Based RSU shall accrue Dividend Equivalents (as defined below) with respect to dividends that would otherwise be paid on the Share underlying such Performance-Based RSU during the period from the Grant Date to the earlier of the date such Share is paid in accordance with this Agreement or the date the Share is forfeited pursuant to the terms of this Agreement. As of any date in this period that the Corporation pays an ordinary cash dividend on its Common Stock, the Corporation shall credit the Participant with an additional number of Performance-Based RSUs equal to (i) the per share cash dividend paid by the Corporation on its Common Stock on such date, multiplied by (ii) the total number of Performance-Based RSUs subject to the award as of the related dividend payment record date (including any Dividend Equivalents previously credited hereunder), divided by (iii) the fair market value (as determined in accordance with the terms of the Plan) of a share of Common Stock on the date of payment of such dividend. Any Performance-Based RSUs credited pursuant to the foregoing provisions of this Section 3 shall be subject to the attainment of the same Performance Measures and time-based vesting requirements applicable to the original Performance-Based RSUs to which they relate, and shall otherwise be subject to the same vesting, payment, delivery and other terms, conditions and restrictions as the original Performance-Based RSUs to which they relate. Any such crediting of Dividend Equivalents shall be conclusively determined by the Administrator. No crediting of Performance-Based RSUs shall be made pursuant to this Section 3 with respect to any Performance-Based RSUs which, as of such record date, have either been delivered or terminated pursuant to the Plan or this Agreement. For purposes of this Agreement, “Dividend Equivalents” means the equivalent value (in cash or Shares) of dividends that would otherwise be paid on the Shares subject to the Performance-Based RSUs but that have not been issued or delivered.
4.Vesting and Payment; Termination.
(a)    The Performance-Based RSUs shall vest and become payable subject to the attainment of the Performance Measures and time-based vesting requirements as set forth in the Grant Notice. Subject to the terms of the Plan, the remaining provisions of this Section 4 and Section 5, all Performance-Based RSUs which have not become vested and payable prior to the date of the Participant’s Termination shall be immediately forfeited.
1 The amendments reflected in Sections 4, 5 and 6 of this Agreement also apply to all other outstanding similarly structured Performance-Based Restricted Stock Units.
- 5 -




(b)    Notwithstanding the foregoing Section 4(a) to the contrary, in the event of the Participant’s Termination due to his or her death, Disability or, except as provided in Section 5(d), Normal Retirement, in each case during the Performance Period and prior to the Shares underlying the Performance-Based RSUs becoming vested and payable, then the Shares underlying the Performance-Based RSUs shall remain outstanding and shall be eligible to become vested and payable on a prorated basis such that the number of such Shares that shall become vested and payable as of the conclusion of the Performance Period shall equal (i) the number of such Shares that would have vested as of the conclusion of the Performance Period based on the attainment of the Performance Measures set forth in the Grant Notice or that would have vested in connection with a change of control or other corporate transaction as provided in Section 5(a) (assuming no termination of employment had occurred), multiplied by (ii) a fraction, the numerator of which shall be the sum of the number of whole months during the Performance Period the Participant was employed by the Corporation or one of its Affiliates (as defined in Appendix A attached hereto), and the denominator of which shall be thirty-six months.
(c)    Notwithstanding the foregoing Section 4(a) to the contrary, in the event of the Participant’s Termination due to his or her death, Disability or Normal Retirement, in each case following the end of the Performance Period and prior to the Shares underlying the Performance-Based RSUs becoming payable, then any Shares underlying the outstanding Performance-Based RSUs that have become eligible for vesting following the end of the Performance Period based on the Corporation’s performance shall become payable.
(d)    Any such Shares that become vested and payable pursuant to this Section 4 shall be paid (together with Shares comprising all accrued Dividend Equivalents with respect to such Shares) to the Participant at the time as specified in Section 6. The vesting and payment provided for in this Section 4 in connection with a Termination due to the Participant’s Disability or Normal Retirement is subject to the condition that the Participant shall have signed a general release agreement on substantially the same form attached to the employment agreement between the Participant and the Corporation (or if the Participant is not party to an employment agreement with the Corporation, in the form attached to the most recently executed executive employment agreement entered into prior to a Change in Control) within 21 days (or such longer period of time required by applicable law) following his or her Termination and such release agreement is not subsequently revoked (the “Release Requirement”).
            (e)    For purposes of this Agreement, “Normal Retirement” means Termination of the Participant, other than for Cause (as defined in Appendix A attached hereto), after the Participant has reached 62 years of age.
5.Change in Control.
(a)    In the event of a corporate transaction described in 7.2 of the Plan (which generally includes transactions that the Corporation does not survive or does not survive as a public company in respect of its Common Stock) during the Performance Period, the Performance Period shall be shortened so that the Performance Year then in effect as well as the Performance Period terminate prior to such transaction as determined by the Administrator (any such shortened Performance Period, the “Shortened Performance Period”). The Adjusted EPS performance levels shall be pro-rated based on the portion of the applicable period completed through the end of such Shortened Performance Period. For purposes of any Performance Year that had not commenced as of the end of such Shortened Performance Period, for purposes of determining the crediting of units, the number of units deemed credited with respect to any such Performance Year shall equal the same percentage of units credited (or deemed credited, as the case may be) in the immediately preceding Performance Year. The Participant shall remain eligible to vest at the conclusion of the Performance Period (or as provided in the next sentence or upon a Termination as provided in Section 4 or this Section 5) in a number of Shares subject to the Performance-Based RSUs (or the equivalent fair market value thereof, as determined by the Administrator, in cash) equal to the greater of (a) 100% of the total number of Performance-Based RSUs set forth in the Grant Notice or (b) the number of Performance-Based RSUs that would have become eligible for time-based vesting in accordance with the terms hereof based on the Corporation’s actual performance for the Shortened Performance Period as determined using the Performance Measures set forth in the Grant Notice as modified by this Section 5(a) (assuming that such performance levels had been achieved for the entire Performance Period). In the event of a corporate transaction
- 6 -




described in 7.2 of the Plan during the Performance Period, in which the Administrator does not make a provision for the substitution, assumption, exchange or other continuation or settlement of the Performance-Based RSUs or (unless the Administrator has provided for the termination of the award) the award would otherwise not continue in accordance with its terms in the circumstances, notwithstanding any continued employment or service requirement or time-based vesting requirement following the end of the Shortened Performance Period in the Plan or this Agreement to the contrary, the Participant shall vest in a number of Shares subject to the Performance-Based RSUs as determined in the preceding sentence.
(b)    In the event of a corporate transaction described in 7.2 of the Plan following the end of the Performance Period, the provisions of Section 7.2 of the Plan shall apply to any Shares underlying the outstanding Performance-Based RSUs that have become eligible for vesting following the end of the Performance Period based on the Corporation’s performance.
(c)    Shares (or the equivalent fair market value thereof, as determined by the Administrator, in cash) underlying the Performance-Based RSUs that become vested and payable in connection with a transaction as described above in Section 5(a) or 5(b) shall be paid (together with any Shares comprising all accrued Dividend Equivalents with respect to such Shares) to the Participant at the time as specified in Section 6. Any Shares underlying Performance-Based RSUs that have been forfeited prior to the date of a transaction as described above in Section 5(a) or 5(b) shall not be eligible to become vested or payable in connection with any such transaction.
(d)    In the event the Participant is Terminated by the Corporation or an Affiliate (including any successor to such entity) without Cause or, in the case of a Participant party to a Change in Control Agreement, the Participant Terminates for Good Reason (as defined in Appendix A attached hereto), in each case during the Performance Period and upon or at any time following a Change in Control and prior to the payment of the Performance-Based RSUs, then any Shares underlying the outstanding Performance-Based RSUs that have become eligible for vesting as provided in Section 5(a) shall become vested and payable. In the event that the Participant would otherwise be entitled to accelerated vesting of the Performance-Based RSUs in connection with his or her Termination under both Section 4(b) and this Section 5(d), the provisions of this Section 5(d) will apply, and the Participant will not be entitled to any accelerated vesting under Section 4(b) with respect to such Termination.
(e)    In the event the Participant is Terminated by the Corporation or an Affiliate (including any successor to such entity) without Cause or the Participant Terminates for Good Reason, in each case following the end of the Performance Period and upon or at any time during the twelve-month period following a Change in Control and prior to the payment or other forfeiture of the Performance-Based RSUs, then any Shares underlying the outstanding Performance-Based RSUs that have become eligible for vesting following the end of the Performance Period shall become vested and payable.
(f)    Any Shares underlying the Performance-Based RSUs that become vested and payable pursuant to this Section 5 shall be paid (together with any Shares comprising all accrued Dividend Equivalents with respect to such Shares) as provided in Section 6. Any Shares underlying Performance-Based RSUs that have been forfeited prior to the date of the Termination without Cause or Termination for Good Reason as described above shall not be eligible to become vested or payable in connection with any such Termination. The vesting and payment provided for in this Section 5 in connection with the Participant’s Termination without Cause or by the Participant for Good Reason is subject to the condition that the Participant shall have satisfied the Release Requirement described in Section 4(d) of this Agreement.
6.Payment of Shares.
(a)    The vesting and payment of the Shares underlying the Performance-Based RSUs shall be subject to the Administrator’s certification of the level of attainment or non-attainment of the performance goals. The Administrator’s determination of performance, and the number of units credited based on performance and eligible to vest, will be final and binding.
- 7 -




(b)    The Shares underlying the Performance-Based RSUs which have become vested and payable at the end of the Performance Period according to the vesting schedule set forth in the Grant Notice, together with Shares comprising all accrued Dividend Equivalents with respect to such Shares, shall be paid by the Corporation to the Participant as soon as reasonably practicable in the year following the year in which the Performance Period ends, but in no event later than 74 days, following the end of the year in which the Performance Period set forth in the Grant Notice ends. The Shares underlying the Performance-Based RSUs which have become vested and payable in connection with a qualifying Termination occurring during the Performance Period pursuant to Section 4(b) or Section 5(d) of this Agreement, together with Shares comprising all accrued Dividend Equivalents with respect to such Shares, shall be paid by the Corporation to the Participant as soon as reasonably practicable in the year following the year in which the Performance Period ends, but in no event later than 74 days, following the end of the year in which the Performance Period set forth in the Grant Notice ends. The Shares underlying the Performance-Based RSUs which have become vested and payable in connection with a qualifying Termination occurring following the end of the Performance Period pursuant to Section 4(c) or Section 5(e) of this Agreement, together with Shares comprising all accrued Dividend Equivalents with respect to such Shares, shall be paid by the Corporation to the Participant as soon as reasonably practicable, but in no event later than 74 days, following the date of the Participant’s death or Disability or the date of the Participant’s “separation from service” (as such term is used for purposes of Section 409A of the Code). The Shares underlying the Performance-Based RSUs which have become vested and payable as a result of a transaction described in 7.2 of the Plan pursuant to Section 5(a) or Section 5(b) of this Agreement, together with Shares comprising all accrued Dividend Equivalents with respect to such Shares, shall be paid by the Corporation to the Participant as soon as reasonably practicable in the year following the year in which the Performance Period ends, but in no event later than 74 days, following the end of the year in which the Performance Period ends, provided, however, that (A) if the Participant dies, incurs a Disability or has a separation from service during the Performance Period, the related payment shall be made to the Participant as soon as reasonably practicable in the year following the year in which the Performance Period ends, but in no event later than 74 days, following the end of the year in which the Performance Period set forth in the Grant Notice ends, or (B) if the Participant dies, incurs a Disability or has a separation from service following the end of the Performance Period, the related payment shall be made to the Participant as soon as reasonably practicable, but in no event later than 74 days, following the date of the Participant’s death or Disability or the date of the Participant’s separation from service. Notwithstanding the foregoing provisions of this Section 6, the Administrator may provide for payment of any Shares underlying the Performance-Based RSUs which have become vested and payable in accordance with the requirements of Treasury Regulation 1.409A-3(j)(4)(ix)(A), (B) or (C) promulgated under Section 409A of the Code (or any similar successor provision), which regulation generally provides that a deferred compensation arrangement may be terminated in limited circumstances following a dissolution or change in control of the Corporation. In the event that the specified period for any payment provided for in this Section 6 spans two calendar years and the payment is subject to the condition that the Participant have satisfied the Release Requirement described in Section 4(d) of this Agreement, the payment shall be made by the Corporation in the second calendar year.
(c)    Any Shares underlying the Performance-Based RSUs that have not become vested and payable following the end of the Performance Period based on the Corporation’s performance or pursuant to Section 4 or Section 5 shall be forfeited as of the last day of the Performance Period. The Participant shall have no rights to receive payment of any Shares, whether pursuant to this Section 6 or any other provision of this Agreement, with respect to Performance-Based RSUs that have been forfeited or cancelled, or for which Shares have previously been delivered. No fractional Shares shall be paid pursuant to this Section 6 or any other provision of this Agreement, and the Shares otherwise payable shall be rounded down to the nearest whole number of Shares.
7.No Ownership Rights Prior to Issuance of Shares.
Neither the Participant nor any other person shall become the beneficial owner of the Shares underlying the Performance-Based RSUs, nor have any rights to dividends (other than rights to Dividend Equivalents pursuant to Section 3) or other rights as a stockholder with respect to any such Shares, until and after such Shares have been actually issued to the Participant and transferred on the books and records of the Corporation or its agent in accordance with the terms of the Plan and this Agreement.
- 8 -




8.Detrimental Activity.
(a)    Notwithstanding any other provisions of this Agreement to the contrary, if at any time prior to the delivery of Shares with respect to the Performance-Based RSUs, the Participant engages in Detrimental Activity (as defined below), such Performance-Based RSUs shall be cancelled and rescinded without any payment or consideration therefor. The determination of whether the Participant has engaged in Detrimental Activity shall be made by the Administrator in its good faith discretion, and the payment of Shares with respect to the Performance-Based RSUs shall be suspended pending resolution to the Administrator’s satisfaction of any investigation of the matter.
(b)    For purposes of this Agreement, “Detrimental Activity” means at any time (i) using information received during the Participant’s employment with the Corporation and/or its Subsidiaries, Affiliates and predecessors in interest relating to the business affairs of the Corporation or any such Subsidiaries, Affiliates or predecessors in interest, in breach of the Participant’s express or implied undertaking to keep such information confidential; (ii) directly or indirectly persuading or attempting to persuade, by any means, any employee of the Corporation or any of its Subsidiaries or Affiliates to breach any of the terms of his or her employment with Corporation, its Subsidiaries or its Affiliates; (iii) directly or indirectly making any statement that is, or could be, disparaging of the Corporation or any of its Subsidiaries or Affiliates, or any of their respective employees (except to the extent necessary to respond truthfully to any inquiry from applicable regulatory authorities or to provide information pursuant to legal process); (iv) directly or indirectly engaging in any illegal, unethical or otherwise wrongful activity that is, or could be, substantially injurious to the financial condition, reputation or goodwill of the Corporation or any of its Subsidiaries or Affiliates; (v) directly or indirectly engaging in an act of misconduct such as, embezzlement, fraud, dishonesty, nonpayment of any obligation owed to the Corporation or any of its Subsidiaries or Affiliates, breach of fiduciary duty or disregard or violation of rules, policies or procedures of the Corporation or any of its Subsidiaries or Affiliates, an unauthorized disclosure of any trade secret or confidential information of the Corporation or any of its Subsidiaries or Affiliates or inducing any customer to breach a contract with the Corporation or any of its Subsidiaries or Affiliates, or (vi) threatening to engage in, engaging in, or accepting a position with duties that involve engaging in Unfair Competition; in each case as determined by the Administrator in its good faith discretion.
(c)    As a condition of receiving the Performance-Based RSUs applicable to this Agreement, Participant agrees not to engage in Unfair Competition. Participant engages in “Unfair Competition” if during the one (1) year period following Termination, Participant does any of the following on behalf of (or for the benefit of) a Competitor without the advance written approval of the Corporation: (i) directly or indirectly provides services to a Competitor that are the same as or similar in a material way to the services Participant provided to the Corporation in the two year period preceding Termination (the “Look Back Period”), supervises or manages such services, or participates in other activities on behalf of a Competitor that create a significant risk of unauthorized use or disclosure of the Corporation’s trade secret, confidential or proprietary information; (ii) participates in the solicitation or servicing of any customer that Participant had material interaction with, supervised interaction with, or was provided confidential information about in the Look Back Period; (iii) knowingly causes or attempt to cause a customer, vendor, supplier, or referral source that Participant dealt with or gained knowledge of during employment to end or reduce business activities with the Corporation; or, (iv) for the benefit of a Competitor, solicits an employee of the Corporation that Participant worked with or was provided Confidential Information about in the Look Back Period to leave the employment of the Corporation, or assists a Competitor in hiring away any such employee of the Corporation. If Participant is offered a position with a Competitor while employed with the Corporation or within the twelve (12) month period immediately following termination of his or her employment, Participant shall provide written notice to the Corporation’s General Counsel, including adequate information about Participant’s new position to determine whether such position would likely lead to a violation of this Agreement and shall meet with the General Counsel or the General Counsel’s designee, if requested to do so, to try and resolve any disputes between the parties before beginning work in the new position.
As used above, a “Competitor” refers to any person or entity engaged in a business that provides products or services that would compete with or displace those of the Corporation. This is understood to include, by way of illustration and without limitation, any person or entity in the business of providing consumer, financial, and
- 9 -




property data, analytics, and services to the real estate, property, mortgage, insurance, and financial services industries and government. The restrictions above are geographically limited in that they apply to activities that occur within or relate to the state where Participant resides and each additional state (or state-equivalent) within the United States and any other country where the Corporation does business or has demonstrable plans to do business as of the date of Participant’s Termination. The restrictions apply to activities undertaken by Participant on behalf of (or for the benefit of) a Competitor whether as owner, partner, participant of a joint venture, trustee, proprietor, stockholder, member, manager, director, officer, employee, independent contractor, capital investor, lender, consultant, advisor or otherwise. However, nothing in this Section 8 prohibits general advertising of a generic nature, such as “want ads” that are not targeted at the Corporation’s employees, or passive ownership of less than five percent (5%) of the equity securities of a publicly-traded company.
(d)    The avoidance of Detrimental Activities is a precondition to Participant’s entitlement to receive and retain the Performance-Based RSUs awarded through this Agreement. Accordingly, unless otherwise prohibited from doing so by law, if Participant engages in Detrimental Activities the Corporation may cancel any outstanding awards and recover from Participant the Performance-Based RSUs or their Fair Market Value at the time received by Participant (less taxes paid by Participant); provided, however, that the foregoing right of recovery shall expire three years after the Performance Period identified in the Notice of Performance-Based Restricted Stock Unit Grant. The foregoing shall be in addition to, and not in lieu of, the Corporation’s right to pursue and secure injunctive relief and/or an order of specific performance to enforce Participant’s agreement not to engage in Unfair Competition, and thereby prevent the irreparable harm to the Corporation that Participant acknowledges would occur if Participant engages in Unfair Competition.
(e)    A material purpose of this Agreement is to fully and finally resolve what is fair and reasonable to consider Unfair Competition. For this reason, Participant agrees not to pursue any legal claim or argument that the restrictions against Unfair Competition provided for in this Agreement are unreasonable or unenforceable as written. In the event the Unfair Competition restrictions are challenged and found unreasonable or unenforceable in any respect deemed material by the Corporation, the Corporation shall have the right to exercise an option to demand and receive the return to it of all Performance-Based RSUs, or their Fair Market Value at the time received by Participant (less taxes paid by Participant), within thirty days of demand for repayment by the Corporation.
(f)    Nothing in this Agreement prohibits Participant from reporting possible violations of federal law or regulation to any governmental agency or entity, or making other disclosures that are protected under the whistleblower provisions of federal law or regulation. Participant does not need any prior authorization to make any such reports or disclosures and is not required to notify the Corporation of such reports or disclosures.
9.No Right to Continued Employment.
None of the Performance-Based RSUs nor any terms contained in this Agreement shall confer upon the Participant any express or implied right to be retained in the employ of the Corporation or any Subsidiary or Affiliate for any period, nor restrict in any way the right of the Corporation or any Subsidiary or any Affiliate, which right is hereby expressly reserved, to terminate the Participant’s employment at any time for any reason. For the avoidance of doubt, this Section 9 is not intended to amend or modify any other agreement, including any employment agreement that may be in existence between the Participant and the Corporation or any Subsidiary or Affiliate.
10.The Plan.
In consideration for this grant, the Participant agrees to comply with the terms of the Plan and this Agreement. This Agreement is subject to all the terms, provisions and conditions of the Plan, which are incorporated herein by reference, and to such regulations as may from time to time be adopted by the Administrator. In the event of any conflict between the provisions of the Plan and this Agreement, the provisions of the Plan shall control, and this Agreement shall be deemed to be modified accordingly, provided that the provisions of Section 4, Section 5 and Section 6 of this Agreement shall control over any conflicting payment provisions of the Plan. The
- 10 -




Plan and the prospectus describing the Plan can be found on Fidelity NetBenefits® at www.netbenefits.com under Plan Information and Documents. A paper copy of the Plan and the prospectus shall be provided to the Participant upon the Participant’s written request to the Corporation at CoreLogic, Inc., 40 Pacifica, Suite 900, Irvine, California 92618, Attention: Incentive Compensation Plan Administrator, or such other address as the Corporation may from time to time specify.
11.Compliance with Laws and Regulations.
(a)    The Performance-Based RSUs and the obligation of the Corporation to sell and deliver Shares hereunder shall be subject in all respects to (i) all applicable Federal and state laws, rules and regulations and (ii) any registration, qualification, approvals or other requirements imposed by any government or regulatory agency or body which the Administrator shall, in its discretion, determine to be necessary or applicable. Moreover, the Corporation shall not deliver any certificates for Shares to the Participant or any other person pursuant to this Agreement if doing so would be contrary to applicable law. If at any time the Corporation determines, in its discretion, that the listing, registration or qualification of Shares upon any national securities exchange or under any state or Federal law, or the consent or approval of any governmental regulatory body, is necessary or desirable, the Corporation shall not be required to deliver any certificates for Shares to the Participant or any other person pursuant to this Agreement unless and until such listing, registration, qualification, consent or approval has been effected or obtained, or otherwise provided for, free of any conditions not acceptable to the Corporation.
(b)    It is intended that the Shares received in respect of the Performance-Based RSUs shall have been registered under the Securities Act. If the Participant is an “affiliate” of the Corporation, as that term is defined in Rule 144 under the Securities Act (“Rule 144”), the Participant may not sell the Shares received except in compliance with Rule 144. Certificates representing Shares issued to an “affiliate” of the Corporation may bear a legend setting forth such restrictions on the disposition or transfer of the Shares as the Corporation deems appropriate to comply with Federal and state securities laws.
(c)    If, at any time, the Shares are not registered under the Securities Act, and/or there is no current prospectus in effect under the Securities Act with respect to the Shares, the Participant shall execute, prior to the delivery of any Shares to the Participant by the Corporation pursuant to this Agreement, an agreement (in such form as the Corporation may specify) in which the Participant represents and warrants that the Participant is purchasing or acquiring the Shares acquired under this Agreement for the Participant's own account, for investment only and not with a view to the resale or distribution thereof, and represents and agrees that any subsequent offer for sale or distribution of any kind of such Shares shall be made only pursuant to either (i) a registration statement on an appropriate form under the Securities Act, which registration statement has become effective and is current with regard to the Shares being offered or sold, or (ii) a specific exemption from the registration requirements of the Securities Act, but in claiming such exemption the Participant shall, prior to any offer for sale of such Shares, obtain a prior favorable written opinion, in form and substance satisfactory to the Corporation, from counsel for or approved by the Corporation, as to the applicability of such exemption thereto.
12.Notices.
All notices by the Participant or the Participant’s assignees shall be addressed to CoreLogic, Inc., 40 Pacifica, Suite 900, Irvine, California 92618, Attention: Incentive Compensation Plan Administrator, or such other address as the Corporation may from time to time specify. All notices to the Participant shall be addressed to the Participant at the Participant’s address in the Corporation's records.
13.Severability.
            In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of this Agreement, and this Agreement shall be construed and enforced as if the illegal or invalid provision had not been included, except where this Agreement expressly provides to the contrary. In the event a restriction on Participant contained in this Agreement is deemed unenforceable because it is unreasonable or overbroad in time, scope, or geography, an enforcing court shall enforce
- 11 -




the restriction to such lesser extent as would be reasonable and enforceable (and/or reform the restriction as necessary to do so), and shall not refuse to enforce the restriction in its entirety.
14.Other Plans.
The Participant acknowledges that any income derived from the Performance-Based RSUs shall not affect the Participant’s participation in, or benefits under, any other benefit plan or other contract or arrangement maintained by the Corporation or any Subsidiary or Affiliate. Performance-Based RSUs and Dividend Equivalents shall not be deemed to be “Covered Compensation” under any other benefit plan of the Corporation.

15.    Adjustments.

    The Performance-Based RSUs and the Shares underlying the Performance-Based RSUs shall be subject to adjustment and conversion pursuant to the terms of Section 7.1 of the Plan.

16.    Tax Withholding.

    Any payment or delivery of Shares pursuant to this Agreement shall be subject to the Corporation’s rights to withhold applicable Federal, state, local and non-United States taxes in accordance with Section 8.5 of the Plan.

17.    Section 409A.

            The provisions of this Agreement shall be construed and interpreted to comply with Section 409A of the Code so as to avoid the imposition of any penalties, taxes or interest thereunder. Notwithstanding any provision of Section 6 of this Agreement to the contrary, if the Participant is a “specified employee” as defined in Section 409A of the Code, the Participant shall not be entitled to any payment of Shares underlying Performance-Based RSUs that are considered deferred compensation subject to the requirements of Section 409A of the Code in connection with the Participant’s separation from service until the earlier of (a) the date which is six months after the Participant’s separation from service for any reason other than the Participant’s death, or (b) the date of the Participant’s death. Any Shares underlying the Performance-Based RSUs otherwise payable to the Participant following the Participant’s separation from service that are not so paid by reason of this Section 17 shall be paid as soon as reasonably practicable (but in no event later than 74 days) after the date that is six months after the Participant’s separation from service (or, if earlier, the date of the Participant’s death). The provisions of this Section 17 shall only apply if, and to the extent, required to comply with Section 409A of the Code.

18.    Clawback.

    The Performance-Based RSUs are subject to the terms of the Corporation’s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of the Performance-Based RSUs or any Shares or other cash or property received with respect to the Performance-Based RSUs (including any value received from a disposition of the Shares acquired upon payment of the Performance-Based RSUs).

- 12 -







    CORELOGIC, INC.

    
    By:______________________________
     Name: Frank Martell
     Title: President and Chief Executive Officer

    Date: [Grant Date]


Acknowledged and agreed as of the Date of Grant:



Printed Name:    [Participant Name]


Date:    [Acceptance Date]


NOTE: GRANT WILL BE ACCEPTED ELECTRONICALLY

- 13 -




APPENDIX A

Certain Definitions

Adjusted EPS” for a Performance Year or for the cumulative Performance Period, as applicable, means, subject to the adjustments set forth in the Grant Notice, (1) the Corporation’s adjusted pre-tax income from continuing operations for the Performance Year or cumulative Performance Period, plus the Corporation’s pre-tax equity earnings from affiliates for the Performance Year or cumulative Performance Period, tax effected at the Corporation’s annual planning rate and determined on a consolidated basis, divided by (2) the weighted average number of shares of the Corporation’s Common Stock outstanding over the Performance Year or cumulative Performance Period, as applicable.

Affiliate” means any entity other than the Corporation and any Subsidiary that is affiliated with the Corporation through stock or equity ownership or otherwise and is designated as an Affiliate for purposes of the Plan by the Administrator.

Beginning Price” means, with respect to the Corporation and any other Corporation Peer Group member, the closing market price of such company’s common stock on the principal exchange on which such stock is traded on the last trading day before the beginning of the applicable measurement period (the relevant Performance Year or cumulative Performance Period). 
Cause” has the same meaning as in the Participant’s Change in Control Agreement (if any) or if the Participant is not a party to a Change in Control Agreement, in the Participant’s employment agreement with the Corporation, a Subsidiary or an Affiliate (if any) as in effect at the time of the Participant’s Termination, or if the Participant is not a party to such an employment agreement (or is not a party to such an employment agreement that contains a definition of “cause”), “Cause” means: (i) embezzlement, theft or misappropriation by the Participant of any property of any of the Corporation or its Affiliates; (ii) the Participant’s breach of any fiduciary duty to the Corporation or its Affiliates; (iii) the Participant’s failure or refusal to comply with laws or regulations applicable to the Corporation or its Affiliates and their businesses or the policies of the Corporation and its Affiliates governing the conduct of its employees or directors; (iv) the Participant’s gross incompetence in the performance of the Participant’s job duties; (v) commission by the Participant of a felony or of any crime involving moral turpitude, fraud or misrepresentation; (vi) the failure of the Participant to perform duties consistent with a commercially reasonable standard of care; (vii) the Participant’s failure or refusal to perform the Participant’s job duties or to perform specific directives of the Participant’s supervisor or designee, or the senior officers or Board of Directors of the Corporation; or (viii) any gross negligence or willful misconduct of the Participant resulting in loss to the Corporation or its Affiliates, or damage to the reputation of the Corporation or its Affiliates.
Change in Control” means the happening of any of the following after the date hereof:

(a)     The consummation of a merger or consolidation of the Corporation with or into another entity or any other corporate reorganization, if fifty percent (50%) or more of the combined voting power of the continuing or surviving entity’s securities outstanding immediately after such merger, consolidation, or other reorganization is owned by persons who were not stockholders of the Corporation immediately prior to such merger, consolidation, or other reorganization.
(b)     The sale, transfer, or other disposition of all or substantially all of the Corporation’s assets or the complete liquidation or dissolution of the Corporation.
(c)     A change in the composition of the Board occurring within a two (2) year period, as a result of which fewer than a majority of the directors are Incumbent Directors. “Incumbent Directors” shall mean directors who are directors of the Corporation immediately following the consummation of the transactions contemplated by the Separation and Distribution Agreement by and between the Corporation and the First American Financial Corporation dated June 1, 2010 (the “Separation Agreement”). “Incumbent
-14-



Directors” shall also include directors who are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such election or nomination, but shall not include an individual not otherwise an Incumbent Director whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Corporation.
(d)     Any transaction as a result of which any person or group is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934), directly or indirectly, of securities of the Corporation representing at least thirty percent (30%) of the total voting power of the Corporation’s then outstanding voting securities. For purposes of this paragraph, the term “person” shall have the same meaning as when used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, but shall exclude: (i) a trustee or other fiduciary holding securities under an employee benefit plan of the Corporation or of a Subsidiary of the Corporation; (ii) so long as a person does not thereafter increase such person’s beneficial ownership of the total voting power represented by the Corporation’s then outstanding voting securities, a person whose beneficial ownership of the total voting power represented by the Corporation’s then outstanding voting securities increases to thirty percent (30%) or more as a result of the acquisition of voting securities of the Corporation by the Corporation which reduces the number of such voting securities then outstanding; or (iii) so long as a person does not thereafter increase such person’s beneficial ownership of the total voting power represented by the Corporation’s then outstanding voting securities, a person that acquires directly from the Corporation securities of the Corporation representing at least thirty percent (30%) of the total voting power represented by the Corporation’s then outstanding voting securities.
A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Corporation’s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Corporation’s securities immediately before such transaction.
For the avoidance of doubt, the consummation of any or all of the transactions in the Separation Agreement is not considered a Change in Control for purposes of this Agreement.
Change in Control Agreement” means the Corporation’s form Change in Control Agreement entered into with certain executives of the Corporation.
Corporation Peer Group” means the Corporation and each of the following companies: Fidelity National Information Services, Inc., Fidelity National Financial, Inc., Realogy Holdings Corp., First American Financial Corp., Global Payments Inc., Equifax Inc., Gartner, Inc., Euronet Worldwide, Inc., FleetCor Technologies, Inc., Verisk Analytics, Inc., Mr. Cooper Group, Inc., Jack Henry & Associates, Inc., Radian Group, Inc., PennyMac Financial Services, Inc., Zillow Group, Inc., MGIC Investment Corp., Black Knight, Inc., Altisource Portfolio Solutions S.A., Fair Issac Corp. and CSG Systems International, Inc.
The Corporation Peer Group shall be subject to adjustment by the Administrator for changes that occur prior to the end of the Performance Year or Performance Period, as applicable, as follows: In the event of a merger or other business combination of two Corporation Peer Group members (including, without limitation, the acquisition of one Corporation Peer Group member, or all or substantially all of its assets, by another Corporation Peer Group member), the surviving, resulting or successor entity, as the case may be, shall continue to be treated as a member of the Corporation Peer Group, provided that the common stock (or similar equity security) of such entity is listed or traded on a national securities exchange as of the end of the applicable period. In the event that the common stock (or similar equity security) of a Corporation Peer Group member is otherwise not listed or traded on a national securities exchange at the end of the Performance Year or Performance Period, as applicable, such entity shall be excluded from the Corporation Peer Group.
Disability” means the inability to engage in any substantial gainful occupation to which the relevant individual is suited by education, training or experience, by reason of any medically determinable physical or mental impairment,
-15-



which condition can be expected to result in death or continues for a continuous period of not less than twelve (12) months.
Ending Price” means, with respect to the Corporation and any other Corporation Peer Group member, the closing market price of such company’s common stock on the principal exchange on which such stock is traded at the end of the applicable measurement period. 
Good Reason” has the same meaning as in the Participant’s Change in Control Agreement.
Termination” means the time when the Participant ceases the performance of services for the Corporation, any Affiliate or Subsidiary, as applicable, for any reason, with or without Cause, including a Termination by resignation with or without Good Reason, discharge, retirement, death or Disability, but excluding the following if in the circumstances the Termination would not constitute a “separation from service” within the meaning of Section 409A of the Code (a) a Termination where there is a simultaneous reemployment or continuing employment of the Participant by the Corporation, any Affiliate or Subsidiary, (b) at the discretion of the Administrator, a Termination that results in a temporary severance, and (c) at the discretion of the Administrator, a Termination of an employee of the Corporation that is immediately followed by the Participant’s service as a non-employee director of the Board.  Notwithstanding any other provisions of the Plan or this Agreement to the contrary, a Termination shall not be deemed to have occurred for purposes of any provision of the Plan or this Agreement providing for payment or distribution with respect to an award constituting deferred compensation subject to Code Section 409A upon or following a termination of employment or services unless such termination is also a “separation from service” within the meaning of Section 409A of the Code.
TSR” means total shareholder return and shall be determined with respect to the Corporation and any other Corporation Peer Group member by dividing (i) the sum of (A) the cumulative amount of dividends for the applicable measurement period, assuming dividend reinvestment, and (B) the difference between the company’s Beginning Price and Ending Price for the applicable Performance Year or Performance Period; by (ii) the company’s Beginning Price. Any non-cash distributions shall be ascribed such dollar value as may be determined by or at the direction of the Administrator.
TSR Percentile” means the percentile ranking of the Corporation’s TSR among the TSRs for the Corporation Peer Group members for the corresponding Performance Year or Performance Period, as applicable.

-16-


EXHIBIT 10.4

FORM OF CHANGE IN CONTROL AGREEMENT
This CHANGE IN CONTROL AGREEMENT is effective as of the _______th day of _________, 20__ (this “Agreement”), by and between CoreLogic, Inc., a Delaware corporation (the “Company”) and _______________ (the “Executive”).
W I T N E S S E T H:
WHEREAS, the Company and the Executive desire to enter into this Agreement on the terms and conditions set forth below to ensure that the Company will have the continued dedication of the Executive, notwithstanding the possibility, threat, or occurrence of a Change in Control (as defined below); and
WHEREAS, this Agreement supersedes and replaces any prior Change in Control Agreement between the Executive and the Company and its predecessors (the “Prior Change in Control Agreement”), and the Executive hereby confirms that he or she is not, and will not in the future become, entitled to any benefits under the Prior Change in Control Agreement.
NOW, THEREFORE, in consideration of the premises and mutual covenants set forth herein, it is hereby agreed by and between the parties as follows:
1.    Term of Agreement. This Agreement shall commence on the date hereof and shall continue through ____________, 20__ (the “Original Term”); provided, however, that on such date and on each December 31 thereafter, the Original Term of this Agreement shall automatically be extended for one (1) additional year (each, an “Extended Term”) unless, not later than the preceding January 1 either party shall have given notice that such party does not wish to extend the term of this Agreement beyond the Original Term and any Extended Term; and provided, further, that if a Change in Control (as defined in paragraph 3 below) shall have occurred during the Original Term or any Extended Term of this Agreement, the term of this Agreement shall continue for a period of twenty-four (24) calendar months beyond the calendar month in which such Change in Control occurs (the Original Term, each Extended Term, if any, and such twenty-four (24) month period, collectively, the “Term”).
2.    Employment After a Change in Control. If the Executive is in the employ of the Company (which for this purpose shall also include any subsidiary of the Company) on the date of a Change in Control, the Company hereby agrees to continue the Executive in its employ (and/or, in the case of any subsidiary of the Company, the employ of such subsidiary) for the period commencing on the date of the Change in Control and ending on the last day of the Term of this Agreement. During the period of employment described in the foregoing provision of this paragraph 2 (the “Employment Period”), the Executive shall hold such position with the Company (which for this purpose shall also include any subsidiary of the Company) and exercise such authority and perform such executive duties as are commensurate with the Executive’s position, authority, and duties immediately prior to the Change in Control. The Executive agrees that during the Employment Period the Executive shall devote full business time exclusively to the executive duties described herein and perform such duties faithfully and efficiently; provided,
1


however, that nothing in this Agreement shall prevent the Company from terminating the Executive’s employment (whether or not such termination of employment constitutes a Termination, but subject to the Company’s obligations pursuant to paragraphs 5 and 6 below) or prevent the Executive from voluntarily resigning from employment upon sixty (60) days written notice to the Company under circumstances which do not constitute a Termination (as defined below in paragraph 5).
3.    Change in Control. For purposes of this Agreement, a “Change in Control” means the happening of any of the following after the date hereof:
(a)    The consummation of a merger or consolidation of the Company with or into another entity or any other corporate reorganization, if fifty percent (50%) or more of the combined voting power of the continuing or surviving entity’s securities outstanding immediately after such merger, consolidation, or other reorganization is owned by persons who were not shareholders of the Company immediately prior to such merger, consolidation, or other reorganization.
(b)    The sale, transfer, or other disposition of all or substantially all of the Company’s assets or the complete liquidation or dissolution of the Company.
(c)    A change in the composition of the Board of Directors of the Company (the “Board”) occurring within a two (2) year period, as a result of which fewer than a majority of the directors are Incumbent Directors. “Incumbent Directors” shall mean directors who are directors of the Company immediately following the consummation of the transactions contemplated by the Separation and Distribution Agreement by and between the Company and the First American Financial Corporation dated June 1, 2010 (“Separation Agreement”). “Incumbent Directors” shall also include directors who are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such election or nomination, but shall not include an individual not otherwise an Incumbent Director whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Company.
(d)    Any transaction as a result of which any person or group is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934), directly or indirectly, of securities of the Company representing at least thirty percent (30%) of the total voting power of the Company’s then outstanding voting securities. For purposes of this paragraph, the term “person” shall have the same meaning as when used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, but shall exclude: (i) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or of a subsidiary of the Company; (ii) so long as a person does not thereafter increase such person’s beneficial ownership of the total voting power represented by the Company’s then outstanding voting securities, a person whose beneficial ownership of the total voting power represented by the Company’s then outstanding voting securities increases to thirty percent (30%) or more as a result of the acquisition of voting securities of the Company by the Company which reduces the number of such voting securities
2


then outstanding; or (iii) so long as a person does not thereafter increase such person’s beneficial ownership of the total voting power represented by the Company’s then outstanding voting securities, a person that acquires directly from the Company securities of the Company representing at least thirty percent (30%) of the total voting power represented by the Company’s then outstanding voting securities.
A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company’s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction.
For the avoidance of doubt, the consummation of any or all of the transactions in the Separation Agreement is not considered a Change in Control for purposes of this Agreement and no action taken that is reasonably related to the Separation Agreement and/or the establishment of the Company as an independent publicly traded company will be considered Good Reason (as defined below) for purposes of this Agreement.
4.    Compensation During the Employment Period. During the Employment Period, the Executive shall be compensated as follows:
(a)    The Executive shall receive an annual salary which is not less than his or her annual salary immediately prior to the Employment Period and shall be eligible to receive an increase in annual salary which is not materially less favorable to the Executive than increases in salary granted by the Company for executives with comparable duties;
(b)    The Executive shall be eligible to participate in short-term and long-term cash-based incentive compensation plans which, in the aggregate, provide bonus opportunities which are not materially less favorable to the Executive than the greater of: (i) the opportunities provided by the Company for executives with comparable duties; and (ii) the opportunities provided to the Executive under all such plans in which the Executive was participating prior to the Employment Period;
(c)    The Executive shall be eligible to participate in stock option, performance awards, restricted stock, and other equity-based incentive compensation plans on a basis not materially less favorable to the Executive than that applicable: (i) to the Executive immediately prior to the Employment Period; or (ii) to other executives of the Company with comparable duties; and
(d)    The Executive shall be eligible to receive employee benefits (including, but not limited to, tax-qualified and nonqualified savings plan benefits, medical insurance, disability income protection, life insurance coverage, and death benefits) which are not materially less favorable to the Executive than: (i) the employee benefits provided by the Company to executives with comparable duties; or (ii) the employee benefits to which the Executive would be entitled under the Company’s employee benefit plans as in effect immediately prior to the Employment Period.
3


5.    Termination. For purposes of this Agreement, the term “Termination” shall mean: (a) termination of the employment of the Executive during the Employment Period by the Company for any reason other than death, Disability (as defined below), or Cause (as defined below); or (b) termination of the employment of the Executive during the Employment Period by the Executive for Good Reason (as defined below).
Notwithstanding anything in this Agreement to the contrary, if: (a) the Executive’s employment is terminated within six (6) months prior to the actual occurrence of a Change in Control for reasons that would constitute a Termination if it had occurred following a Change in Control; (b) the Executive reasonably demonstrates that such termination (or Good Reason event) was at the request of a third party who had indicated an intention or had taken steps reasonably calculated to effect a Change in Control; and (c) a Change in Control involving such third party (or a party competing with such third party to effectuate a Change in Control) does occur, then for purposes of this Agreement, the date immediately prior to the date of such termination of employment or event constituting Good Reason shall be treated as a Change in Control and such termination shall be treated as a Termination. For purposes of determining the timing of payments and benefits to the Executive under this Agreement as a result of this paragraph, payment shall be made in the month following the month in which occurs the first date that the Change in Control constitutes a “change in the ownership” of the Company, a “change in the effective control” of the Company or a “change in the ownership of a substantial portion of the assets” of the Company (each as defined under Section 409A of the Internal Revenue Code and the regulations thereunder (the “Code”)). As a condition precedent to any payment of amounts or benefits pursuant to this paragraph, the Executive shall execute a general release agreement on substantially the same form attached to the employment agreement between the Executive and the Company within twenty one (21) days after the Change in Control (which shall not contain any non-solicitation, non-competition or other restrictive covenants), and such release agreement shall have not been revoked by the Executive pursuant to any revocation rights afforded by applicable law.
The date of the Executive’s Termination under this paragraph 5 shall be the date of the Executive’s “Separation from Service” (as defined under Section 409A of the Code).
For purposes of this Agreement, “Disability” means such physical or mental disability or infirmity of the Executive which, in the opinion of a competent physician, renders the Executive unable to perform properly his or her duties set forth in paragraph 2 of this Agreement, and as a result of which the Executive is unable to perform such duties for six (6) consecutive calendar months or for shorter periods aggregating one hundred eighty (180) business days in any twelve (12) month period. For purposes of this paragraph, a competent physician shall be a physician mutually agreed upon by the Executive and the Board. If a mutual agreement cannot be reached, the Executive shall designate a physician and the Board shall designate a physician and these two physicians shall select a third physician who shall be the “competent physician.”
For purposes of this Agreement, the term “Cause” means: (a) the willful and continued failure by the Executive to substantially perform the Executive’s duties with the Company (which for purposes of this paragraph shall also include subsidiaries of the Company) after
4


written notification by the Board; (b) the willful engaging by the Executive in conduct which is demonstrably injurious to the Company, monetarily or otherwise; or (c) the engaging by the Executive in egregious misconduct involving serious moral turpitude. For purposes of this Agreement, no act, or failure to act, on the Executive’s part shall be deemed “willful” unless done, or omitted to be done, by the Executive not in good faith and without reasonable belief that such action was in the best interest of the Company. Notwithstanding the foregoing, the Executive will not be deemed to have been terminated for Cause for purposes of this Agreement, unless (1) the Company has provided written notice to the Executive of the act(s) or circumstance(s) underlying the Company’s basis for terminating the Executive for Cause and (2) the Company has given the Executive thirty (30) days following the date such written notice is received by the Executive in which to reasonably cure such act(s) or circumstance(s) before the Company terminates the Executive for Cause.
For purposes of this Agreement, the term “Good Reason” means, without the Executive’s express written consent, the occurrence after a Change in Control of any of the following circumstances:
(a)    The assignment to the Executive by the Company of duties which, in the reasonable determination of the Executive, are a significant adverse alteration in the nature or status of the Executive’s position, responsibilities, duties, or conditions of employment from those in effect immediately prior to the occurrence of the Change in Control; or any other action by the Company that, in the reasonable determination of the Executive, results in a material diminution in the Executive’s position, authority, duties, or responsibilities from those in effect immediately prior to the occurrence of the Change in Control;
(b)    A reduction in the Executive’s annual base compensation as in effect on the occurrence of the Change in Control;
(c)    The relocation of the Company’s offices at which the Executive is principally employed immediately prior to the Change in Control (the “Principal Location”) to a location more than fifty (50) miles from such location or the Company’s requiring the Executive to be based anywhere other than the Principal Location, except for required travel on the Company’s business to an extent substantially consistent with the Executive’s business travel obligations prior to the Change in Control;
(d)    The Company’s failure to pay to the Executive any portion of the Executive’s compensation or to pay to the Executive any portion of an installment of deferred compensation under any deferred compensation program of the Company within ten (10) days of the date such compensation is due; or
(e)    The Company’s failure to continue in effect any material compensation or benefit plan or practice in which the Executive is eligible to participate on the occurrence of the Change in Control, unless an equitable arrangement (embodied in an ongoing substitute or alternative plan) has been made with respect to such plan or practice, or the Company’s failure to continue the Executive’s participation therein (or in such substitute
5


or alternative plan) on a basis not materially less favorable, both in terms of the amount of benefits provided and the level of the Executive’s participation relative to other participants, as existed at the time of the Change in Control.
6.    Severance Payments and Benefits. Subject to the provisions of paragraph 8 below, the Company shall pay the Executive as soon as practicable following any termination of employment: (1) the Executive’s base salary through and including the date of termination of employment and any bonus amounts which have become payable, to the extent either has not theretofore been paid; (2) accrued and unpaid vacation pay through and including the date of termination of employment; and (3) unreimbursed business expenses through and including the date of termination of employment. In addition, in the event the termination of employment is a Termination, in lieu of the amount otherwise payable under paragraph 4 above and subject to the provisions of paragraph 8 below, the Company shall:
(a)    Pay the Executive a lump-sum payment in cash in the month following the month in which the date of Termination occurs equal to the sum of:
(i)    Unless a greater amount is provided for under the Company’s annual incentive compensation plan, a pro rata portion of the Executive’s target annual cash bonus amount established for the fiscal year in which the date of Termination occurs under the Company’s annual incentive compensation plan, calculated by multiplying such target annual bonus amount by a fraction, the numerator of which is the number of days in the fiscal year in which the date of Termination occurs through and including the date of Termination, and the denominator of which is three hundred sixty-five (365);
(ii)    An amount equal to the product of the Applicable Multiple (as defined below) and the Executive’s annual salary in effect immediately prior to the date of Termination; and
(iii)    An amount equal to the product of the Applicable Multiple and the Executive’s Bonus Amount (as defined below);
(b)     Subject to the Executive’s (i) continued payment of the same percentage of the applicable premiums as the Executive was paying immediately prior to the date of Termination (or, if more favorable to the Executive, the percentage of the premiums the Executive was paying immediately prior to the Change in Control) and (ii) election to receive continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act or any applicable similar state law (“COBRA”), pay or reimburse the Executive for the Executive’s premiums charged to continue medical and dental coverage pursuant to COBRA for the Executive (and, if applicable, the Executive’s dependents), during the [eighteen (18); twenty-four (24); thirty-six (36)] month period commencing with continuation coverage for the month following the month in which the date of Termination occurs, provided, that if the Executive is not eligible to receive, or if the Company is not able to provide, continuation coverage under COBRA for any month during the continuation period, the Company shall pay the Executive a cash payment
6


equal to its portion of the applicable COBRA premiums on an after-tax basis (with such payment to be made in the same month for which the continuation coverage was otherwise to be provided) . Notwithstanding the foregoing provisions of this paragraph, in the event the Executive becomes reemployed with another employer and becomes eligible to receive medical and dental benefits from such employer during any month in the [eighteen (18); twenty-four (24); thirty-six (36)] month continuation period provided for by this paragraph, the Company shall have no obligation to pay, reimburse or otherwise provide the Executive with continuation coverage for any such month.
Notwithstanding the provisions of this paragraph 6, with respect to any payments or benefits which constitute a deferral of compensation subject to Section 409A of the Code and provided the Executive is a “Specified Employee” (as defined under Section 409A of the Code) as of the date of Termination, such payments and benefits shall not be paid to the Executive until the earlier of (i) the date which is six (6) months after the Executive’s Separation from Service for any reason other than death, or (ii) the date of the Executive’s death. Any amounts otherwise payable to the Executive upon or in the six (6) month period following the Executive’s Separation from Service that are not so paid by reason of this paragraph shall be paid (without interest) as soon as practicable (and in all events within ten (ten) business days) after the date that is six (6) months after the Executive’s Separation from Service (or, if earlier, as soon as practicable, and in all events within ten (10) business days, after the date of the Executive’s death).
    As a condition precedent to any Company obligation to the Executive pursuant to sections (a) and (b) of this paragraph 6, the Executive shall, upon or promptly following the date of Termination (and, in all events, within twenty one (21) days of), execute a general release agreement on substantially the same form attached to the employment agreement between the Executive and the Company, and such release agreement shall have not been revoked by the Executive pursuant to any revocation rights afforded by applicable law.
For purposes of this Agreement, the term “Applicable Multiple” means [three (3); two (2); one and one half (1.5)].
For purposes of this Agreement, the term “Bonus Amount” means the target annual cash bonus amount established for the fiscal year in which the date of Termination occurs under the Company’s applicable annual incentive compensation plan.
7.    Possible Limitation of Benefits. Notwithstanding anything contained in this Agreement to the contrary, if following a Change in Control, the tax imposed by Section 4999 of the Code or any similar or successor tax (the “Excise Tax”) applies to any payments, benefits and/or amounts received by the Executive pursuant to this Agreement or otherwise, including, without limitation, any acceleration of the vesting of outstanding stock options, restricted stock or performance shares (collectively, the “Total Payments”), then the Total Payments shall be reduced (but not below zero) so that the maximum amount of the Total Payments (after reduction) shall be one dollar ($1.00) less than the amount which would cause the Total Payments to be subject to the Excise Tax; provided that such reduction to the Total Payments shall be made only if the total after-tax benefit to the Executive is greater after giving effect to
7


such reduction than if no such reduction had been made. If such a reduction is required, the Company shall reduce or eliminate the Total Payments by first reducing or eliminating any cash payments under this Agreement, then by reducing or eliminating any accelerated vesting of stock options, then by reducing or eliminating any accelerated vesting of other equity awards, then by reducing or eliminating any other remaining Total Payments, in each case in reverse order beginning with the payments which are to be paid the farthest in time from the date of the transaction triggering the Excise Tax. The preceding provisions of this paragraph shall take precedence over the provisions of any other plan, arrangement or agreement governing the Executive’s rights and entitlements to any benefits or compensation.
8.    Withholding. All payments to the Executive under this Agreement will be subject to all applicable withholding of state and federal taxes.
9.    Arbitration of All Disputes. Any controversy or claim arising out of or relating to this Agreement or the breach thereof shall be settled by arbitration in Santa Ana, California, in accordance with the laws of the State of California or such other location mutually agreeable to the parties, by three (3) arbitrators appointed by the parties. If the parties cannot agree on the appointment of the arbitrators, one shall be appointed by the Company and one by the Executive and the third shall be appointed by the first two arbitrators. The arbitration shall be conducted in accordance with the rules of the American Arbitration Association, except with respect to the selection of arbitrators which shall be as provided in this paragraph 9. Judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction thereof. In the event that it shall be necessary or desirable, as determined by the Executive in his or her sole discretion, for the Executive to retain legal counsel or incur other costs and expenses in connection with interpretation or enforcement of his or her rights under this Agreement, the Company shall pay (or the Executive shall be entitled to recover from the Company, as the case may be) his or her reasonable attorneys’ fees and costs and expenses in connection with interpretation or enforcement of his or her rights (including the enforcement of any arbitration award in court). Payments shall be made to the Executive at the time such fees, costs, and expenses are incurred. If, however, the arbitrators shall determine that, under the circumstances, payment by the Company of all or a part of any such fees and costs and expenses would be unjust, the Executive shall repay such amounts to the Company in accordance with the order of the arbitrators. Any award of the arbitrators shall include interest at a rate or rates considered just under the circumstances by the arbitrators.
10.    Mitigation and Set-Off. The Executive shall not be required to mitigate the amount of any payment provided for in this Agreement by seeking other employment or otherwise. The Company shall not be entitled to set off against the amounts payable to the Executive under this Agreement any amounts owed to the Company by the Executive, any amounts earned by the Executive in other employment after termination of his employment with the Company, or any amounts which might have been earned by the Executive in other employment had he or she sought such other employment.
11.    Notices. Except as provided in paragraph 2, any notice of termination of the Executive’s employment by the Company or the Executive for any reason shall be upon no less
8


than ten (10) days’ and no greater than thirty (30) days’ advance written notice to the other party. Any notices, requests, demands, and other communications provided for by this Agreement shall be sufficient if in writing and if sent by registered or certified mail to the Executive at the last address he or she has filed in writing with the Company or, in the case of the Company, to the attention of the Chief Executive Officer of the Company, at its principal executive offices.
12.    Non-Alienation. The Executive shall not have any right to pledge, hypothecate, anticipate, or in any way create a lien upon any amounts provided under this Agreement; and no benefits payable hereunder shall be assignable in anticipation of payment either by voluntary or involuntary acts, or by operation of law. Nothing in this paragraph shall limit the Executive’s rights or powers to dispose of his or her property by will or limit any rights or powers which his or her executor or administrator would otherwise have.
13.    Governing Law. The provisions of this Agreement shall be construed in accordance with the laws of the State of California, without application of conflict of laws provisions thereunder.
14.    Amendment. This Agreement may not be amended, modified, waived, or terminated except by mutual agreement of the parties in writing.
15.    Heirs of the Executive. This Agreement shall inure to the benefit of and be enforceable by the Executive’s personal and legal representatives, executors, administrators, successors, heirs, distributees, devisees, and legatees. If the Executive should die while any amounts are still payable to the Executive hereunder, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to the Executive’s devisee, legatee, or other designee or, if there be no such designee, to the Executive’s estate.
16.    Successors to the Company. This Agreement shall be binding upon and inure to the benefit of the Company and any successor of the Company. The Company shall require: (i) any successor (whether direct or indirect, by purchase, merger, consolidation, or otherwise) to all or substantially all of the business and/or assets of the Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place; and (ii) the parent entity of any successor in such business combination to guarantee the performance of such successor hereunder. Failure of the Company to obtain such assumption and agreement (and, if applicable, such guarantee) prior to the effectiveness of any such succession shall be a breach of this Agreement and shall entitle the Executive to terminate his or her employment for Good Reason and receive the compensation and benefits provided for in paragraph 6. Unless expressly provided otherwise, the term “Company” as used herein shall mean the Company as defined in this Agreement and any successor to its business and/or assets as aforesaid.
17.    Reimbursements and In-Kind Benefits. To the extent that any reimbursements pursuant to this Agreement are taxable to the Executive, any reimbursement payment due to the Executive pursuant to this Agreement shall be paid to the Executive on or before the last day of the Executive’s taxable year following the taxable year in which the related expense was incurred. The in-kind benefits and reimbursements pursuant to this Agreement are not subject to
9


liquidation or exchange for another benefit and the amount of such in-kind benefits and reimbursements that the Executive receives in one taxable year shall not affect the amount of such in-kind benefits or reimbursements that the Executive receives in any other taxable year.
18.    Employment Status. Nothing herein contained shall be deemed to create an employment agreement between the Company and the Executive, providing for the employment of the Executive by the Company for any fixed period of time. The Executive’s employment with the Company is terminable at will by the Company or the Executive and each shall have the right to terminate the Executive’s employment with the Company at any time, with or without Cause, subject to: (a) the notice provisions of paragraphs 2, 5, and 11, (b) the Company’s obligation to provide severance payments as required by paragraph 6 and (c) the terms and conditions of any employment agreement between the Company and the Executive. Except as otherwise provided in paragraph 5 of this Agreement, upon a termination of the Executive’s employment prior to the date of a Change in Control, there shall be no further rights under this Agreement.
19.    Severability. In the event that any provision or portion of this Agreement shall be determined to be invalid or unenforceable for any reason, the remaining provisions of this Agreement shall be unaffected thereby and shall remain in full force and effect.
20.    Counterparts. This Agreement may be executed in two (2) or more counterparts, any one (1) of which shall be deemed the original without reference to the other.
21.    Entire Agreement. This Agreement contains the entire understanding of the parties hereto with respect to the subject matter contained herein and supersedes all prior agreements and understandings, oral and written, with respect thereto between the Executive and the Company and its predecessors (including, without limitation, any Prior Change in Control Agreement); provided, for the avoidance of doubt, that this Agreement does not supersede all or any portion (including, without limitation, any provision governing the effect of any change in control) of any benefit plan or compensation plan of the Company or any employment agreement, non-solicitation agreement, agreement governing the disclosure of confidential information or the ownership of developments or other intellectual property or any similar agreement to which the Executive is a party. The Executive hereby confirms that he or she is not, and will not in the future become, entitled to any benefits under any Prior Change in Control Agreement.
22.    Section 409A. This Agreement shall be construed and interpreted to comply with Section 409A of the Code so as to avoid any payment of interest, penalties or taxes thereunder.
10


IN WITNESS WHEREOF, the Executive has hereunto set his or her hand and the Company has caused these presents to be executed in its name and on its behalf, all as of the day and year first above written.

“Executive”

Name:
Title:
CORELOGIC, INC.
Name:
Title:

    

11

EXHIBIT 10.5
CoreLogic, Inc.

___________, 2020

[FULL NAME]
CoreLogic, Inc.
40 Pacifica
Irvine, California, 92618

Dear [FIRST NAME]:

You are party to that certain Change in Control Agreement with CoreLogic, Inc. (the “Company”), dated __________ and as amended from time to time (the “CIC Agreement”), as well as an Employment Agreement with the Company, dated __________ and as amended from time to time (the “Employment Agreement”). The Company has approved the following amendments to the terms of your CIC Agreement. Capitalized terms used in this letter without definition shall have the same meaning as in the CIC Agreement.

The CIC Agreement is amended to provide that prior to the Company being able to terminate your employment for Cause, the Company must provide written notice to you of the act(s) or circumstance(s) underlying the Company’s basis for terminating your employment for Cause, and you shall have thirty days from the date such written notice is received by you to cure such act(s) or circumstance(s) giving rise to the Company’s basis to terminate your employment for Cause before the Company may terminate you for Cause.

The CIC Agreement is amended so that the form of release agreement that is required to be executed by you in order for you to receive severance benefits under the CIC Agreement upon your qualifying termination of employment shall be in the form attached to your Employment Agreement.

Except as provided in this letter, the CIC Agreement and the Employment Agreement will continue in effect in accordance with their respective terms. By executing this letter, you hereby agree to the amendments described above. This letter may not be amended other than by a written agreement executed by both you and the Company. This letter may be executed by you and the Company in any number of counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same agreement. Photographic copies of such signed counterparts may be used in lieu of the originals for any purpose.

***
                        
                        

                        




EXHIBIT 10.5
CORELOGIC, INC.

                        
                        By:_________________________________
                         Name:
                         Title:
                    


ACCEPTED AND AGREED:

________________________                



EXHIBIT 10.6
CoreLogic, Inc.

Amendment to Executive Supplemental Benefit Plan and Management Supplemental Benefit Plan (collectively, the “Supplemental Benefit Plans”)

On September 3, 2020, CoreLogic, Inc. (the “Company”) approved the following amendments to the Supplemental Benefit Plans.

Prior to the Company being able to terminate a participant’s employment for Good Cause, the Company must provide written notice to the participant of the act(s) or circumstance(s) underlying the Company’s basis for terminating the participant for Good Cause, and the participant shall have thirty days from the date such written notice is received to cure such act(s) or circumstance(s) giving rise to the Company’s basis to terminate the participant for Good Cause before the Company may terminate the participant for Good Cause.

The form of separation agreement that is required to be executed by a participant in order for the participant to receive his or her payment of benefits under the Supplemental Benefit Plans shall be in the form attached to the participant’s employment agreement in effect with the Company (or if the participant is not party to an employment agreement with the Company, in the form attached to the most recently executed executive employment agreement entered into prior to a Change of Control).

Except as amended hereby, the Supplemental Benefit Plans will continue in effect in accordance with their respective terms.

***
                    



Exhibit 31.1

CERTIFICATIONS

I, Frank D. Martell, certify that:

1.I have reviewed this quarterly report on Form 10-Q of CoreLogic, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 3, 2020
 
By: /s/  Frank D. Martell
Frank D. Martell
President and Chief Executive Officer
(Principal Executive Officer)


Exhibit 31.2

CERTIFICATIONS

I, James L. Balas, certify that:

1.I have reviewed this quarterly report on Form 10-Q of CoreLogic, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 3, 2020
 
By: /s/ James L. Balas
James L. Balas
Chief Financial Officer
(Principal Financial Officer)


Exhibit 32.1

Certification pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report on Form 10-Q of CoreLogic, Inc. (the “Company”) for the period ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Frank D. Martell, President, Chief Executive Officer and Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

  
  By: /s/   Frank D. Martell
  Frank D. Martell
  President and Chief Executive Officer
(Principal Executive Officer)
  Date: November 3, 2020

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. §1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.



Exhibit 32.2

Certification pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report on Form 10-Q of CoreLogic, Inc. (the “Company”) for the period ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James L. Balas, Chief Financial Officer and Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
  By: /s/ James L. Balas
  James L. Balas
  Chief Financial Officer
(Principal Financial Officer)
  Date: November 3, 2020

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. §1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.